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Modulation of ASIC1a Function by Sigma-1 Receptors: Physiological  
and Pathophysiological Implications 
 
 
Yelenis Herrera 
 
 
ABSTRACT 
 
 
Acid-sensing ion channels (ASIC) are a class of ligand gated plasma 
membrane ion channels that are activated by low extracellular pH. During 
ischemia, ASIC1a are activated and contribute to the demise of neurons. 
Pharmacological block of ASIC1a provides neuroprotection at delayed time 
points. However, no endogenous receptors have been implicated in the 
modulation of ASIC1a activity. The hypothesis presented is that sigma 
receptor activation inhibits ASIC1a function and ASIC1a-induced [Ca2+]i 
elevations during acidosis and ischemia, which may be a mechanism by 
which sigma ligands provide neuroprotection following stroke. This 
hypothesis is based on the following observations: First, sigma (σ) receptors 
regulate multiple ion channels that become activated during ischemia. Second, 
ASIC1a remain functionally active hours beyond the ischemic insult and σ 
receptors have been shown to be neuroprotective at delayed time points 
following stroke.  
Ratiometric Ca2+ fluorometry and whole-cell patch clamp experiments 
showed that σ-1 receptor activation depresses elevations in [Ca2+]i and 
 viii
membrane currents mediated by ASIC1a channels in cortical neurons. 
Furthermore, most of the elevations in [Ca2+]i  triggered by acidosis are the result 
of Ca2+ channels opening downstream of ASIC1a activation. Stimulation of σ-1 
receptors effectively suppressed these secondary Ca2+ fluxes both by inhibiting 
ASIC1a and the other channels directly.  
The signaling cascade linking σ-1 receptors and ASIC1a was determined 
to involve a pertussis toxin-sensitive G protein and A-Kinase Anchoring Protein 
150/calcineurin complex, which resulted in a decrease of acid-induced [Ca2+]i 
elevations and ASIC1a-mediated currents. Furthermore, immunohistochemical 
studies confirmed that σ-1 receptors, ASIC1a and AKAP150 colocalize in the 
plasma membrane of cortical neuron cell bodies and in the dendritic processes of 
these cells.  
Additionally, concurrent exposure to acidosis and ischemia resulted in 
synergistic potentiation of [Ca2+]i dysregulation. Although ASIC1a activation does 
not induce long-lived priming of synaptic vesicles for release, channel activation 
does have a temporal effect on ischemia-mediated [Ca2+]i increases after 
ischemia onset. Moreover, presynaptic ASIC1a channels promote synaptic 
transmission during ischemia by overcoming block of neurotransmission and thus 
enhance postsynaptic [Ca2+]i elevations. σ -1 receptor actvation decreased 
ischemia-mediated Ca2+ dysregulation at pH values of 7.4 - 6.0 and prevented 
the synergistic interaction between ischemia and acidosis. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
Significance 
 
 
ASIC are proton activated ion channels expressed in the brain and are 
involved in several physiological functions including neurotransmission and 
excitability. ASIC are also activated during pathological conditions, like stroke, 
resulting in Ca2+ dysregulation and eventually neurodegeneration. Furthermore, 
regulation of ASIC function would result in neuroprotection. σ receptors are 
known to regulate multiple ion channels in neurons, all of which are activated 
during ischemia. Taken together, these observations demonstrate the importance 
of studying the regulation of ASIC function by σ receptors under physiological as 
well as during ischemic conditions and to determine the signaling cascade 
involved. Results from this study will identify potential therapeutic targets for the 
treatment of stroke.  
 
Background 
 
Stroke is the third leading cause of death in the industrialized world behind 
heart disease and cancer, and the major cause of long-term disability. Stroke is a 
sudden interruption in the blood supply to the brain. Ischemic (embolic) stroke is 
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the most common type of stroke, accounting for almost 88% of all strokes, and is 
caused by a clot or other blockage within a cerebral artery. Following a stroke, 
there are two major regions of injury within the ischemic cerebrovascular bed: the 
core ischemic region and the ischemic penumbra region (Dirnagl et al., 1999). 
Within minutes of the ischemic insult, the core area forms. The core region is an 
area characterized by reduced blood flow, leading to a loss of adequate supply of 
oxygen and glucose resulting in rapid depletion of cellular energy 
stores. Ischemia results in neuronal death and supporting cellular elements such 
as glial cells by necrosis (characterized by cell swelling, cell rupture and 
activation of inflammatory response) within the severely ischemic core area 
(Dirnagl et al., 1999).  
The penumbra region is an area that is generally defined to be ischemic 
but still containing viable cerebral tissue. Brain cells within the penumbra, a rim of 
compromised ischemic tissue lying between tissue that is normally perfused and 
the area in which infarction is evolving, may remain viable for several days 
(Dirnagl et al., 1999; Lo et al., 2004). The penumbral region is supplied with 
blood by collateral arteries. However, even cells in this region will die if 
reperfusion is not established in a timely manner since collateral circulation is 
inadequate to maintain the neuronal demand for oxygen and glucose indefinitely. 
As time goes by, hours and days after the insult, apoptosis in the penumbra 
results in cell death and expansion of the core (Dirnagl et al., 1999; Lo et al., 
2005). Most of research taking place today focuses on the prevention of the 
apoptotic death that occurs within the penumbra region. This may be achieved by 
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restoring blood flow to the penumbral zone and/or by disrupting several pathways 
that are activated resulting in neuronal death. 
The thrombolytic agent, tissue plasminogen activator (tPA), is the only 
drug approved for clinical treatment of acute stroke. tPA cleaves the precursor 
molecule plasminogen producing the active enzyme plasmin, which in turn 
dissolves blood clots. Thus, tPA is not a neuroprotective drug. The limitations of 
tPA arise from the high risk of intracranial hemorrhage associated with its use, 
and the short therapeutic window in which it must be administered (≤ 3 hours) 
(Dirnagl et al., 1999). Additionally, tPA can not be administered to hemorrhagic 
stroke patients or patients with either hypertension or diabetes. Therefore, there 
is only a very small percentage of people (~ 3%) that are candidates for this drug. 
The significant inadequacy of current acute stroke therapy has increased the 
demand for the development of alternative drugs to improve outcome following 
stroke injury.  
A major component of current stroke research focuses on excitotoxicity 
and less is known about acidotoxicity or the interaction of ASIC1a channel 
activation and ischemia. Currently, there are no drugs that directly enhance 
neuronal survival approved for clinical use. Furthermore, drugs that have 
targeted a single component in the pathobiology cascade of stroke (e.g. NMDA 
receptors, glutamate receptors and voltage-gated Ca2+ channels) have failed in 
clinical trials.  
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Pathobiology of Stroke 
To better understand neurodegeneration during ischemia, it is important to 
analyze the pathobiology of stroke. Ischemia is a restriction of blood flow to the 
brain triggering a series of events that lead to necrotic neuronal death in the 
affected infarct area (core region) and delayed apoptotic neuronal death in the 
penumbra.  Brain ischemia is associated with glucose and oxygen deprivation, 
and a cellular switch to anaerobic glycolysis that results in energy failure (Figure 
1.1). The accumulation of lactic acid produced by anaerobic glycolysis leads to 
acidosis in the ischemic region, and acidotoxicity eventually results in cell death 
(Xiong et al., 2004; Yermolaieva et al., 2004). Dysregulation of intracellular 
calcium (Ca2+) triggers various events that also result in cell death (Figure 1.1). 
Loss of adenosine triphosphate (ATP) production results in membrane 
dysfunction and a rapid depolarization of neurons promotes Ca2+ entry, which in 
turn evokes the release of neurotransmitters, such as glutamate (Figure 1.1). 
Glutamate, acting via postsynaptic receptors, elicits depolarization of the neurons 
and further elevations in intracellular Ca2+ (Figure 1.1). At the same time, the 
depletion of ATP blocks the reuptake of glutamate, which leads to an 
accumulation of glutamate at synaptic and extrasynaptic sites. Accumulation of 
glutamate in the extracellular space leads to over-stimulation of N-methyl-D-
aspartate (NMDA) receptors resulting in Ca2+ overload. This becomes a vicious 
cycle that leads to ion fluxes into the cell via the activation of Cl-, Na+, Ca2+ and 
K+ channels (Tanaka et al., 1997). The accumulation of extracellular K+ allows 
surrounding neurons to depolarize, whereas the buildup of intracellular Na+ 
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results in cell swelling, or oedema (Figure 1.1). Intracellular Ca2+ dysregulation 
promotes neuronal death by disrupting plasma membrane function via activation 
of Ca2+-sensitive ion channels (Murai et al., 1997), and by triggering biochemical 
cascades that lead to proteolysis, lipolysis, and the production of reactive oxygen 
species (Mattson, 2000) (Figure 1.1). Ca2+ overload and energy depletion leads 
to activation of secondary events including release of inflammatory mediators, 
expression of pro-apoptotic genes, all of which result in cell death and 
subsequent expansion of the core (Figure 1.1). 
Though not depicted in Figure 1.1, cell death and expansion of the core 
region is also enhanced by inflammation caused by the immune response.  
Activated microglia and reactive astrocytes are capable of entering the central 
nervous system since the blood brain barrier is degraded (Stoll et al., 1998). 
These cells then exacerbate damage by activating proinflammatory mediators, 
releasing nitric oxide and glutamate (Heales et al., 1999; Hertz et al., 2001; Bal-
Price et al., 2002; Trendelenburg and Dirnagl, 2005). All these events are also 
detrimental to the neurons and result in subsequent expansion of the core.  
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Figure 1.1 - Pathobiology of ischemic stroke. Intracellular calcium plays a critical 
role during ischemia. Ischemia leads to acidosis and acidotoxicity in the ischemic 
region, which results in further increases in [Ca2+]i. Calcium dysregulation 
ultimately leads to the activation of all these events that result in cell death and 
subsequent expansion of the core region. 
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Acid-Sensing Ion Channels (ASIC) 
Recently, the acid-sensing ion channel has been shown to be a major 
contributor to ischemic injury in the central nervous system. Physiological 
extracellular and intracellular pH is maintained at ~ 7.3 and 7.0 through various 
proton transporting mechanisms. Under pathological conditions, like stroke, the 
metabolic switch to anaerobic glycolysis produces lactic acid leading to a drop in 
pH and acidotoxicity in the ischemic region. During ischemia, the pH can drop to 
as low as 6.0 (Nedergaard et al., 1991). More recent studies imaging brains in 
rats post-MCAO and patients with cortical ischemic stroke symptoms show that 
lactate accumulations remain elevated for 3-5 days (Weinstein et al., 2004; 
Munoz Maniega et al., 2008). The decrease in pH is sufficient to trigger the 
opening of ASIC and consequently, permitting calcium influx into the neurons 
(Xiong et al., 2004). Both in vitro and in vivo studies have shown that 
acidotoxicity aggravates ischemic neuronal injury and a direct correlation has 
been shown between infarct size and brain acidosis (Xiong et al., 2004; 
Pignataro et al., 2007). Thus, activation of ASIC has now been unequivocally 
linked to brain injury resulting from ischemic stroke. It has been suggested that 
low tissue pH may lead to protein and nucleic acid denaturation, trigger cell 
swelling via activation of proton exchangers, lead to excitotoxicity by inhibiting 
astrocyte glutamate reuptake, and damage glial cells (see review (Xiong et al., 
2006)). In contrast, mild acidosis has been implicated to be beneficial due to 
NMDA receptor inhibition by extracellular low pH. Therefore, during ischemia, 
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other calcium influx pathways may exist independently of NMDA receptor 
function. 
ASIC are a class of ligand-gated ion channels that are members of the 
degenerin/epithelial sodium channel (Deg/ENac) superfamily (Benos and 
Stanton, 1999). ASIC are expressed in both peripheral and central nervous 
system neurons and become activated as a result of low extracellular pH caused 
by ischemia (Xiong et al., 2004; Yermolaieva et al., 2004). Four genes (ASIC1 – 
ASIC4) encoding for six ASIC subunits have been cloned, and four of those 
subunits can form functional homomultimeric or heteromultimeric channels that 
are activated by extracellular protons. Recent stoichiometric studies of the 
chicken ASIC1a subtype suggests that 3 subunits are required to form a 
functional channel (Jasti et al., 2007). The pH of half-maximal activation (pH0.5) of 
these channels and the tissue expression pattern differs between each subtype.  
Pertinent to ischemia, ASIC1a has a pH0.5 = 6.2, and is mainly expressed 
in the brain (Waldmann et al., 1997b; Alvarez de la Rosa et al., 2003). ASIC1a is 
a nonselective cation channel that is sodium and calcium permeable and 
generates fast activating and inactivating membrane currents (Waldmann et al., 
1997b; Chu et al., 2002; Xiong et al., 2004; Yermolaieva et al., 2004). ASIC1b, a 
splice variant of ASIC1a with a unique N-terminal, has a pH0.5 = 5.9 (Chen et al., 
1998) and is only expressed in sensory neurons (Chen et al., 1998; Bassler et 
al., 2001). ASIC2a is widely expressed in peripheral and central nervous system  
with a pH0.5 = 4.4 (Garcia-Anoveros et al., 1997; Lingueglia et al., 1997). ASIC2a 
channels generate slower activating and inactivating currents compared to the 
 10
ASIC1a subtype. ASIC3 has a pH0.5 = 6.5, and it is predominantly expressed in 
neurons of the dorsal root ganglia (Waldmann et al., 1997a), while ASIC4 is 
highly expressed in the pituitary gland but does not form functional channels on 
their own (Akopian et al., 2000; Grunder et al., 2000). It is been established that 
neither ASIC2b nor ASIC4 can form functional homomeric channels, but ASIC2b 
can associate with other subunits and modulate their activity, and thus 
biophysical properties of the channels. For example, studies of heteromeric 
ASIC1a/2a channels have shown that ASIC1a establishes the current amplitude, 
while ASIC2a influences desensitization, recovery from desensitization, and pH 
sensitivity of the channel (Askwith et al., 2004).  
ASIC contain two transmembrane domains flanked by a large cysteine-
rich extracellular loop and short intracellular N- and C- termini (Waldmann et al., 
1997b; Alvarez de la Rosa et al., 2000; Saugstad et al., 2004). In the peripheral 
nervous system, ASIC localize to neurons innervating skin, heart, gut, and 
muscle, and have also been detected in the eye, ear, taste buds, and bone (see 
review (Wemmie et al., 2006)). These channels are known to be involved in 
various processes such as mechanoreception (Price et al., 2000), taste 
transduction (Ugawa et al., 2003), maintenance of retinal integrity (Ettaiche et al., 
2004), and nociception (Allen and Attwell, 2002), particularly in the ischemic 
myocardium where ASIC are believed to transduce anginal pain (Benson et al., 
1999). 
ASIC1a have a wide spread distribution in the brain including 
hippocampus, cerebral cortex, cerebellum, striatum, habenula, amygdale, and 
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olfactory (Wemmie et al., 2002; Alvarez de la Rosa et al., 2003). The ASIC1a 
subtype have been localized to dendrites and dendritic spines, axons, and 
throughout neurons with no preferential distribution to synapses (Wemmie et al., 
2003). In the central nervous system, ASIC1a is involved in synaptic plasticity, 
fear conditioning, and learning and memory (Wemmie et al., 2002; Wemmie et 
al., 2003). It has been shown that loss of ASIC1a disrupted hippocampal-
dependent long term potentiation and spatial memory, impaired cerebellum-
dependent learning, and reduced fear response in the amygdala (freezing 
behavior) (Wemmie et al., 2003). Conversely, overexpression of ASIC1a in the 
amygdala and different regions of the brain leads to increased ASIC1a currents 
and enhanced context of fear conditioning (anxiety) (Wemmie et al., 2004). 
ASIC1 and ASIC1 gene knockout studies have shown that this ion channel is 
calcium permeable and is involved in acidosis-mediated ischemic brain injury and 
neuronal death (Xiong et al., 2004; Yermolaieva et al., 2004; Pignataro et al., 
2007).  
ASIC also belong to the amiloride-sensitive superfamily and studies have 
shown that inhibition of ASIC by this nonspecific blocker leads to diminished 
[Ca2+]i elevations during acidosis. It has been shown that amiloride dose-
dependently blocked ASIC currents in mouse cortical neurons with an IC50 of 
16.4 µM (Xiong et al., 2004). It has also been demonstrated that amiloride and its 
derivatives benzamil and ethylisopropylamiloride (EIPA) reversibly blocked 
proton-activated inward ASIC currents in sensory neurons (Kd = 10 µM) 
(Waldmann et al., 1997b). Mutation studies have suggested that residues within 
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the pore and extracellular domain are critical for amiloride binding (Kleyman et 
al., 1999). This observation suggests that the sites that interact with amiloride 
within the channel’s extracellular domain may be in close proximity to residues 
within the channel’s pore region. Supporting the notion that amiloride blocks the 
outer pore of ASIC and Deg/ENac include the voltage dependence of block, kon 
increases, and koff decreases linearly at hyperpolarizing membrane voltages, 
and, therefore, indicates amiloride senses 20% of the membrane electrical field 
(Alvarez de la Rosa et al., 2000). Amiloride affinity for binding the mouth of the 
pore also decreases by increasing extracellular sodium concentrations, indicating 
a competitive mechanism for the pore binding between amiloride and its 
permeable cation (Alvarez de la Rosa et al., 2000).  
Studies with the venom of the South American tarantula Psalmopoeus 
cambridgei (psalmotoxin 1, PcTx1) have provided great insight about the role of 
ASIC1a during ischemia. PcTx1 is the first potent and specific blocker of ASIC1a 
(Escoubas et al., 2000; Pidoplichko and Dani, 2006; Diochot et al., 2007). It has 
been shown that PcTx1 blocks ASIC1a current in heterologous expression 
systems (IC50=0.9 nM) at pH 6.0 and also at pH 4 or 5 (10 nM PcTX1). In 
subpopulations of dorsal root ganglia neurons, the toxin is also effective at nM 
concentrations (Escoubas et al., 2000) as well as in mice cortical neurons (Xiong 
et al., 2004). In whole animal studies, administration of the venom (500 ng/ml) 
following middle cerebral artery occlusion (MCAO) produced a significant 
reduction in infarct size and volume (Xiong et al., 2004). It has been suggested 
that the mechanism by which PcTx1 inhibits ASIC1a channels is via chronic 
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desensitization of the channel caused by increased affinity of the channel for 
protons (Chen et al., 2005). Interestingly, this PcTx1-induced shift of the pH-
dependent inactivation of ASIC1a is Ca2+-dependent, where increasing 
extracellular Ca2+ results in a decrease of the PcTx1 inhibition. 
Acidosis occurs within minutes of stroke onset (mainly affecting the core 
region but also the inner penumbral zone) (Back et al., 2000) and ASIC1a remain 
functionally active beyond 4 hrs following the ischemic insult (Pignataro et al., 
2007). Additionally, pharmacological blockade of ASIC1a by amiloride or PcTx1 
and administration of PcTx1 even 5 hrs after middle cerebral artery occlusion 
(MCAO) diminishes stroke injury (Xiong et al., 2004; Pignataro et al., 2007). 
These observations are consistent with studies showing the presence of lactate 
72 hours following transient MCAO in rats (Weinstein et al., 2004). It remains to 
be elucidated whether endogenous receptors could regulate ASIC1a channel 
function. 
 
ASIC1a Channels, Calcineurin and Scaffolding Proteins 
Several extracellular and intracellular modulators of ASIC have been 
identified. It has been established that various divalent cations (Zn2+, Pb2+, Ca2+) 
(Baron et al., 2001; Chu et al., 2004; Gao et al., 2004; Wang et al., 2006), lactate 
(Immke and McCleskey, 2001), serine proteases (Poirot et al., 2004) and redox 
reagents (Andrey et al., 2005; Chu et al., 2006) may interact with the extracellular 
domain of ASIC and influence the function of the channels. Other investigators 
have shown that there is a conserved phosphorylation site within the intracellular 
 14
C-terminal domain of ASIC1a for calcium/calmodulin protein kinase II (CaMKII) 
(Gao et al., 2005), protein kinase C (Baron et al., 2002) and protein kinase A 
(PKA) (Leonard et al., 2003) to bind. However, phosphorylation of ASIC1a has 
been shown to potentiate ASIC1a function in neurons (Xiong et al., 2004; Gao et 
al., 2005).  
Calcineurin-dependent dephosphorylation of ASIC1a channels is the only 
modulator of ASIC1a that results in downregulation of channel function (Chai et 
al., 2007).  Calcineurin, a second messenger, is a serine/threonine phosphatase 
that is activated by calcium-calmodulin, and a heterodimer consisting of 2 
subunits, A and B (Shibasaki et al., 2002; Dodge and Scott, 2003). The 
calcineurin A subunit has 3 domains consisting of a catalytic domain, calmodulin-
binding domain, and an autoinhibitory domain. The regulatory subunit, 
calcineurin B subunit, encodes the calcium-binding domain. The 
immunosuppressive drugs, cyclosporine A and FK-506, are well known 
calcineurin inhibitors. Cyclosporine A-cyclophilin A and FK-506-FKBP form drug-
immunophilin complexes that bind to the calcineurin active site heterodimer to 
inhibit calcineurin activity competitively and thus, covering the catalytic groove 
(see review (Dumont, 2000; Shibasaki et al., 2002; Martinez-Martinez and 
Redondo, 2004)).  
Calcineurin, also known as PPB2, may exist as free calcineurin in the 
cytosol but some is also found bound to scaffolding protein A-kinase anchoring 
protein (AKAP). AKAP is a diverse protein family with more than 50 members 
which are abundantly expressed in the brain (Feliciello et al., 2001). Neuronal 
 15
AKAP150 (rat) and AKAP79 (human) share a high degree of sequence 
homology, differing primarily in a 9 amino acid repeat sequence insert found only 
in rodents which has no known function (Dell'Acqua et al., 2006). AKAP150 
anchors both kinases (cAMP-dependent Protein Kinase A and Protein Kinase C) 
and phosphotases (calcineurin) that are inhibited when bound. AKAP150 targets 
these proteins to specific subcellular sites through various targeting motifs 
(Dell'Acqua et al., 1998). AKAP150 has 2 domains: (1) a PKA-anchoring domain 
to interact with hydrophobic residues in the N-terminal of the RII dimmer, forming 
an amphipathic helix of residues, and (2) a targeting domain that anchors to the 
plasma membrane via phospholipids (phosphotidylinositol-4,5-biphosphate, 
PIP2) (see reviews (Dell'Acqua et al., 1998; Diviani and Scott, 2001)). Moreover, 
AKAP is regulated by calcium-calmodulin. 
AKAP150 has been shown to be involved in the regulation of receptor 
activity, localization, and synaptic structure during synapse formation during 
development, synaptic plasticity in learning and memory, and neuronal 
dysfunction and cell death under pathophysiological conditions (Dell'Acqua et al., 
2006). In addition to ASIC1a regulation, AKAP150 modulates internalization of 
AMPA and NMDA receptors during long term potentiation and depression 
(Rosenmund et al., 1994; Westphal et al., 1999; Colledge et al., 2000; Gomez et 
al., 2002; Smith et al., 2006) and voltage-gated Ca2+ channels function (Oliveria 
et al., 2007). All these proteins are possible constituents of the signaling cascade 
involving ASIC1a channels and σ receptors.  
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Sigma Receptors 
Sigma receptors have been shown to regulate multiple ion channel 
function in neurons. This observation raises the possibility that σ receptors could 
modulate ASIC1a function. σ receptors were discovered by Martin et al. in 1976, 
and were thought to be an opioid receptor (Martin et al., 1976). Further studies 
proved that opioid receptors have a high affinity for the (-) enantiomer of 
benzomorphans while σ receptors prefer to bind the (+) enantiomer. Moreover, in 
vitro and in vivo studies suggested that the opioid antagonists, naloxone or 
naltrexone, do not affect σ receptor-mediated events (Iwamoto, 1981; Brady et 
al., 1982; Slifer and Balster, 1983; Vaupel, 1983; Katz et al., 1985). Thus, σ 
receptors were then classified as their own unique receptor type.  
Two σ receptor subtypes have been identified on the basis of 
pharmacology. σ receptors have been shown to bind a range of substances 
including opiates, antipsychotics, antidepressants, phencyclidine (PCP)-related 
compounds, and neurosteroids (Walker et al., 1990; Bowen, 2000). σ-1 receptors 
have a higher affinity for the positive isomer of benzomorphans such as (+)-
pentazocine and (+)-SKF-10,047, and the σ-2 receptors have high affinity for 
ibogaine and its congeners (Bowen, 2000; Vilner and Bowen, 2000). σ ligands 
like 1,3-di-o-tolyguanidine (DTG) and haloperidol have been shown to be pan-
selective and bind to both σ receptor subtypes with high affinity. Evidence 
suggest that progesterone, neuropeptide Y, peptide YY, and zinc are possible 
endogenous σ ligands (Su et al., 1988; Roman et al., 1989; Connor and Chavkin, 
1992). 
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To date, only the σ-1 receptor has been cloned (Hanner et al., 1996). The 
structure of the σ-1 receptor subtype is thought to consist of 2 transmembrane-
spanning domains with internal C- and N-terminals (Aydar et al., 2002). While σ-
1 receptors do not posesses sequence homology to other mammalian proteins, it 
does have similar homology to fungal sterol isomerases (Hanner et al., 1996; 
Kekuda et al., 1996; Seth et al., 1998). The cDNA of σ-1 receptors encodes a 
protein of 223 amino acids with a molecular weight of 25 kDa. In humans, the σ-1 
receptor gene is located on chromosome 9p13, a region commonly associated 
with psychiatric disorders (Prasad et al., 1998). σ -1 receptors are found in the 
plasma membrane as well as in intracellular membranes like the endoplasmic 
reticulum (Hanner et al., 1996; Kekuda et al., 1996; Aydar et al., 2002).  
In contrast to σ-1 receptors, the molecular identity of σ-2 receptors 
remains to be determined. Reports suggest that a splice variant of σ-1 receptors 
displays σ-2 receptor binding activities (Monassier and Bousquet, 2002). 
However, studies with σ-1 receptor knockout mouse showed that σ-1 and σ-2 
receptors were not isoforms of the same protein because σ-2 effects were still 
seen in the absence of the σ-1 receptor subtype (Langa et al., 2003). Similar to 
σ-1 receptors, pharmacological experiments suggest that σ-2 receptors are 
located in the intracellular membrane of the endoplasmic reticulum and the 
mitochondria (Bowen, 2000). 
σ receptors are ubiquitously expressed in the immune system, the kidney 
and liver, as well as throughout the central nervous system (Wolfe and De 
Souza, 1993; Hellewell et al., 1994). Microglia activation is one of the main 
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contributors of the immune response in the brain. Under physiological conditions, 
microglia respond to substances released by degenerating neurons by migrating 
to the site of injury, phagocytosing debris and releasing proinflammatory 
mediators (Streit et al., 2004). However, under pathological conditions, activated 
microglia are thought to be detrimental since these cells contribute to the demise 
of compromised neurons, and thus, exacerbate neurodegeneration (Streit et al., 
2004). Therefore, the immune response plays a critical role in pathological 
conditions like stroke. Sigma receptor activation has been shown to inhibit 
multiple aspects of microglial activation in vitro, including the ability to rearrange 
the actin cytoskeleton, migrate, and release cytokine (Hall et al., 2008). 
Furthermore, in vivo studies also suggest that sigma receptor activation 
decreases reactive gliosis following stroke (Ajmo et al., 2006). 
In the central nervous system, σ receptors are found in brainstem areas 
that regulate motor function, limbic structures, some predominantly sensory 
areas, and areas associated with endocrine function (della Puppa and London, 
1989; Matsumoto et al., 1989; Matsumoto et al., 1990b; Walker et al., 1990; 
Elsinga et al., 2004). σ receptors have been implicated in numerous physiological 
and pathophysiological processes such as learning and memory (Senda et al., 
1996; Maurice and Privat, 1997), movement disorders (Matsumoto et al., 1990a), 
and drug addiction (McCracken et al., 1999a; McCracken et al., 1999b). These 
receptors are emerging as therapeutic targets for various diseases such 
neuropsychiatric disorders and cancer (Casellas et al., 2004; Hayashi and Su, 
2004).  
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σ -2 receptors have been shown to regulate sodium and calcium 
channels. σ receptor activation blocks several types of calcium channels 
including N-, T-, P/Q- and R-type in neonatal intracardiac (parasympathetic 
neurons) and superior cervical ganglia (sympathetic neurons) neurons, and also 
inhibits voltage-gated sodium channels (Zhang and Cuevas, 2002; Katnik et al., 
2006). Studies of mouse and rat hippocampal neurons have demonstrated that 
σ-2 ligands inhibit voltage-gated calcium channels while σ-1 selective agonists 
failed to show the same effect, indicating the inhibition is mediated via σ-2 
receptors (Fletcher et al., 1995).   
In contrast, σ-1 receptors regulate inositol 1,4,5-triphosphate (IP3) 
receptors and calcium signaling at the endoplasmic reticulum, mobilization of 
cytoskeletal adaptor proteins, modulation of nerve growth factor-induced neurite 
sprouting, modulation of neurotransmitter release and neuronal firing, and 
modulation of potassium channels as regulatory subunits (see review, (Su and 
Hayashi, 2003)). σ -1 agonists are known to cause amplification of signal 
transduction incurred upon activation of the glutamatergic, dopaminergic, IP3-
related metabotropic, or nerve growth factor-related systems (Su and Hayashi, 
2003). Immunohistochemistry studies have shown that σ-1 receptor, IP3 type-3 
receptor, and ankyrin B are colocalized in NG-108 cells in perinuclear areas and 
regions of cell-to-cell communication, suggesting that σ-1 ligands may play a role 
in cells by controlling the function of cytoskeleton proteins and regulating calcium 
signaling may represent a site of action for neurosteroids and cocaine (Hayashi 
and Su, 2001).  
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σ -1 receptors have been implicated in the regulation of various ion 
channels. σ -1 receptors are directly coupled to potassium channels in 
intracardiac neurons and activation of this receptor subtype depresses the 
excitability of these neurons, blocking parasympathetic input to the heart (Zhang 
and Cuevas, 2005). In cultured frog melanotrope cells, DTG and (+)-pentazocine 
have been shown to modulate electrical activity by reducing both a tonic K+ 
current and a voltage-dependent K+ conductance through activation of a cholera 
toxin-sensitive G protein (Soriani et al., 1998; Soriani et al., 1999). In Xenopus 
oocytes, the signal transduction cascade between Kv1.4 and σ receptors has 
been shown to be dependent on protein-protein interaction (Aydar et al., 2002). 
The σ ligand, (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ((+)3-PPP), has 
been shown to depolarize sympathetic neurons of the mouse isolated 
hypogastric ganglion by inhibiting the M-current , A-current and calcium-
dependent K+ current (Kennedy and Henderson, 1990).  
Activation of sigma receptors regulate multiple ion channels subtypes in 
neurons (Aydar et al., 2002; Zhang and Cuevas, 2002; Zhang and Cuevas, 
2005). This regulation of ion channels may result in neuroprotection during 
ischemia. It has been suggested that the neuroprotective properties of σ ligands 
depend in part on their ability to depress elevations in [Ca2+]i  associated with 
glutamate receptor-mediated excitotoxicity (Klette et al., 1995; Klette et al., 1997; 
Katnik et al., 2006), neurotransmitter release regulation (Matsuno et al., 1993; 
Couture and Debonnel, 1998), and modulation of multiple ion channel subtypes. 
The studies of σ receptor modulation of glutamate evoked changes in 
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intracellular calcium have resulted in considerable controversy in the literature. 
There are conflicting reports as to whether σ receptor ligands exert their effects 
as a result of σ receptor activation (Hayashi et al., 1995) or through non-specific 
interaction with other targets, in particular, NMDA receptors (Kume et al., 2002). 
σ receptors and NMDA receptors both bind PCP and related compounds like 
MK-801 with high affinity (Sircar et al., 1987), and thus, such drugs cannot be 
used to discriminate between direct and indirect effects. Activation of σ receptors 
has been shown to be neuroprotective at delayed time points in a rat model of 
ischemic stroke (Ajmo et al., 2006) and blocks ischemia-induced increases in 
[Ca2+]i (Katnik et al., 2006). σ -1 receptor activation has also been shown to 
prevent neuronal death associated with glutamate excitotoxicity in cultured 
neurons (Takahashi et al., 1996; Kume et al., 2002), diminish infarct size by 
blocking nitric oxide production in vivo (Goyagi et al., 2001), inhibit pro-
inflammatory factors (TNFα) and activate the expression of anti-inflammatory 
agents like IL-10 (Bourrie et al., 1995; Bourrie et al., 1996; Bourrie et al., 2002). 
Stimulation of σ receptors have been found to block voltage-gated calcium and 
potassium channels (Zhang and Cuevas, 2002; Zhang and Cuevas, 2005) in 
intracardiac neurons and ionotropic glutamate receptors (Monnet et al., 2003). All 
of these channel types are involved in the dysregulation of intracellular calcium 
homeostasis accompanying ischemia, and blocking the function of these 
channels provides neuroprotection (Schurr, 2004). Thus, σ receptor ligands have 
been targeted for the treatment of stroke due to the neuroprotective properties 
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observed in both in vivo and in vitro models of ischemia (Lockhart et al., 1995; 
Takahashi et al., 1996). 
 
In Vitro Chemical Ischemia Models 
The role of acidotoxicity, ASIC1a channels and acid-induced Ca2+ 
dysregulation during ischemia remains to be established. Furthermore, the 
effects of σ receptor activation on acidotoxicity remain to be determined. It is well 
known that in response to hypoxia-ischemia, an in vivo model of stroke, the brain 
relies on anaerobic glycolysis as the source of energy (Vannucci et al., 1994). 
This is energetically unfavorable and results in rapid depletion of ATP along with 
subsequent activation of deliterious biochemical cascades. All of these events 
are similar to those observed in cultured neurons (in vitro): (1) Ca2+ dysregulation 
due to glutamate accumulation and activation of NMDA receptors (Shalak and 
Perlman, 2004; Vannucci and Hagberg, 2004), (2) production of free oxygen 
radicals (Shalak and Perlman, 2004) , (3) damage to proteins and lipids (Shalak 
and Perlman, 2004), (4) mitochondrial dysfunction leading to activation of 
apoptotic pathways (Northington et al., 2001), and (5) activation of secondary 
mechanisms including release of proinflammatory mediators (Silver and Miller, 
2004; Chew et al., 2006; Fukui et al., 2006; Van Lint and Libert, 2007).  
There are several models of in vitro chemical ischemia that are used to 
mimic the injury profile seen in animal models of stroke and conditions 
associated with cerebral ischemia in vivo. These models include: (1) oxygen 
glucose deprivation (Monyer et al., 1989; Laake et al., 1999) and the addition of 
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either (2) sodium azide (Dawson et al., 1991; Dawson et al., 2002; Katnik et al., 
2006; Marino et al., 2007), (3) sodium cyanide (Vornov et al., 1994; Vornov, 
1995; Zhang et al., 2000), or (4) 2,4-dinitrophenol (Riepe et al., 1996; Sullivan et 
al., 2003) in glucose-free solutions. These ischemic models are associated with 
Ca2+ overload triggered by the excess influx of extracellular Ca2+ through Ca2+-
sensitive ion channels and receptors (Monyer et al., 1989; Goldberg and Choi, 
1993; Katnik et al., 2006). All of these models affect the electron transport chain 
in the mitochondria, which is the site of oxidative phosphorylation in eukaryotes. 
Oxidative phosphorylation is the main pathway that uses energy released by the 
oxidation of nutrients to drive the production of adenosine triphosphate (ATP), 
which supplies energy for metabolism. Inhibition of enzymes, like cytochrome c, 
during this metabolic process results in energy failure due to the lack of ATP 
production. 
Sodium-azide and sodium-cyanide are both compounds that inhibit 
oxidative phosphorylation. Azide and cyanide bind to the iron-copper center 
(when the iron is in the ferric state) of cytochrome c with greater affinity than 
oxygen. This prevents the reduction of oxygen and stops the electron transfer 
preventing translocation of protons across the membrane, which disrupts the 
electrochemical gradient that powers ATP synthase. Therefore, these 
compounds are inhibitors of the enzyme cytochrome c oxidase in the fourth 
complex of the electron transport chain and both prevent the aerobic production 
of ATP as the source of cellular energy. However, the main disadvantage of 
cyanide is that it is a very toxic and lethal compound to humans since cyanide 
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interacts with pH and produces hydrogen cyanide, thus making difficult to control 
its concentration. Thus, azide is a safer compound to handle. In contrast to azide 
and cyanide, 2,4-dinitrophenol (DNP) uncouples the electron transport from 
oxidative phosphorylation, which disrupts the proton gradient by transporting 
protons back across the inner mitochondrial membrane. There are several 
disadvantages to using oxygen depletion: (1) pre and early post natal rat tissue is 
resistant to oxygen depletion, (2) difficult to completely remove oxygen and thus 
requires long incubation to produce significant injury (Rothman, 1984), and (3) 
requires using a closed-chamber, making patch-clamp experiments difficult. The 
major advantage of the sodium azide/glucose deprivation model over the 
oxygen/glucose deprivation model is that it elicits neurochemical responses that 
are significantly more rapid and robust, thus facilitating the recording of changes 
in [Ca2+]i increases (Katnik et al., 2006). Disadvantages of this model are that 
azide has multiple affects including inhibition of cytochrome aa3, superoxide 
dismutase and DNA synthesis (Varming et al., 1996). Azide breaks down to nitric 
oxide and thus enhances excitatory neurotransmission (Varming et al., 1996). 
Moreover, because of the short duration of the application of azide, this only 
models acute ischemia. This azide/glucose deprivation model has previously 
been used in rat cortical neurons to study σ receptor inhibition of ischemia-
induced [Ca2+]i elevations (Katnik et al., 2006). Moreover, calcium influx through 
the plasma membrane and not release from the mitochondria or endoplasmic 
reticulum, accounts for most of the ischemia-mediated [Ca2+]i increases in cortical 
neurons using this azide model of ischemia (Katnik et al., 2006).  
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CHAPTER 2 
 
 
SIGMA-1 RECEPTOR MODULATION OF ASIC1a CHANNELS AND ASIC1a-
INDUCED Ca2+ INFLUX IN RAT CORTICAL NEURONS 
 
 
Introduction 
 
 
Acid-sensing ion channels are a class of ligand-gated channels that are 
members of the degenerin/epithelial sodium channel superfamily and are 
expressed in both peripheral and central nervous system neurons (Waldmann et 
al., 1997b). Thus far, four genes (ASIC1 – ASIC4) and two splice variants of 
ASIC1 and ASIC2 (a and b) have been cloned (Wemmie et al., 2006) which 
encode protein subunits that form functional proton-gated homomultimeric or 
heteromultimeric channels (Wemmie et al., 2006).The pH of half-maximal 
activation and the tissue expression patterns differ between each channel 
subtype.   
One of the most common ASIC subtypes in the central nervous system 
(CNS) contains the ASIC1a subunit, which can form homomultimeric or 
heteromultimeric channels with ASIC2a (Askwith et al., 2004). These channels 
are activated by pH ≤ 7 and have a pH of half-maximal activation of ~ 6.0 - 6.5 
(Waldmann et al., 1997b; Hesselager et al., 2004). ASIC1a homomultimeric 
channels differ from other ASIC subtypes in that they are highly permeable to 
both Na+ and Ca2+ ions (Waldmann et al., 1997b; Yermolaieva et al., 2004). This 
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ASIC subtype has been implicated in a number of physiological processes such 
as synaptic plasticity, fear conditioning, and learning and memory (Wemmie et 
al., 2002; Wemmie et al., 2003; Wemmie et al., 2004). ASIC1a has also been 
shown to be activated following cerebral ischemia, and has been unequivocally 
linked to neuronal cell death (Xiong et al., 2004; Gao et al., 2005; Pignataro et 
al., 2007). Transgenic mice deficient in ASIC1a have reduced infarct size in 
response to middle cerebral artery occlusion (MCAO) relative to wild-type mice 
(Xiong et al., 2004). Moreover, pharmacological inhibition of ASIC1a with either 
amiloride or psalmotoxin1, which is selective for homomultimeric ASIC1a 
channels  (Diochot et al., 2007), diminishes ischemic brain injury (Xiong et al., 
2004). Several studies have suggested that Ca2+ influx through these channels is 
a key mechanism leading to neurodegeneration (Xiong et al., 2004; Yermolaieva 
et al., 2004).   
Despite efforts to determine the function of ASIC1a and the role of these 
channels in ischemia, little is known about endogenous mechanisms which 
control ASIC1a activity. Thus far, only the NMDA receptor, acting via a Ca2+-
calmodulin kinase II cascade (CaMKII), has been shown to modulate ASIC1a 
(Gao et al., 2005). Activation of NMDA receptors enhances ASIC1a-mediated 
currents, which consequently exacerbates acidotoxicity during ischemia (Gao et 
al., 2005).  
σ receptor activation has been shown to modulate multiple cell membrane 
ion channels in neurons. σ -1 receptors regulate ionotropic glutamate receptors 
and voltage-gated K+ channels, whereas σ-2 receptors modulate voltage-gated 
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Ca2+ channels (Hayashi et al., 1995; Aydar et al., 2002; Zhang and Cuevas, 
2002; Zhang and Cuevas, 2005). The inhibition of ionotropic glutamatergic 
receptors by σ receptors prevents elevations in [Ca2+]i associated with glutamate-
induced excitotoxicity (Klette et al., 1995). All of these voltage-gated ion channels 
and NMDA receptors have been shown to contribute to the demise of neurons 
during an ischemic insult. Our laboratory has recently shown that σ-1 receptors 
inhibit Ca2+ dysregulation evoked by ischemia and that activation of σ receptors 
is neuroprotective at delayed time points in a rat model of ischemic stroke (Ajmo 
et al., 2006; Katnik et al., 2006). Interstitial pH in the brain remains low several 
hours after an ischemic event (Nedergaard et al., 1991), and pharmacological 
blockade of ASIC1a by amiloride or psalmotoxin1 administered even 5 hours 
after MCAO has been shown to diminish stroke injury (Simon, 2006). These 
observations raise the possibility that σ receptors may regulate ASIC1a function 
and ASIC1a-induced intracellular calcium transients, and provide neuroprotection 
when stimulated at delayed time points after an ischemic insult. 
Experiments were conducted to determine the effects of σ receptors on 
ASIC-mediated membrane currents and transient [Ca2+]i elevations. It was 
determined that σ receptor agonists inhibit acidosis-induced increases in [Ca2+]i 
and peak membrane currents in cells expressing homomeric ASIC1a channels. 
Pharmacological studies demonstrated that the σ-1 receptor subtype was 
responsible for these effects. Moreover, acidosis was also shown to activate 
downstream Ca2+ influx pathways (e.g. NMDA and AMPA/kainate receptors and 
voltage-gated Ca2+ channels, VGCC), and activation of σ-1 receptors also 
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diminished Ca2+ entry via these channels. Therefore, σ-1 receptors couple to 
ASIC1a channels to inhibit channel function and also block ASIC1a-induced 
[Ca2+]i dysregulation. Our findings suggest that σ-1 receptors represent potential 
targets for improving outcome of stroke injury and expanding the therapeutic 
window for ischemic stroke treatment.  
 
Materials and Methods 
Primary Rat Cortical Neuron Preparation 
 Primary cortical neurons from embryonic (E18) rats were cultured as 
previously described by our laboratory (Katnik et al., 2006). All procedures were 
done in accordance with the regulations of the University of South Florida 
Institutional Animal Care and Use Committee. Briefly, dams were sacrificed, 
uterus removed, and embryos dissected out and placed in isotonic buffer 
consisting of (in mM): 137 NaCl, 5 KCl, 0.2 NaH2PO4, 0.2 KH2PO4, 5.5 glucose, 
and 6.0 sucrose, titrated to pH 7.4 with NaOH. Cortices were excised and 
minced, followed by digestion in isotonic buffer containing 0.25% trypsin/EDTA 
for 10 minutes at 37°C and added to 3X volume of Dulbecco’s modified Eagle’s 
Medium (DMEM) (Invitrogen Inc, Carlsbad, CA) supplemented with 10% (v/v) 
fetal bovine serum, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. Cells were 
counted using a hemocytometer, plated (0.5 X 106 cells/well) on 18-mm pre-
treated poly-L-lysine coverslips, and incubated at 37°C under 95% air, 5% CO2 
atmosphere. After 24 hours, the media was replaced with Neurobasal medium 
supplemented with B27 and 0.5 mM L-glutamine (Invitrogen Inc, Carlsbad, CA) 
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to minimize astrocyte proliferation in the cultures. Cells were used between 10-21 
days in culture. 
Calcium Imaging Measurements 
The effects of acidosis on intracellular Ca2+ concentrations were examined 
in isolated cultured cortical neurons using fluorescent imaging techniques. 
Cytosolic free-Ca2+ was measured using the Ca2+ sensitive dye, fura-2, as 
previously described (Katnik et al., 2006). Cells, plated on poly-L-lysine coated 
coverslips, were incubated for 1 hour at room temperature in Neurobasal 
(Invitrogen) medium supplemented with B27 (Invitrogen) and 0.5 mM L-
glutamine, or in physiological saline solution (PSS) consisting of (in mM): 140 
NaCl, 5.4 KCl, 1.3 CaCl2, 1.0 MgCl2, 20 glucose, and 25 HEPES (pH to 7.4 with 
NaOH), 330 ± 10 mOsm. Both solutions contained 3 μM acetoxymethyl ester 
fura-2 and 0.3 % dimethyl sulfoxide. The coverslips were washed in PSS (fura-2 
free) prior to the experiments being carried out. All solutions were applied via a 
rapid application system identical to that previously described (Cuevas and Berg, 
1998).  
A DG-4 high-speed wavelength switcher (Sutter Instruments Co., Novato, 
CA) was used to apply alternating excitation light. Fluorescent emission was 
captured using a Sensicam digital CCD camera (Cooke Corporation, Auburn 
Hills, MI) and recorded with Slidebook 4.02 software (Intelligent Imaging 
Innovations, Denver, CO). Slidebook 4.02 software was used to calculate 
changes in [Ca2+]i from the intensity of the emitted fluorescence following 
excitation with 340 nm and 380 nm light, respectively, using the Grynkiewicz 
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equation: [Ca2+]i = Kd *Q(R-Rmin)/(Rmax-R), where R represents the 
fluorescence intensity ratio (F340/F380) as determined during experiments, Q is 
the ratio of Fmin to Fmax at 380 nm, and Kd is the Ca2+ dissociation constant for 
fura-2 (224 μM). The system was calibrated using a Fura-2 Calcium Imaging 
Calibration Kit (Molecular Probes; Eugene, OR) and values for Fmin/Fmax, 
Rmin, and Rmax were determined. 
Electrophysiology Recordings 
 Neurons plated on glass coverslips (as described above) were transferred 
to a recording chamber mounted on a Zeiss Axiovert 200 and visualized at 400x.  
Membrane currents were amplified using an Axopatch 200B (Axon Instruments), 
filtered at 1 kHz, digitized at 5 kHz with a Digidata 1322A (Axon), and acquired 
using Clampex 8 (Axon). Electrical access was achieved using the amphotericin 
B perforated-patch method to preserve intracellular integrity of neurons (Rae et 
al., 1991). An amphotericin B stock solution (60 mg/ml in DMSO) was made 
daily, kept on ice, light protected, and diluted to 240 µg/ml (0.4% DMSO) in 
control pipette solution immediately prior to patch clamp experiments. The pipette 
solution consisted of (in mM): 75 K2SO4, 55 KCl, 5 MgSO4, and 25 HEPES (titrated 
to pH 7.2 with N-methyl-d-glucamine, 300 ± 5 mOsm). Patch electrodes were 
pulled from thin-walled borosilicate glass (World Precision Instruments Inc., 
Sarasota, FL) using a Sutter Instruments P-87 pipette puller (Novato, CA) and 
had resistances of 1.0–1.5 MΩ. Access resistance (Rs) were monitored 
throughout experiments for stable values ≤ 20 MΩ and were always 
compensated at 40% (lag, 10 µs). All cells were voltage-clamped at -70 mV. 
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Solutions and Reagents 
The control bath solution for all experiments was PSS.  In one series of 
experiments requiring high extracellular K+, an additional 34.6 mM of KCl was 
isosmotically substituted for NaCl. All drugs were applied in PSS (or high K+ 
PSS) using a rapid application system identical to that previously described 
(Cuevas and Berg, 1998). ASIC activation was induced by applying PSS with a 
pH of 6.0 (+/- drug) to specifically target ASIC1a (Askwith et al., 2004). Individual 
cells were exposed to no more than four low pH applications, and no rundown of 
the responses was observed with this protocol. All chemicals used in this 
investigation were of analytic grade. The following drugs were used: DTG, 
opipramol, ibogaine, metaphit, nifedipine, AP5 and PB28 (Sigma-Aldrich, St. 
Louis, MO); carbetapentane, BD1063, CNQX and PRE-084 (Tocris Bioscience, 
Ellisville, MO); dextromethorphan (MP Biomedicals, Inc, Solon, OH); 
psalmotoxin1 (Spider Pharm, Yarnelle, AZ); tetrodotoxin and thapsigargin 
(Alomone Labs, Jerusalem, Israel); amiloride (Alexis Biochemicals, Lausen, 
Switzerland); cadmium (Fischer Scientific, Fair Lawn, NJ); and fura-2 
acetoxymethyl ester (Molecular Probes, Eugene, OR).    
Data Analysis 
  Analyses of measured intracellular Ca2+ and membrane current responses 
were conducted using Clampfit 9 (Axon instruments). Fluorescence intensities were 
recorded from fura-2-loaded neuronal cell bodies. Time-lapse imaging data files 
collected with SlideBook 4.02 (Intelligent Imaging Innovations, Inc.) were converted 
to a text format and imported into Clampfit for subsequent analysis. Statistical 
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analysis was conducted using SigmaPlot 9 and SigmaStat 3 software (Systat 
Software, Inc.). Statistical differences were determined using paired and unpaired 
t-tests for within group and between group experiments, respectively, and were 
considered significant if p < 0.05.  For multiple group comparisons either a 1-way or 
a 2-way ANOVA, with or without repeat measures, were used, as appropriate.  
When significant differences were determined with an ANOVA, post-hoc analysis 
was conducted using a Tukey Test to determine differences between individual 
groups.  For the generation of concentration response curves, data were best fit 
using a single-site Langmuir-Hill equation.   
 
Results 
ASIC subtypes are distinguishable by pH sensitivity and ion selectivity, 
with homomultimeric ASIC1a being the only subtype that is Ca2+ permeable 
(Yermolaieva et al., 2004). Experiments were carried out to determine the effects 
of ASIC activation on intracellular Ca2+ transients and to identify the specific 
ASIC subtype(s) affecting [Ca2+]i in our rat cortical neuron model. Figure 2.1A 
shows representative traces of [Ca2+]i as a function of time recorded from a 
single neuron during acidosis (pH 6.0) in the absence (Control) and presence of 
amiloride (100 µM), and following a 10 minute washout of drug (Wash). The 
general ASIC inhibitor, amiloride, reversibly blocked ASIC-mediated increases in 
[Ca2+]i by 88 ± 1 % (Figure 2.1B). Psalmotoxin1 (PcTx1) from the venom of the 
tarantula Psalmopoeus cambridgei has been shown to be a selective blocker of 
homomultimeric ASIC1a channels (Diochot et al., 2007). Figure 2.1C shows 
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representative traces of [Ca2+]i as a function of time recorded from a neuron prior 
to (Control), following a 10 - 20 min preincubation in bath applied PcTx1 (500 
ng/ml venom protein), and after washout of the toxin (Wash). In identical 
experiments, PcTx1 produced a statistically significant reversible decrease in 
ASIC1a-mediated elevations in [Ca2+]i  (57 ± 2 %) (Figure 2.1D). The effects 
produced by this concentration of PcTx1 are consistent with results obtained for 
ASIC1a responses in mouse cortical neurons (Xiong et al., 2004). These data 
indicate that, in cultured cortical neurons from embryonic rats, acidosis results in  
elevations in [Ca2+]i that are mediated via the activation of homomultimeric 
ASIC1a channels, as reported for cultured cortical neurons from embryonic mice 
(Xiong et al., 2004).  
Activation of σ receptors has been shown to inhibit numerous plasma 
membrane ion channels in neurons (Hayashi et al., 1995; Zhang and Cuevas, 
2002; Zhang and Cuevas, 2005). Therefore, experiments were carried out to 
study the effects of σ receptor activation on ASIC1a function using the pan-
selective σ receptor agonist, DTG. Figure 2.2A shows representative traces of 
[Ca2+]i recorded from a single neuron during acidosis in the absence (Control) 
and presence of 100 μM DTG, a concentration previously shown to effectively 
regulate other ion channels (Zhang and Cuevas, 2002; Zhang and Cuevas, 
2005), and following 10 minute washout of the drug (Wash). DTG rapidly and 
reversibly inhibited the low pH-induced transient increases in [Ca2+]i. In identical 
experiments, 100 μM DTG produced a statistically significant decrease (46 ± 3 
%) in ASIC1a-mediated elevations in [Ca2+]i (Figure 2.2B). Opipramol (10 µM), 
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another pan-selective σ-1/σ-2 agonist, also inhibited ASIC1a-mediated increases 
in [Ca2+]i by 57 ± 1 % (Figure 2.2B). The concentration-response relationship for 
DTG inhibition of ASIC1a was determined to confirm that the actions of DTG on 
ASIC1a are consistent with σ receptor activation. Increasing DTG concentrations 
resulted in further depression of ASIC1a-mediated increases in [Ca2+]i (Figure 
2.2C).  A plot of the concentration-response relationship obtained from 
measurements made in multiple cells is shown in Figure 2.2D. The data were 
best fit using a single-site Langmuir-Hill equation with an IC50 value of 109 µM 
and a Hill coefficient of 0.9. These values are consistent with the effects of DTG 
being mediated via activation of σ receptors (Zhang and Cuevas, 2002; Zhang 
and Cuevas, 2005; Katnik et al., 2006). Taken together these results suggest that 
σ receptors depress acid-induced increases in [Ca2+]i and modulate ASIC1a 
function. 
σ receptor subtype-selective agonists were used to identify the specific σ 
receptor subtype(s) mediating these effects. Representative traces of [Ca2+]i as a 
function of time recorded from two cells during acidosis in the absence (Control) 
and presence of the σ-1 selective agonists carbetapentane (CBP) and 
dextromethorphan (DEX) at the indicated concentrations are shown in Figures 
2.3A and 2.3B, respectively. σ-1 selective agonists blocked the low pH-induced 
elevations in [Ca2+]i in a concentration dependent and reversible manner. 
Concentration-response plots for mean changes in peak [Ca2+]i recorded in 
identical experiments using the σ-1 selective ligands CBP, DEX, and PRE-084, 
are shown in Figure 2.3C. The data were best fit using the Langmuir-Hill equation 
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and values obtained for IC50 and Hill coefficients were 13.8 μM and 0.7 (CBP), 22 
µM and 0.8 (DEX), and 13.7 μM and 0.6 (PRE-084), respectively. Presented for 
comparison is the best fit to the data obtained for CBP inhibition, via σ-1 
receptors, of chemical ischemia-induced increases in [Ca2+]i in cortical neurons 
(dotted line, IC50 =18.7 µM; Hill coefficient, 0.8) (Katnik et al., 2006).  This curve 
superimposes on the responses to CBP observed in the current study.   
To provide further evidence that σ-1 receptors modulate ASIC1a-induced 
Ca2+ elevations experiments were conducted using the irreversible σ antagonist, 
metaphit, and a selective σ-1 antagonist, BD1063, in combination with the σ-1 
agonist, CBP. Cells were exposed to acidosis in the absence and presence of 
CBP (30 μM), with or without preincubation in metaphit (50 μM; 30 min -1hr, 
23˚C). CBP decreased the acid-induced elevations in [Ca2+]i in control cells, and 
this inhibition was lessened by preincubation with metaphit (Figure 2.4A). Figure 
2.4B shows results from several similar experiments determining percent 
inhibition of acid-induced increases in [Ca2+]i observed in the presence of CBP in 
control neurons (Control) and neurons preincubated with metaphit (MET). 
Whereas CBP decreased the elevations in [Ca2+]i evoked by acidosis in control 
cells by 52 ± 2 %, the σ-1 receptor agonist only reduced the response by          
30 ± 3 % in cells preincubated in the irreversible σ receptor antagonist. This 
>40% decrease in the effects of CBP following metaphit preincubation was 
statistically significant (p < 0.001). The selective σ-1 antagonist, BD1063, showed 
more pronounced effects. Figure 2.4C shows representative traces of [Ca2+]i as a 
function of time recorded from two neurons during acidosis in absence (Control) 
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and presence of CBP (30 µM), without (PSS) and with co-application in BD1063 
(BD1063, 10 nM). In identical experiments, the σ agonist CBP completely loses 
its ability to block the low pH-induced elevations in [Ca2+]i in the presence of the σ 
antagonist BD1063 when compared to 40% block in control cells (Figure 2.4D). 
Inhibition of σ-1 receptors by BD1063 significantly blocked the effects of CBP on 
ASIC1a-mediated [Ca2+]i elevations when compared to control cells (p <0.001). 
These data confirm the effects of σ-1 agonists on ASIC1a mediated increases in 
[Ca2+]i are the result of these compounds acting on σ-1 receptors. 
Further experiments were carried out using the σ-2 selective ligands 
ibogaine and PB28 to determine if the σ-2 receptor subtype also affects ASIC1a 
function. Figure 2.5A shows representative traces of [Ca2+]i as a function of time 
recorded from two cells during acidosis in the absence (Control) and presence of 
ibogaine (IBO, left traces) and PB28 (right traces) at the indicated 
concentrations. The σ-2 ligands inhibited acidosis-evoked increases in mean 
peak changes in [Ca2+]i in a concentration dependent manner (Figure 2.5B). Best 
fits to the data demonstrated that application of ibogaine and PB28 resulted in 
inhibition of ASIC1a-mediated increases in [Ca2+]i with IC50 values of 69 µM and 
11 μM, and Hill coefficients of 0.86 and 0.85, respectively. For comparison, the 
best fit to the data obtained for ibogaine inhibition of ICa-induced increases in 
[Ca2+]i is presented, which has been shown to be mediated by σ-2 receptors 
(dashed line; IC50 = 31 µM; Hill coefficient, 1.1) (Zhang and Cuevas, 2002).  
Unlike the similar concentration-response relationship observed for CBP 
inhibition of ASIC1a and ischemia responses, there is a discrepancy between the 
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ibogaine block of responses mediated by ASIC1a and by voltage-gated Ca2+ 
channels (VGCC). To determine if the effects of these σ-2 ligands were mediated 
by activation of σ-2 receptors, experiments using metaphit were carried out.  
PB28 (20 μM) produced an inhibition of ASIC1a-mediated increases in [Ca2+]i in 
both control (PSS) and metaphit (+MET) treated cells (Figure 2.5C). PB28 
blocked ASIC1a-mediated increases in [Ca2+]i by 67 ± 1% and 60 ± 2 % in the 
absence and presence of metaphit preincubation, respectively (Figure 2.5D). The 
~10% reduction in the effects of PB28 produced by metaphit was not statistically 
significant (p = 0.64). Furthermore, BD1063 (10 nM) failed to block the effects of 
PB28 (20 µM) on ASIC1a-induced elevations in [Ca2+]i (Figure 2.5D). These 
results demonstrate that the effects of PB28 on ASIC1a-medited increases in 
[Ca2+]i are not mediated by σ-2 receptors since the inhibition of these responses 
to acidosis by PB-28 is metaphit-insensitive and occurs at concentrations 
inconsistent with σ-2 receptor activation.  
The activation of σ receptors has previously been shown to directly affect 
Ca2+ release from intracellular stores (Cassano et al., 2006). Thus, experiments 
were conducted to resolve if σ receptor activation reduces acid-induced 
increases in [Ca2+]i in part via the inhibition of calcium-induced-calcium release 
from the endoplasmic reticulum, triggered by Ca2+ influx through the plasma 
membrane. For these experiments, thapsigargin was used to block the 
sarcoplasmic/endoplasmic reticulum Ca2+-ATPase, which results in depletion of 
both ryanodine- and IP3-sensitive stores. Figure 2.6A shows representative 
traces of [Ca2+]i  as a function of time recorded from a neuron during acidosis in 
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the absence (Control) and presence of 100 µM DTG (DTG), while Figure 2.6B 
shows traces in the absence and presence of DTG following pre-incubation (1 hr, 
23˚C) in 10 μM thapsigargin (THAP and THAP + DTG, respectively). 
Thapsigargin alone did not decrease the elevations in [Ca2+]i produced by 
acidosis, and DTG depressed the increases in [Ca2+]i under both conditions (± 
thapsigargin preincubation). Analysis of the data collected in identical 
experiments indicates that preincubation with thapsigargin does not significantly 
alter the effects of DTG on acid-mediated increases in [Ca2+]i (Figure 2.6C). 
Thus, DTG does not decrease the low pH-induced elevations in [Ca2+]i by 
affecting release of calcium from intracellular stores. The fact that depletion of 
intracellular stores fails to depress increases in [Ca2+]i evoked by acidosis 
suggests that Ca2+ influx through the plasma membrane accounts for most, if not 
all, of the increases in [Ca2+]i evoked by ASIC1a activation.  
Simultaneous Ca2+ fluorometry and whole-cell patch clamp recordings 
were performed to study ASIC1a-mediated membrane currents and to determine 
how much of the observed Ca2+ influx is due to Ca2+ entry through ASIC1a 
channels. Cells were voltage-clamped at -70 mV to minimize NMDA receptor and 
VGCC activation, and thus, isolate ASIC1a currents. Figure 2.7A shows that 
ASIC1a stimulation by low pH solution (pH 6.0), resulted in a small intracellular 
Ca2+ transient measured in a patched cell ([Ca2+]i V-Clamp). In contrast, a 
second cell ([Ca2+]i Control) in the same field of view, which was not voltage 
clamped, had a significantly larger increase in [Ca2+]i. Acidosis also resulted in a 
large inward current in the patched cell (Figure 2.7A, inset). The cumulative 
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results from several similar experiments demonstrate that ASIC1a activation of 
neurons voltage clamped at -70 mV resulted in elevations in [Ca2+]i which were 
an order of magnitude smaller than changes evoked in cells that were not 
voltage-clamped (Figure 2.7B). These data confirm ASIC1a activation results in 
minimal Ca2+ influx through the ASIC1a channel itself and that the majority of the 
acid-induced [Ca2+]i increases are mediated by downstream Ca2+ influx 
pathways. 
To test the possibility that ASIC1a channels promote cell depolarization, 
cortical neurons were held under current-clamp mode. Figures 2.8A and 2.8C 
show representative traces of membrane potential as a function of time recorded 
from a single cell in absence (Control) and presence of amiloride (100 µM) and 
from a different neuron in the absence (Control) and presence of PcTx1 peptide 
(50 nM). A summary of the changes in membrane potential recorded from 
several cells in the absence (Control) and presence of ASIC blockers, amiloride 
and PcTx1 peptide, are shown in Figures 2.8C and 2.8D. Inhibition of ASIC1a 
channels by amiloride, but not PcTx1 peptide, produced a significant reduction in 
changes in membrane potential (Figure 2.8C). Thus, these data suggest that 
activation of ASIC1a channels depolarizes cortical neurons to potentials capable 
of activating other Ca2+ channels.  
Application of protons evoked a rapid depolarization of neurons held under 
current-clamp mode which, unlike the case in voltage-clamped neurons, was 
associated with pronounced elevations in [Ca2+]i. Thus, ASIC1a channels are 
likely promoting significant Ca2+ influx into the neurons by depolarizing the cells. 
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To mimic this change in membrane potential evoked upon ASIC1a activation, 
cells were exposed to high K+ (40 mM) extracellular solution. Figure 2.9A shows 
representative [Ca2+]i traces recorded in response to high K+o application in the 
absence (Control) and presence of CBP (100 μM, +CBP). Depolarizing the 
neurons in this manner evoked robust [Ca2+]i elevations which were blocked by 
addition of CBP. In identical experiments CBP reduced the high K+o-evoked 
increases in [Ca2+]i by 83 ± 1% and this decrease was statistically significant (p < 
0.001) (Figure 2.9B).  Thus, σ receptor activation inhibits Ca2+ channels 
downstream of ASIC1a in addition to the proton-gated channels themselves.   
To determine the specific ion channels contributing to the ASIC1a-induced 
[Ca2+]i  influxes, several inhibitors of plasma membrane ion channels were used.  
Activation of ASIC1a depolarizes these neurons which could stimulate action 
potential firing and, consequently, synaptic transmission, both of which may 
elevate [Ca2+]i. Thus, tetrodotoxin (TTX, 500 nM) was used to inhibit voltage-
gated Na+ channels to prevent the genesis of action potentials. Figure 2.10A 
shows that application of TTX inhibited ~ 10% of the acid-induced increases in 
[Ca2+]i, but did not significantly affect CBP (50 µM) modulation of the Ca2+ 
responses,  when compared to the PSS group. Because TTX had no effect on 
the σ-1/ASIC1a interaction, all subsequent experiments included 500 nM TTX in 
the bath solutions to prevent spontaneous action potentials from contributing to 
the measured increases in [Ca2+]i. Inhibition of NMDA receptors by AP5 (100 µM) 
significantly reduced the acid-induced elevations in [Ca2+]i, and co-application 
with CBP (50 µM) resulted in a further decrease in [Ca2+]i which was statistically 
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significant (Figure 2.10A). These results show that ~ 30% of ASIC1a-induced 
[Ca2+]i increases are dependent on NMDA receptor activation. Furthermore, 
since the effects of AP5 and CBP are less than additive, activation of σ-1 
receptors depresses ASIC1a-evoked increases in [Ca2+]i in part by blocking this 
NMDA receptor-dependent component. Blockade of L-type VGCC by nifedipine 
(10 µM) significantly inhibited (>75%) acid-induced [Ca2+]i elevations, and CBP 
(50 µM) continued to provide further blockade of the residual increases in [Ca2+]i 
(Figure 2.10A). Cadmium (100 µM), a broad-spectrum blocker of plasma 
membrane calcium channels, inhibited ~ 90% of the acid-induced increases in 
[Ca2+]i and CBP (50 µM) had no effect on the remaining Ca2+ influx (Figure 
2.10A). Thus, voltage-gated Ca2+ channels either directly (influx through the 
channel) or indirectly (facilitating glutamate release) account for most of the 
[Ca2+]i increases resulting from  ASIC1a activation, and σ-1 receptor activation 
provides an inhibition similar to that observed with Cd2+.  
Further experiments were conducted to determine if AMPA/kainate 
receptors are involved in the [Ca2+]i elevations elicited upon ASIC1a activation.  
Figure 2.10B shows relative changes in [Ca2+]i in the absence (Control) and 
presence of the AMPA/kainate receptor blocker CNQX (10 µM), and the effects 
of CBP at two different concentrations (50 µM and 300 µM). Maximal blockade of 
AMPA/kainate receptors alone produced ~ 40% reduction of the elevations of 
[Ca2+]i and 50 µM CBP did not provide additional, statistically significant block. 
Increasing the CBP concentration to 300 µM, however, did produce an additional 
block of the Ca2+ response on top of the effects of CNQX. Figure 2.10B shows 
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that co-application of 300 µM CBP and CNQX blocked >80% of the acid-induced 
increases in [Ca2+]i and this was statistically significant when compared to CNQX 
alone. Thus, [Ca2+]i elevations elicited upon ASIC1a activation involve Ca2+ influx 
through both ASIC1a and other Ca2+ permeable plasma membrane ion channels 
expressed in cortical neurons. Importantly, it is also evident that activation of σ-1 
receptors results in depression of Ca2+ influx through all of these sources, either 
by inhibiting ASIC1a or the downstream channels themselves.  
Two ASIC blockers, amiloride and PcTx1, were used to confirm that the 
acid-activated inward currents observed in our cortical neuron model were 
mediated by ASIC1 channels. Figure 2.11A shows representative traces of 
membrane currents as a function of time recorded from a single cell in absence 
(Control) and presence of amiloride (100 µM, top traces, i), and from a different 
neuron in the absence (Control) and presence of PcTx1 (500 ng/ml venom, 
bottom traces, ii). Figure 2.11B summarizes the normalized peak proton-gated 
whole-cell currents recorded from several cells in the absence (Control) and 
presence of amiloride and PcTx1. Amiloride produced a 79 ± 6 % inhibition of 
acid-activated currents while 500 ng/ml of PcTx1 containing venom produced a 
42 ± 11 % reduction in this current. Both reductions were significantly different 
from control (p<0.01). Experiments were also carried out to confirm that ASIC1a 
currents were not affected by the channel blockers used in the imaging studies 
described above. Figure 2.11C shows relative peak proton-gated currents, 
normalized to control (PSS), during acidosis in the absence (PSS) and presence 
of the indicated drugs. These data demonstrate that neither TTX, AP5, CNQX, 
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nifedipine, nor cadmium have any direct effects on ASIC1a channels.  
σ receptor activation has been shown to modulate multiple cell membrane 
ion channels in neurons that are activated following ASIC1a stimulation (Hayashi 
et al., 1995; Zhang and Cuevas, 2002). This fact raises the possibility that σ-1 
receptors only couple to the secondary events that result from ASIC1a activation 
and not to ASIC1a itself. To investigate if σ receptors affect ASIC1a function, 
whole-cell patch clamp recordings were performed in the presence of σ agonists. 
Figure 2.12A shows representative membrane current traces as a function of 
time recorded from a cell in the absence (Control) and presence of the pan-
selective σ agonist DTG (100 µM). Results from several similar experiments 
show that activation of σ receptors with the DTG inhibited ASIC1a-mediated 
currents by 53 ± 9 %, and this decrease was statistically significant manner 
(Figure 2.12B). To determine if the effects of DTG on ASIC1a currents were 
mediated by σ-1 or σ-2 receptors, the effects of the σ-1 selective agonist, CBP, 
on whole-cell currents were measured. Figure 2.12C shows representative 
membrane current traces as a function of time recorded in the absence (Control) 
and presence of CBP (50 µM). After multiple experiments, analysis of the 
measured current densities showed that control cells had statistically significant 
larger current densities than CBP treated cells (Figure 2.12D). In the presence of 
50 μM CBP, ASIC1a-mediated currents were decreased by 30 ± 5 % relative to 
control. In contrast, the σ-2 selective agonist, PB28 (20 µM), failed to inhibit 
ASIC1a-mediated membrane currents, suggesting σ-2 receptors do not regulate 
ASIC1a function (Figure 2.12D). Therefore, these results demonstrate that σ-1 
 44
receptors functionally couple to ASIC1a channels in cortical neurons as well as to 
targets downstream of ASIC1a activation. 
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Figure 2.1 - ASIC1a blockers inhibit proton-evoked increases in [Ca2+]i in cultured 
cortical neurons from embryonic (E18) rats. A, Representative traces of [Ca2+]i as 
a function of time recorded from a single cell during acidosis in the absence 
(Control, Wash) and presence of 100 μM Amiloride (Amiloride). B, Mean change 
in peak [Ca2+]i (± SEM) measured in response to low pH solution (pH 6.0) under 
the indicated conditions (n = 69). C, Representative traces of [Ca2+]i as a function 
of time recorded from a neuron during acidosis (Control, Wash) and following 20 
minutes preincubation in 500 ng/ml Psalmotoxin1 venom (PcTx1). Psalmotoxin1 
venom was only present in the pH 7.4 conditioning solution. D, Mean change in 
peak [Ca2+]i (± SEM) measured during acidosis under the indicated conditions (n 
= 158). Asterisks denote significant difference from Control and Wash groups in 
(B) and (D) (p <0.001).  
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Figure 2.2 - Pan-selective sigma agonists inhibit proton-evoked transient 
increases in [Ca2+]i. A, Representative traces of [Ca2+]i as a function of time 
recorded from a single neuron during acidosis in the absence (Control, Wash) 
and presence of 100 μM DTG (DTG). B, Mean change in peak [Ca2+]i (± SEM) 
measured during acidosis in the absence (Control, n = 119) and presence of 100 
μM DTG (DTG; n = 99) or 10 μM opipramol (OPI, n = 119). Asterisks denote 
significant difference from Control group (p < 0.001), and pound symbol indicates 
significant difference from DTG group (p < 0.05). C, Representative traces of 
[Ca2+]i as a function of time recorded from a neuron during acidosis in the 
absence (Control) and presence of 100 μM and 300 μM DTG. D, Concentration-
response relationship for DTG inhibition of mean change in peak [Ca2+]i (± SEM).  
Values obtained for each cell were normalized to their respective controls (no 
DTG) (n = 117-124). Line represents a best fit to the data using a single-site 
Langmuir-Hill equation. 
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Figure 2.3 - Activation of σ-1 receptors inhibits ASIC1a-induced increases in 
[Ca2+]i. Representative traces of [Ca2+]i as a function of time recorded from two 
cells during acidosis in the absence (Control) and presence of 10 μM and 100 
μM carbetapentane (A, CBP), or in the absence (Control) and presence of 10 μM 
and 100 μM dextromethorphan (B, DEX). C, Concentration-response 
relationships for mean change in peak [Ca2+]i (± SEM) measured during acidosis 
in the presence of the indicated σ-1 selective ligands DEX, PRE-084, and CBP. 
Values were normalized to control (absence of σ ligand). Solid and dashed lines 
represent best fits to the data using single-site Langmuir-Hill equations. Dotted 
line represents best fit to the data obtained for CBP inhibition of chemical 
ischemia-induced (4 mM azide in glucose-free PSS) increases in [Ca2+]i, and is 
shown for comparison (Katnik et al., 2006). For each condition n > 73.   
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Figure 2.4 - Inhibition of σ-1 receptors blocks CBP-mediated suppression of 
proton-evoked increases in [Ca2+]i. A, Representative traces of [Ca2+]i as a 
function of time recorded from 2 different neurons during acidosis in the absence 
(Control) and presence of 30 µM CBP (CBP), without (PSS, left traces) and with 
1hr preincubation in 50 µM metaphit (Metaphit, right traces). B, Percent inhibition 
of [Ca2+]i increases (± SEM) by CBP measured during acidosis under control 
conditions (Control, n = 135) and following metaphit preincubation (MET, n = 
113). C, Representative traces of acid-induced increases in [Ca2+]i as a function 
of time recorded from 2 different neurons in the absence (Control) and presence 
of 30 µM CBP (CBP), without (PSS, left traces) and with co-application of 10 nM 
BD1063  (BD1063, right traces). D, Percent inhibition of [Ca2+]i increases (± 
SEM) by CBP under control conditions (Control, n = 178) and in the presence of 
BD1063 (BD1063, n = 116). Asterisks in (B) and (D) denote significant difference 
from Control groups (p < 0.001). 
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Figure 2.5 - Sigma-2 receptor ligands inhibit ASIC1a-mediated elevations in 
[Ca2+]i at concentrations inconsistent with σ-2 mediated effects and in a metaphit-
insensitive manner. A, Representative traces of [Ca2+]i as a function of time 
recorded from two neurons during acidosis in the absence (Control) and 
presence of 10 µM and 100 µM ibogaine (IBO, left traces), or in the absence 
(Control) and presence of 1 µM  and 10 µM PB28 (right traces). B, Mean change 
in peak [Ca2+]i (± SEM) measured during acidosis in the presence of the σ-2 
selective ligands PB28 and IBO. Solid lines represent best fits to the data using 
single-site Langmuir-Hill equations. Dashed line represents best fit to the data 
obtained for IBO inhibition of ICa, and is shown for comparison (Zhang and 
Cuevas, 2002). For each condition, n > 108 cells. C, [Ca2+]i as a function of time 
recorded from 2 different neurons during acidosis in the absence (Control) and 
presence of 20 µM PB28 (PB28), without (PSS) and with (+MET) 1hr 
preincubation in 50 µM metaphit. D, Percent inhibition of [Ca2+]i (± SEM) by PB28 
measured during acidosis under control conditions (Control, n = 324), following 
metaphit preincubation (+MET, n = 276) and co-applied with 10 nM BD1063 
(BD1063, n = 139). There is no significant difference between Control and +MET 
groups, (p = 0.64) or Control and BD1063 groups (p = 0.70).  
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Figure 2.6 - Intracellular Ca2+ stores are not involved in DTG modulation of 
ASIC1a-induced increases in [Ca2+]i. A, Representative traces of [Ca2+]i as a 
function of time recorded from a neuron during acidosis in the absence (Control) 
and presence of 100 µM DTG (DTG). B, Representative traces of [Ca2+]i as a 
function of time recorded from a neuron during acidosis following preincubation in 
10 μM thapsigargin (1 hr, 23º C) in the absence (THAP) and presence of 100 μM 
DTG (THAP + DTG). C, Mean change in peak [Ca2+]i (± SEM) measured in 
response to acidosis with (THAP, n = 346) or without (PSS, n = 216) thapsigargin 
preincubation in the absence (Control) and presence of 100 μM DTG (DTG).  
Asterisks denote significant difference from Control group (p < 0.001). There was 
no significant difference between PSS and THAP groups (p = 0.48). 
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Figure 2.7 - ASIC1a-mediated [Ca2+]i increases are membrane potential 
dependent. A, Representative traces of [Ca2+]i recorded in response to ASIC1a 
activation from a neuron electrically accessed using the perforated patch whole-
cell configuration and held at -70 mV ([Ca2+]i V-Clamp), and from a second 
neuron in the same field of view which was not electrically accessed ([Ca2+]i 
Control). Inset, whole-cell current trace recorded simultaneously from the 
voltage-clamped neuron. Lines above traces indicate application of pH 6.0 
solution.  Scale bars: 500 pA, 5 sec. B, Mean change in peak [Ca2+]i (± SEM) 
measured during acidosis in non voltage-clamped neurons (Control, n = 37) and 
in voltage-clamped neurons (V-Clamp, n = 4). Asterisks denote significant 
difference between groups (p < 0.001).  
 
 
 
 
 
 
 
 
 
 
 
 58
 59
Figure 2.8 - ASIC1a activation promotes membrane depolarization. A, 
Representative traces of ASIC1a-mediated membrane potential changes as a 
function of time recorded from a neuron held under current-clamp mode in the 
absence (Control) and presence of 100 μM amiloride (Amiloride). B, Changes in 
peak membrane potential (± SEM) recorded from neurons in normal PSS 
(Control) or in PSS containing 100 μM amiloride (Amiloride, n = 3). Asterisk 
denotes significant difference from Control group (p < 0.05). C, Representative 
traces of ASIC1a-mediated membrane potential changes as a function of time 
recorded from a different cell held under current-clamp mode in the absence 
(Control) and presence of 50 nM PcTx1 peptide (PcTx1). D, Changes in peak 
membrane potential (± SEM) recorded from neurons in the absence (Control) or 
presence of 50 nM PcTx1 peptide (PcTx1, n = 3). No significant difference 
between Control and PcTx1 groups were noted (p = 0.11). 
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Figure 2.9 - Sigma-1 receptor activation inhibits Ca2+ channels downstream of 
ASIC1a. A, Representative traces of [Ca2+]i recorded in response to application 
of extracellular high K+ (40 mM) solution in the absence (Control) and presence 
of 100 μM CBP. B, Bar graph of mean change in peak [Ca2+]i (± SEM) measured 
after multiple experiments (n = 59). Asterisks denote significant difference 
between groups (p < 0.001). 
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Figure 2.10 - Multiple plasma membrane ion channels downstream of ASIC1a 
activation contribute to acidosis-evoked [Ca2+]i increases. A, Relative changes in 
[Ca2+]i (± SEM) during acidosis in the absence (PSS) and presence of 500 nM 
tetrodotoxin (TTX) alone or TTX (500 nM) co-applied with 100 μM AP5, 10 μM 
nifedipine or 100 μM cadmium. All combinations were done without (Control) and 
with 50 µM CBP (CBP). For each condition n > 101. Asterisks denote significant 
differences from respective control groups (p < 0.001), pound symbol from PSS 
group (p < 0.01 for TTX vs. PSS, p < 0.001 for all others), and dagger symbols 
from TTX group (p < 0.001). B, Relative changes in [Ca2+]i (± SEM) during 
acidosis in the absence (Control) and presence of 10 μM CNQX (CNQX) without 
CBP (PSS) or with CBP at the indicated concentrations. For each condition n > 
95. Asterisks denote significant differences from PSS group within Control or 
CNQX groups (p < 0.001), pound symbols indicate significance differences 
between 50 μM and 300 μM CBP groups within Control or CNQX groups (p < 
0.001), and daggers denote significant differences between Control and CNQX 
within PSS (p < 0.001) and 300 µM CBP (p < 0.05) groups. 
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Figure 2.11 - ASIC1a blockers inhibit acidosis-mediated currents in voltage-
clamped neurons. A, Representative traces of ASIC1a-mediated currents as a 
function of time recorded from two neurons held at -70 mV in the absence 
(Control) and presence of 100 μM amiloride (Amiloride) (i.) or 500 ng/ml 
Psalmotoxin1 venom (PcTx1) (ii.). B, Relative mean peak proton-gated currents 
(± SEM) recorded from neurons in normal PSS (Control) or in PSS containing 
either 100 μM amiloride (Amiloride, n = 6) or 500 ng/ml Psalmotoxin1 venom 
(PcTx1, n = 4). Values were normalized to the maximum proton-evoked response 
recorded for control conditions (no drug) in each cell (I/Imax). Asterisks denote 
significant difference from Control group (p < 0.01). C, Relative peak proton-
gated currents (I/Imax, ± SEM) recorded in the absence (PSS) and presence of 
500 nM tetrodotoxin (TTX, n = 4) alone and TTX with 100 μM AP-5 (n = 3), 10 
μM CNQX (n = 4), 10 μM nifedipine (Nif, n = 6) or 100 μM cadmium (Cd, n = 3) 
inthe bath solution. Cells were voltage-clamped at -70 mV. No significant 
differences between the groups were noted (p = 0.826). 
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Figure 2.12 - Sigma receptor agonists inhibit ASIC1a-mediated currents in 
voltage-clamped neurons. A, Representative traces of ASIC1a currents as a 
function of time recorded from a single perforated-patched neuron held at -70 mV 
in the absence (Control) and presence of 100 μM DTG (DTG). B, Mean peak 
proton-gated current densities (± SEM) measured from neurons held at -70 mV 
without (Control) or with 100 μM DTG (DTG) in the bath solution (n = 6). C, 
Representative traces of ASIC1a-mediated currents as a function of time 
recorded from a voltage-clamped neuron (-70 mV) in the absence (Control) and 
presence of 50 μM CBP (CBP). D, Mean peak proton-gated current densities (± 
SEM) recorded from neurons held at -70 mV without (Control) or with 50 μM CBP 
(CBP, n = 6) or 20 μM PB28 (PB28, n = 4). Asterisks in (B) and (C) denote 
significant differences from respective Control groups (p < 0.001). 
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Discussion 
Activation of σ receptors depresses membrane currents and elevations in 
[Ca2+]i mediated by ASIC1a channels in cortical neurons. The pharmacological 
properties of the receptor involved are consistent with the effects being 
specifically mediated by the σ-1 receptor subtype. Furthermore, most of the 
elevations in [Ca2+]i  triggered by acidosis are the result of Ca2+ channels opening 
downstream of ASIC1a activation. Stimulation of σ-1 receptors effectively 
suppressed these secondary Ca2+ fluxes both by inhibiting ASIC1a and the other 
channels directly.  
ASIC are regulated by various factors such as pH, membrane distention 
and arachidonic acid, and therefore, function as signal integrators in the CNS 
(Allen and Attwell, 2002; Lopez, 2002). All of these factors elicit or potentiate 
ASIC-mediated responses. Information on endogenous mechanisms that inhibit 
ASIC function is lacking. It has been shown that NMDA receptors modulate 
ASIC1a function via the activation of a CaMKII signaling cascade, but activation 
of this pathway results in an increase in currents through ASIC1a (Gao et al., 
2005). Thus, our finding that activation of σ receptors depresses ASIC1a-
mediated responses is novel. Our conclusion that the responses observed are 
mediated specifically by ASIC1a is supported by the inhibition produced with the 
selective ASIC1a channel blocker, PcTx1 (Diochot et al., 2007), and that cultured 
cortical neurons from embryonic mice deficient in the ASIC1a subunit fail to show 
increases in [Ca2+]i or membrane currents at the proton concentrations used here 
(Xiong et al., 2004). ASIC2a and ASIC2b subunits are also expressed in the 
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CNS, but homomeric ASIC2a channels are activated below pH 5.5, and ASIC2b 
does not generate currents in response to low pH (Lingueglia et al., 1997).  
Furthermore, neither homomeric ASIC2a nor heteromultimeric ASIC1a/ASIC2a 
channels conduct Ca2+, and thus could not account for the changes in [Ca2+]i 
observed here (Yermolaieva et al., 2004). 
  Results from Ca2+ imaging experiments suggest that it is specifically the 
σ-1 receptor subtype that modulates neuronal responses to ASIC1a activation.  
Studies have shown that the affinity of carbetapentane for σ-1 receptors is     
>50-fold greater than for σ-2 receptors (Rothman et al., 1991; Vilner and Bowen, 
2000). The calculated IC50 for carbetapentane inhibition of ischemia-evoked 
increases in [Ca2+]i via σ-1 receptor activation is 18.7 µM (Katnik et al., 2006), 
which is comparable to the 13.8 μM IC50 for CBP inhibition of ASIC1a-induced 
[Ca2+]i increases. Carbetapentane also inhibits epileptiform activity in rat 
hippocampal slices via σ-1 receptors with an IC50 value of 38 µM (Thurgur and 
Church, 1998). Similarly, we show that the σ-1 agonists dextromethorphan    
(IC50 = 22 μM) and PRE-084 (IC50 = 13.7 μM), both of which have >100-fold 
greater affinities for σ-1 than σ-2 receptors, block ASIC1a-mediated responses at 
concentrations consistent with those reported in the literature.  
Dextromethorphan inhibits spreading depression in rat neocortical brain slices 
with an IC50 ~ 30 μM (Anderson and Andrew, 2002), whereas PRE-084 protects 
human retinal cells against oxidative stress with an IC50 ~ 10 μM (Bucolo et al., 
2006). The fact that IC50 values determined here for carbetapentane, 
dextromethorphan and PRE-084 are in the low μM range suggests that it is 
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unlikely these agonists are affecting ASIC1a activity via σ-2 receptors, since high 
μM to mM concentrations of these compounds are required to stimulate σ-2 
receptors. Moreover, σ-2-selective agonists failed to inhibit ASIC1a-mediated 
responses at concentrations consistent with σ-2 specific effects.  
 The strongest evidence that σ-1 receptor activation modulates ASIC1a 
comes from experiments using the σ antagonists, metaphit and BD1063.  
Metaphit has been shown to bind irreversibly to σ-1 receptors with an IC50 value 
of 50 μM (Wu, 2003). Preincubation in metaphit blocks σ-1 receptor mediated 
modulation of voltage-gated K+ channels in intracardiac neurons and depression 
of ischemia-induced elevations in [Ca2+]i in cortical neurons (Zhang and Cuevas, 
2005; Katnik et al., 2006). Preincubation of cortical neurons in 50 μM metaphit 
antagonized CBP inhibition of ASIC1a by ~ 40%. BD1063 has been shown to 
have a higher affinity for σ-1 than σ-2 receptors and attenuates the dystonia 
produced by DTG in rats in a dose-dependent manner, suggesting this ligand 
acts as an antagonist at σ sites (Matsumoto et al., 1995). Here we show that 
CBP is unable to block acid-induced increases in [Ca2+]i when co-applied with 
BD1063. In addition, we found that metaphit fails to inhibit the effects of the σ-2 
agonist, PB28, on ASIC1a-mediated responses. Taken together, these data 
show that increases in [Ca2+]i in response to ASIC1a activation are modulated 
only by σ-1 receptors. 
Several studies have suggested that Ca2+ influx through ASIC1a channels 
is a key mechanism leading to cell death (Xiong et al., 2004; Yermolaieva et al., 
2004). Depletion of Ca2+ from intracellular stores indicates that most, if not all, of 
 72 
 
the acid-induced increases in [Ca2+]i is due to plasma membrane influx. However, 
our results show that multiple ion channels downstream of ASIC1a activation 
contribute to acidosis-induced elevations in [Ca2+]i, including NMDA and 
AMPA/kainate receptors and VGCC. The activation of NMDA and AMPA/kainate 
receptors following ASIC1a stimulation was observed even when neuronal 
conduction was inhibited with tetrodotoxin. This observation suggests a 
presynaptic localization of ASIC1a, whereby activation of the channel by protons 
results in synaptic transmission and subsequent activation of postsynaptic 
glutamatergic receptors. Consistent with this hypothesis, ASIC1a has been found 
to regulate neurotransmitter release probability in mouse hippocampal neurons 
(Cho and Askwith, 2008). 
σ receptors have been identified in both presynaptic and postsynaptic 
sites (Gonzalez-Alvear and Werling, 1995; Alonso et al., 2000), and thus may 
modulate channels in both regions. In the presence of specific inhibitors of 
ionotropic glutamate receptors, activation of σ-1 receptors with CBP further 
decreased proton-evoked increases in [Ca2+]i, but the effects of CBP and the 
glutamate channel inhibitors were less than additive. Thus, σ-1 receptors also 
inhibit Ca2+ entry via NMDA and AMPA/kainate receptors directly by inhibiting 
these channels and indirectly by depressing ASIC1a activation. Application of the 
L-type VGCC inhibitor, nifedipine, and the broad-spectrum Ca2+ channel inhibitor, 
cadmium, blocked ASIC1a-induced increases in [Ca2+]i by >70% and >90%, 
respectively. This observation indicates that most of the increases in [Ca2+]i 
produced upon ASIC1a activation is dependent on Ca2+ influx through VGCC. 
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Co-application of CBP with nifedipine, but not with Cd2+, resulted in further 
reduction in the proton-evoked increases in [Ca2+]i. The conclusion that Ca2+ 
influx through ASIC1a channels itself contributed only a small fraction to the total 
observed [Ca2+]i increases was confirmed with simultaneous Ca2+ fluorometry 
and whole-cell patch clamp recordings. Cells voltage-clamped at –70 mV, which 
prevents NMDA receptor and VGCC activation, demonstrated minimal acid-
evoked elevations in [Ca2+]i. Taken together, our results show that the increases 
in [Ca2+]i evoked by ASIC1a activation are the result of synaptic transmission and 
subsequent opening of multiple Ca2+ channels, and that stimulation of σ-1 
receptors downregulates all of these events. However, the fact that activation of 
σ-1 receptors depressed ASIC1a-mediated currents in cells voltage-clamped at   
-70 mV indicate that σ-1 receptors are functionally coupled to ASIC1a, and that 
the depression in acid-evoked increases in [Ca2+]i is not exclusively the result of 
σ-1 receptors blocking channels downstream of ASIC1a. 
The finding that σ-1 receptors can inhibit ASIC1a channels has significant 
physiological and pathophysiological implications. It has been proposed that 
ASIC1a activation may facilitate neurotransmission by compensating for the 
decrease in excitatory neurotransmission caused by direct inhibition of post-
synaptic Na+ and Ca2+ channels by protons which are released during exocytosis 
(Krishtal et al., 1987; Zha et al., 2006). Furthermore, the expression levels of 
ASIC1a have direct effects on the density of dendritic spines in hippocampal 
neurons (Zha et al., 2006). Thus, σ-1 receptors may influence cell-to-cell 
signaling in the CNS by affecting ASIC1a activity. One of the consequences of 
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ASIC1a overexpression in mice is enhanced fear conditioning (Wemmie et al., 
2004), whereas stimulation of σ-1 receptors is known to ameliorate conditioned 
fear stress (Kamei et al., 1997). These observations, coupled with our current 
report, suggest that σ-1 receptor activation may produce anxiolytic effects via the 
inhibition of ASIC1a channels.   
The inhibition of ASIC1a by σ-1 receptors is a potential component of the 
neuroprotective properties of σ receptors, since activation of ASIC1a has been 
shown to contribute to stroke injury (Xiong et al., 2004). Importantly, inhibition of 
ASIC1a has been shown to be neuroprotective at delayed time points following 
ischemic stroke (Simon, 2006). Thus, σ-1 receptor-mediated inhibition of ASIC1a 
may contribute to the enhanced neuronal survival following σ receptor activation 
24 hr post-stroke in rats (Ajmo et al., 2006). Furthermore, our data suggests that 
activation of ASIC1a stimulates the activity of NMDA and AMPA/kainate 
receptors and VGCC, all of which have been linked to ischemia-induced brain 
injury. Thus, σ-1 receptor activation may provide further neuroprotection by 
reducing the activity of these channels which occurs subsequent to ASIC1a 
stimulation. Consistent with this pleiotropic effect of σ-1 receptors is our 
observation that σ-1 receptor activation suppressed extracellular high K+-induced 
increases in [Ca2+]i, which would also activate these downstream effectors. In 
conclusion, σ-1 receptors inhibit ASIC1a channel function and blunt acidosis-
evoked ionic fluxes and increases in [Ca2+]i. Thus, σ-1 receptors can be targeted 
for therapeutic intervention in pathophysiological conditions involving ASIC1a 
activation. 
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CHAPTER 3 
 
 
SIGMA-1 RECEPTOR ACTIVATION INHIBITS ASIC1a CHANNELS VIA A 
PERTUSSIS TOXIN SENSITIVE G PROTEIN AND AN  
AKAP/CALCINEURIN COMPLEX 
 
 
Introduction 
 
 
Acid-sensing ion channels (ASIC) are a class of ligand-gated ion channels 
that are members of the degenerin/epithelial sodium channel (Deg/ENac) 
superfamily (Waldmann et al., 1997b; Benos and Stanton, 1999). ASIC are 
expressed in both peripheral and central nervous system neurons. Several 
extracellular and intracellular modulators of ASIC have been identified. Divalent 
cations (Zn2+, Pb2+, Ca2+) (Baron et al., 2001; Chu et al., 2004; Gao et al., 2004; 
Wang et al., 2006), lactate (Immke and McCleskey, 2001), serine proteases 
(Poirot et al., 2004) and redox reagents (Andrey et al., 2005; Chu et al., 2006) 
have been shown to interact with the extracellular domain of ASIC and influence 
the function of these channels. Moreover, there is a conserved phosphorylation 
site within the intracellular C-terminal domain of ASIC1a that is also the 
calcium/calmodulin protein kinase II (CaMKII) (Gao et al., 2005), protein kinace C 
(PKC) (Baron et al., 2002) and protein kinase A (PKA) (Leonard et al., 2003) 
binding site. Phosphorylation of ASIC1a has been shown to potentiate ASIC1a 
function in neurons (Xiong et al., 2004; Gao et al., 2005). In contrast, the second 
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messenger, calcineurin, dephosphorylates ASIC1a channels and results in 
downregulation of channel function (Chai et al., 2007). 
 Dephosphorylation of ASIC1a is mediated through the interaction with 
cytoskeletal anchoring protein, A-kinase anchoring protein (AKAP). Interestingly, 
AKAP150 and calcineurin have been implicated in the downregulation of both 
ASIC1a and ASIC2a channels (Chai et al., 2007). AKAP is a diverse protein 
family with more than 50 members which are abundantly expressed in the brain 
(Feliciello et al., 2001). Neuronal AKAP150 (rat) and AKAP79 (human) share a 
high degree of sequence homology, differing primarily in a 9 amino acid repeat 
sequence insert found only in rodents which has no known function (Dell'Acqua 
et al., 2006). AKAP150 anchors both kinases (cAMP-dependent Protein Kinase A 
and Protein Kinase C) and phosphatases (calcineurin) that are inhibited when 
bound. AKAP150 targets these proteins, through a unique targeting motif,  to 
specific subcellular sites and plasma membrane via association with structural 
proteins, membranes, or cellular organelles (Dell'Acqua et al., 1998; Diviani and 
Scott, 2001).  
AKAP150 has been shown to modulate the internalization of AMPA 
receptors, NMDA receptors during long term potentiation and depression 
(Rosenmund et al., 1994; Westphal et al., 1999; Colledge et al., 2000; Gomez et 
al., 2002; Smith et al., 2006) and voltage-gated Ca2+ channel function (Oliveria et 
al., 2007). All of these ion channels have shown to be regulated by σ receptor 
activation in neurons via various signaling cascade mechanisms. σ receptor 
activation has been shown to depress both membrane currents and elevations in 
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[Ca2+]i mediated by ASIC1a channels in cortical neurons. Furthermore, most of 
the elevations in [Ca2+]i  triggered by acidosis were determined to be the result of 
Ca2+ channels opening downstream of ASIC1a activation, and activation of σ-1 
receptors effectively suppressed these secondary Ca2+ fluxes by both inhibiting 
ASIC1a and/or the Ca2+ channels directly. But the signaling cascade mechanism 
by which σ-1 receptors regulate ASIC1a channels remains to be elucidated.  
σ-1 receptors are directly coupled to potassium channels in intracardiac 
neurons and activation of this receptor subtype depresses the excitability of 
these neurons, blocking parasympathetic input to the heart (Zhang and Cuevas, 
2005). In cultured frog melanotrope cells, DTG and (+)-pentazocine have been 
shown to modulate electrical activity by reducing both a tonic K+ current and a 
voltage-dependent K+ conductance through activation of a cholera toxin-sensitive 
G protein (Soriani et al., 1998; Soriani et al., 1999). In Xenopus oocytes, the 
signal transduction cascade between Kv1.4 and σ receptors has been shown to be 
dependent on protein-protein interactions (Aydar et al., 2002).  
In this study, experiments were conducted to determine the signaling 
cascade linking σ-1 receptors to ASIC1a channels and downstream Ca2+ 
channels. σ-1 receptors, ASIC1a and AKAP150 were shown to colocalize not 
only in the plasma membrane of cortical neuron cell bodies but also in the 
dendritic processes of these cells. Calcineurin inhibitors, cyclosporin A and FK-
506, and the G protein inhibitor pertussis toxin (PTX) diminished the 
downregulation of ASIC1a by σ-1 receptors, suggesting that σ-1 receptors exert 
their effect via calcineurin-dependent dephosphorylation of ASIC1a and a PTX-
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sensitive G protein. Furthermore, disruption of the actin cytoskeleton or 
dissociation AKAP150 from the plasma membrane were shown to diminish σ-1 
receptor mediated inhibition of ASIC1a channels. Moreover, whole-cell patch 
clamp experiments confirmed that preincubation in PTX or disruption of the 
AKAP/calcineurin interaction with VIVIT, prevented σ-1 receptor modulation of 
ASIC1a-mediated membrane currents, suggesting σ-1 receptors couple to 
ASIC1a channels via a PTX-sensitive G protein and an AKAP150/calcineurin 
complex. This is the second report of receptor-mediated functional 
downregulation of ASIC1a channels. Thus far, σ-1 receptors are the only 
receptors identified to inhibit ASIC1a channel function.  
 
Materials and Methods 
Primary Rat Cortical Neuron Preparation 
 Primary cortical neurons from embryonic (E18) rats were cultured as 
previously described by our laboratory (Katnik et al., 2006).  All procedures were 
done in accordance with the regulations of the University of South Florida 
Institutional Animal Care and Use Committee.  Cells were used after 10-21 days 
in culture. 
Calcium Imaging Measurements 
The effects of acidosis on intracellular Ca2+ concentrations were examined 
in isolated cortical neurons using ratiometric calcium imaging. Cytosolic free-Ca2+ 
was measured using the Ca2+ sensitive dye, fura-2. The membrane permeable 
ester form of fura-2, fura-2 AM, acetoxymethyl ester (AM), was loaded and 
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imaged as we have previously described (DeHaven and Cuevas, 2004; Katnik et 
al., 2006). Briefly, cells plated on coverslips were incubated for 1 hour at room 
temperature in Neurobasal (Invitrogen) medium supplemented with B27 
(Invitrogen) and 0.5 mM L-glutamine, or in physiological saline solution (PSS) 
consisting of (in mM): 140 NaCl, 5.4 KCl, 1.3 CaCl2, 1.0 MgCl2, 20 glucose, and 
25 HEPES (pH to 7.4 with NaOH). Both solutions contained 4 μM of fura-2, 
acetoxymethylester (fura-2 AM) and 0.4 % dimethyl sulfoxide. The coverslips 
were washed in PSS (fura-2-AM free) prior to the experiments being carried out.   
Electrophysiology Recordings 
 ASIC1a-mediated membrane currents were recorded using the protocol 
previously described by our laboratory. Briefly, neurons plated on glass 
coverslips were transferred to a recording chamber and membrane currents were 
amplified, filtered at 1 kHz, digitized at 5 kHz, and acquired using Clampex 8 
(Axon).  Electrical access was achieved using the amphotericin B perforated-
patch method to preserve intracellular integrity of neurons (Rae et al., 1991). An 
amphotericin B stock solution (60 mg/ml in DMSO) was made fresh everyday, 
kept on ice, light protected, and diluted to 240 µg/ml (0.4% DMSO) in control 
pipette solution immediately prior to patching. The control pipette solution 
consisted of (in mM): 75 K2SO4, 55 KCl, 5 MgSO4, and 10 HEPES (titrated to pH 
7.2 with N-methyl-d-glucamine). Patch electrodes were pulled from thin-walled 
borosilicate glass (World Precision Instruments Inc., Sarasota, FL) using a Sutter 
Instruments P-87 pipette puller (Novato, CA) and had resistances of 1.0–1.5 MΩ. 
Access resistances (Rs) were monitored throughout experiments for stable 
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values ≤ 20 MΩ and were always compensated at 40% (lag, 10 µs). All cells 
were voltage-clamped at -70 mV. 
Immunohistochemistry 
Cortical neurons plated on coverslips were first rinsed with phosphate 
buffer saline (PBS) to remove excess media. Cells were fixed by incubating in 
95% ethanol and 5% acetic acid at -20°C for 20 minutes, followed by four 2-
minute incubations at room temperature in 95%, 75%, 50% and 0% ethanol. 
Neurons were then permeabilized with PBS solution containing 0.1% Triton X for 
15 minutes and rehydrated with 3 washes in PBS and 5 washes in PBS with 
0.5% bovine serum albumin (BSA). The cells were then blocked with 2% BSA in 
PBS for 45 minutes at room temperature. Neurons were incubated in the primary 
antibodies (ASIC1 guinea-pig polyclonal IgG at 1:500 dilution, AKAP150 goat 
polyclonal IgG at 1:50 dilution and σ -1 rabbit polyclonal IgG at 1:500 dilution) in 
0.5% BSA in PBS solution overnight at 4°C and in the secondary antibodies 
(Alexa-Fluor 633 goat anti-guinea pig, Alexa-Fluor 555 donkey anti-goat and 
Alexa-Fluor 488 goat anti-rabbit, all at 1:1000 fold dilutions) for an hour at room 
temperature. Primary antibodies were purchased from: AKAP150 (Santa Cruz 
Biotechnology, Santa Cruz, CA) and ASIC1a (Lifespan Biosciences, Seattle, 
WA). σ-1 receptor antibody was kindly provided by Drs. T. P. Su and Teruo 
Hayashi (Baltimore, Maryland). Secondary antibodies were purchased from 
Invitrogen (Eugene, OR): Alexa Fluor 488 anti-rabbit, Alexa Fluor 555 anti-goat, 
and Alexa Fluor 633 anti-guinea-pig. Coverslips with labeled cells were then 
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mounted onto a microscope slide using VectaShield Hardset Media with DAPI 
purchased from Vector Laboratories (Burlingame, CA).  
Confocal Microscopy 
 Confocal images of triple labeled neurons were collected using a Leica 
DMI6000 inverted microscope, TCS SP5 confocal scanner and a 100x/1.4 N.A. 
Plan Apochromat oil immersion objective (Leica Microsystems, Germany). Laser 
lines (405 Diode, Argon, HeNe 543, and HeNe 633) were applied to excite 
stained cells and tunable filters were used to minimize crosstalk between 
fluorchromes. Image sections at 0.4 μm were acquired with photomultiplier 
detectors, processed and analyzed using Leica LAS AF software version 1.8.2 
(Leica Microsystems, Germany). 2-D images of fluorescence emission for each 
fluorophore (AF488, green; AF555, red; AF633, purple) were collected for 20-30 
optical sections along the z-axis for each field of view. Areas of colocalization for 
pairs of fluorophores in a single z-section are depicted as white pixels in the 
merged images and represent pixels within the boundaries drawn in the scatter 
plot (Figure 3.1). The area underneath the arc represents background pixels 
which have been eliminated, while pixels outside the two straight lines are pixels 
with intensities greater than background in only one of the images. The Overlap 
Coefficient (R), a correlation coefficient relating two images or regions within an 
image, is defined as 
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where S1i is the intensity of pixel i in image 1 and S2i its intensity in image 2 
(Manders, 1993). R ranges from 1, complete colocalization, to 0, complete non-
colocalization and was calculated for entire images and within regions of interest 
drawn around individual cells.  
Solutions and Reagents 
The control bath solution for all experiments was PSS.  All drugs were 
applied in this solution using a rapid application system identical to that 
previously described (Cuevas and Berg, 1998). ASIC activation was induced by 
applying PSS with a pH of 6.0 (+/- drug) to specifically target ASIC1a. Individual 
cells were exposed to ≤ 3 low pH applications. No rundown of responses was 
observed using this protocol. All chemicals used in this investigation were of 
analytic grade. The following drugs were used: DTG and pertussis toxin (Sigma-
Aldrich, St. Louis, MO); carbetapentane and NMDA (Tocris Bioscience, Ellisville, 
MO); latrunculin-A, cyclosporineA and VIVIT (Calbiochem, San Diego, CA); FK-
506 (LC Laboratories, Woburn, MA); tetrodotoxin (Alomone Labs, Jerusalem, 
Israel); and fura-2 AM (Molecular Probes, Eugene, OR).  
Data Analysis 
 Analysis of measured intracellular Ca2+ and membrane current responses 
was conducted using Clampfit 9 (Axon instruments). Imaging data files collected 
with SlideBook 4.02 (Intelligent Imaging Innovations, Inc.) were converted to a 
text format and imported into Clampfit for subsequent analysis. Statistical 
analysis was conducted using SigmaPlot 9 and SigmaStat 3 software (Systat 
Software, Inc.). Statistical differences were determined using paired and 
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unpaired t-tests for within group and between group experiments, respectively, 
and were considered significant if p < 0.05. For multiple group comparisons 
either a 1-way or a 2-way ANOVA was used, as appropriate. When significant 
differences were determined with an ANOVA, post-hoc analysis was conducted 
using a Tukey’s Test to determine interaction between individual groups.   
 
Results 
To answer whether the signaling cascade linking σ receptors to ASIC 
channels might involve protein-protein interactions, immunohistochemical 
fluorescent staining experiments were performed on cortical neurons to 
determine if σ-1 receptors, ASIC1a channels and AKAP150 colocalize. Figure 
3.1A shows fluorescent images of neurons triple labeled for σ-1 receptors(i), 
AKAP150 (ii) and ASIC1a channels (iii) from the same field of view. The white 
pixels represent areas in the image where σ-1 receptor and AKAP150 (Figure 
3.1B, i) labeling appear together as selected in the scatter plot (Figure 3.1B, ii). 
The scatter plot maps pixel intensities from the σ-1 receptor labeling versus 
intensities from the AKAP150 labeling. The overlap coefficient for σ-1 receptor 
and AKAP150 colocalization calculated using Eq. 1 for the entire image was 
calculated to be 0.74. Figure 3.1C, i, shows the merged image of σ-1 receptor 
and ASIC1a labeling with colocalized pixels represented in white and the 
colocalization scatter plot (Figure 3.1C, ii). The overlap coefficient for σ-1 
receptors and ASIC1a channels for the entire image was calculated to be 0.78. 
After multiple experiments (3 stains with a total of 59 cell bodies and 45 neuronal 
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processes), the mean overlap coefficient for σ-1 receptor colocalization with 
AKAP150 and ASIC1a channels for individual cell bodies was calculated to be 
0.723 ± .007 and 0.790 ± .008, and for defined dendritic processes to be 0.696 ± 
.013 and 0.751 ± .009, respectively (Figure 3.1D). These images suggest that σ-
1 receptors colocalize with both AKAP150 and ASIC1a in the cell body and in the 
dendritic processes. The similarity of the pixel patterns in both sets of images 
(Figure 3.1A, ii and iii) is consistent with previous results showing colocalization 
of AKAP150 and ASIC1a (Chai et al., 2007).  
Reports suggest that calcineurin may be involved in the functional 
downregulation of ASIC1a and ASIC2a (Chai et al., 2007). Thus, experiments 
were carried out to determine if calcineurin is a constituent of the signaling 
cascade linking σ-1 receptors to ASIC1a channels. Figure 3.2A show 
characteristic traces of [Ca2+]i as a function of time recorded from three cells 
exposed to normal PSS solution (PSS, i) or PSS containing the calcineurin 
inhibitors FK-506 (1 μM, ii) and cyclosporin A (1 μM, cyclo A, iii), all in the 
absence and presence of CBP (10 μM). Both calcineurin inhibitors reversed the 
effects of σ-1 receptor activation on ASIC1a function. A summary of data 
collected from identical experiments is shown in Figure 3.2B. Bath application of 
FK-506 or cyclosporin A alone had no effects on control responses. However, 
following inhibition of calcineurin with either FK-506 or cyclosporin A, CBP 
blocked ASIC1a-mediated responses significantly less than under control 
conditions (Figure 3.2B). The percent-inhibition of ASIC1a-mediated responses 
by CBP was significantly decreased from 45 ± 1% in control cells to 31 ± 1% and 
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4 ± 2% in the presence of FK-506 and cyclosporin A, respectively (Figure 3.2C). 
These results suggest σ-1 receptors are functionally linked to ASIC1a via a 
signaling cascade involving calcineurin. These observations are consistent with 
reports in the literature which suggest that dephosphorylation of ASIC1a and 
ASIC2a channels by this phosphatase may be involved in the functional 
downregulation of ASIC (Chai et al., 2007).   
Calcineurin has been shown to be activated by a pertussis toxin-sensitive 
G protein, specifically Gi2 (Gromada et al., 2001). Previous reports suggest that 
σ-1 receptors may couple to ion channels, such as voltage-sensitive K+ channels, 
via G proteins (Soriani et al., 1998; Soriani et al., 1999). Experiments were 
performed to determine whether G proteins were also involved in σ-1 receptor 
regulation of ASIC1a channels. Figures 3.3A and 3.3B show representative 
traces of [Ca2+]i as a function of time recorded during acidosis in the absence 
(Control) and presence of CBP (CBP, 50uM) without (A) and with PTX 
preincubation (200 ng/ml for 24 hrs at 37°C, B). Results from multiple 
experiments suggest that PTX alone has some effect on ASIC1a-mediated 
[Ca2+]i increases but it does not change the kinetics of the responses (Figure 
3.3B). Preincubation in PTX significantly reduced σ-1 receptor mediated 
inhibition of ASIC1a-induced [Ca2+]i increases (Figure 3.3C). While CBP inhibited 
41 ± 1% of acid-induced increases in [Ca2+]i in control cells, the σ-1 ligand only 
blocked 26 ± 1% of the increases following PTX treatment. This inhibition was 
statistically significant (Figure 3.3D). These results suggest that σ-1 receptor 
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activation inhibits ASIC1a-induced increases in [Ca2+]i via a PTX-sensitive G 
protein.  
Having identified calcineurin and a PTX-sensitive G protein in the 
signaling pathway linking ASIC1a and σ-1 receptors, it was of interest to 
determine other constituents of the signaling cascade. The scaffolding protein 
AKAP150 has been shown to anchor kinases (PKA and PKC) and the 
phosphatase calcineurin to regulate ion channels and receptors (Dell'Acqua et 
al., 1998; Dodge and Scott, 2000; Feliciello et al., 2001; Moita et al., 2002; Wong 
and Scott, 2004; Beene and Scott, 2007). Activation of NMDA due to Ca2+ influx 
through the receptor has been shown to cause rearrangement of the 
cytoskeleton resulting in dissociation of AKAP150 from the plasma membrane 
(Gomez et al., 2002). Figures 3.4A and 3.4B show representative traces of [Ca2+]i 
as a function of time recorded during acidosis in the absence (Control) and 
presence of CBP (CBP, 50 μM) without (PSS, A) and with NMDA (10 μM, B) pre-
incubation. Pre-incubation in NMDA significantly reduced ASIC1a-mediated 
elevations in [Ca2+]i (Figure 3.4C). In addition, pre-incubation in NMDA also 
significantly reduced σ-1 receptor mediated inhibition of the remaining ASIC1a-
induced [Ca2+ ]i increase (Figure 3.4C). While CBP inhibited 44 ± 1% of acid-
induced increases in [Ca2+]i in control cells, it only inhibited 40 ± 1% in NMDA 
treated cells and this inhibition was statistically significant (Figure 3.4D). The 
small but significant block by NMDA of σ-1 receptor modulation of ASIC1a can 
probably be attributed to additional effects of Ca2+ overload following 
preincubation in NMDA which led to increases in basal calcium levels. These 
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results are consistent with the theory that the scaffolding protein AKAP150 is 
involved in σ-1 receptors modulation of ASIC1a-induced increases in [Ca2+]i, 
assuming NMDA receptor activation results in AKAP150 dissociation. 
AKAP150 has been shown to associate with the plasma membrane in 
neurons by binding to the cytoskeleton via f-actin (Dell'Acqua et al., 1998; Dodge 
and Scott, 2000; Diviani and Scott, 2001; Feliciello et al., 2001; Wong and Scott, 
2004). Latrunculin-A, a bioactive 2-thiazolidinone macrolide, reversibly disrupts 
the actin cytoskeleton resulting in AKAP dissociation away from the membrane 
(Allison et al., 1998; Sattler et al., 2000; Zhou et al., 2001; Popp and Dertien, 
2008). Figures 3.5A and 3.5B show representative traces of [Ca2+]i as a function 
of time recorded during acidosis in the absence (Control) and presence of CBP 
(CBP, 50 μM) without (DMSO, A) and with latrunculin-A (5 μM, B) preincubation 
for 4 hours at 37°C. While latrunculin-A alone did not significantly reduce 
ASIC1a-mediated [Ca2+]i elevations, disruption of the neuronal cytoskeleton more 
substantially affected σ-1 receptor mediated inhibition of ASIC1a Ca2+ 
dysregulation (Figure 3.5C). In control cells CBP inhibited 47 ± 1% of acid-
induced increases in [Ca2+]i but only inhibited 29 ± 1% of these increases in 
latrunculin-A treated cells (Figure 3.5D). This inhibition was statistically 
significant. Disruption of the cytoskeleton by latrunculin-A was confirmed using 
phalloidin stain, which detects actin filaments cytochemically (Figure 3.6). 
Results showed that control cells had preserved cytoskeleton staining around the 
cell body and along the dendritic processes, while latrunculin-A treated cells 
 88 
 
showed staining patterns consistent with retraction of the cytoskeleton from the 
processes and synapses (Figure 3.6).    
  Previous studies have demonstrated that the major component of acid-
induced increases in neuronal [Ca2+]i is from influx through Ca2+ channels 
activated by ASIC1a-induced membrane depolarization. To isolate what direct 
effects disruption of the σ-1/G-protein/calcineurin/AKAP150 protein structure has 
on ASIC1a function, whole-cell patch clamp experiments using the perforated 
patch method were performed. Cells were voltage-clamped at -70 mV to prevent 
NMDA receptor and voltage-gated Ca2+ channel activation, thus isolating ASIC1a 
channels. In these experiments the pan-selective σ agonist DTG was used 
instead of the σ-1 selective agonist CBP. Figures 3.7A and 3.7B show 
superimposed ASIC1a currents evoked by application of low pH solution (pH = 6) 
in the absence (Control) and presence (DTG) of 100 μM DTG (DTG) without (A) 
and with (B) pertussis toxin (PTX, 24 hr preincubation at 37 °C, 200 ng/ml). 
Figure 3.7C  shows a bar graph of mean percent inhibition (± SEM) of ASIC1a-
mediated currents elicited by bath application of 100 μM DTG in neurons under 
control conditions and following preincubation in pertussis toxin (PTX, n = 7). 
Preincubation in PTX significantly decreased the effects of DTG on acid-evoked 
currents, 10% versus 30% inhibition, respectively (Figure 3.7B). Therefore, in 
cortical neurons, the effects of σ-1 receptors on ASIC1a currents are dependent 
on activation of a PTX-sensitive G protein. 
VIVIT is peptide that selectively and potently inhibits calcineurin/AKAP 
interaction by disrupting calcineurin binding to a PxIxIT-docking motif in AKAP 
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(Oliveria et al., 2007). Moreover, VIVIT does not affect phosphatase activity 
(Hogan et al., 2003; Im and Rao, 2004). To elucidate the effects of VIVIT on the 
signaling cascade linking ASIC1a channels to σ-1 receptors, cortical neurons 
were voltage-clamped at -70 mV to isolate ASIC1a currents. Figure 3.8A shows 
representative ASIC1a-mediated currents evoked by low pH solution in the 
absence (Control) and presence of CBP (CBP, 100 μM). In contrast, Figure 3.8B 
shows traces of ASIC1a-mediated current during acidosis from a different neuron 
in the absence (Control), presence of preincubation in the cell permeable peptide 
VIVIT (VIVIT, 10 nM, 5 minutes) and coapplication of VIVIT and CBP (VIVIT/CBP 
100 μM). Analysis of the currents densities shows that while CBP significantly 
inhibited ASIC1a-mediated currents compared to control cells (Figure 3.8C), 
VIVIT alone or in combination with CBP had no affect on ASIC1a-mediated 
currents (Figure 3.8D). Taken together, these data, consistent with Ca2+ imaging 
results, suggest that σ-1 receptors couple to ASIC1a channels via a 
calcineurin/AKAP complex in addition to a PTX-sensitive G protein.  
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Figure 3.1 - Sigma-1 receptors colocalize with both ASIC1a channels and 
AKAP150 in cortical neurons. A, Representative fluorescent images of neurons 
triple labeled for σ-1 receptors(i), AKAP150 (ii) and ASIC1a channels (iii) in the 
same field of view. B, From A, merged image of σ-1 receptor and AKAP150. The 
white pixels represent areas in the image where σ-1 receptor and AKAP150 
labeling appear together (B, i) as selected in the scatter plot (B, ii). The scatter 
plot maps pixel intensities from the σ-1 receptor labeling versus intensities from 
the AKAP150 labeling. The overlap coefficient for σ-1 receptor and AKAP150 
colocalization for the entire image was calculated to be 0.74. C, From A, merged 
image of σ-1 receptor and ASIC1a labeling with colocalized pixels represented in 
white (C, i) and the colocalization scatter plot (C, ii). The overlap coefficient for σ-
1 receptor and AKAP150 colocalization for the entire image was calculated to be 
0.78. All scale bars (A, B, C) are 25 µm. D, Mean overlap coefficient for σ-1 
receptor colocalization with AKAP150 and ASIC1a channels for individual cell 
bodies was calculated to be 0.723 ± .007 and 0.790 ± .008, and for defined 
dendritic processes 0.696 ± .013 and 0.751 ± .009, respectively.  
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Figure 3.2 - Calcineurin inhibition prevents σ-1 receptor modulation of ASIC1a.  
A, Characteristic traces of [Ca2+]i as a function of time recorded from three 
neurons in the absence (Control) and presence of 10 µM carbetapentane (CBP) 
during acidosis in normal PSS (i), or PSS containing 1 μM FK-506 (ii, FK-506) or 
1 μM cyclosporin A (iii, Cyclo A). B, Mean peak proton-evoked changes in [Ca2+]i 
recorded from neurons in the absence (Control) and presence of 10 µM 
carbetapentane (CBP) in normal PSS (n = 184), or PSS containing either 1 μM 
FK-506 (n = 216) or 1 μM cyclosporin A (n = 155). Asterisks denote significant 
differences from respective control groups (p < 0.05), and pound symbols 
indicate significant differences from the PSS group within CBP (p < 0.05). C, Bar 
graph of mean CBP-induced inhibitions of peak proton-evoked changes in [Ca2+]i 
from the same experiments as B. Control group represents cells exposed to 
acidosis in PSS alone. Asterisks denote significant differences from control group 
(p < 0.05). 
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Figure 3.3 - Sigma-1 receptors inhibit acid-induced elevations in [Ca2+]i via a 
PTX-sensitive G protein. A, Representative traces of [Ca2+]i as a function of time 
recorded from a vehicle treated (PSS) neuron during acidosis in the absence 
(Control) and presence of 50 µM CBP (CBP). B,  Representative traces of [Ca2+]i 
as a function of time recorded from a different neuron during acidosis following 
preincubation in 200 ng/ml PTX (PTX, 24 hrs at 37º C) in the absence (Control) 
and presence of 50 μM CBP (CBP). C, Mean changes in peak [Ca2+]i (± SEM) 
measured in response to acidosis with (PTX, n = 246) or without (PSS, n = 188) 
PTX preincubation in the absence (Control) and presence of 50 μM CBP (CBP).  
Asterisks denote significant differences from respective Control groups (p < 
0.05), pound symbol indicates significant difference between PSS and PTX 
groups within CBP (p < 0.05), and dagger denotes significant difference between 
PSS and PTX groups within Control (p < 0.05). D, Percent inhibitions of [Ca2+]i 
increases (± SEM) by CBP under control conditions (Control) and in the 
presence of PTX (PTX). Asterisk denotes significant difference between the 
groups (p < 0.05). 
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Figure 3.4 - AKAP150 dissociation from the plasma membrane prevents σ-1 
receptor modulation of acid-induced elevations in [Ca2+]i. A, Representative 
traces of [Ca2+]i as a function of time recorded from a neuron during acidosis 
(PSS) in the absence (Control) and presence of 50 µM CBP (CBP). B, 
Representative traces of [Ca2+]i as a function of time recorded from a different 
neuron during acidosis following preincubation in 10 μM NMDA (NMDA, 5 min -1 
hr) in the absence (Control) and presence of 50 μM CBP (CBP). C, Mean 
changes in peak [Ca2+]i (± SEM) measured in response to acidosis with (NMDA, 
n = 398) or without (PSS, n = 198) NMDA preincubation in the absence (Control) 
and presence of 50 μM CBP (CBP). Asterisks denote significant differences from 
respective Control groups (p < 0.05), pound symbol indicates significant 
difference between PSS and NMDA groups within CBP (p < 0.05), and dagger 
denotes significant difference between PSS and NMDA groups within Control (p 
< 0.05). D, Percent inhibition of [Ca2+]i increases (± SEM) by CBP under control 
conditions (Control) and in the presence of NMDA (NMDA). Asterisk denotes 
significant difference between the groups (p < 0.05). 
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Figure 3.5 - Disruption of the actin cytoskeleton prevents σ-1 receptor inhibition 
of acid-induced increases in [Ca2+]i. A, Representative traces of [Ca2+]i as a 
function of time recorded from a vehicle (DMSO) treated neuron during acidosis 
in the absence (Control) and presence of 50 µM CBP (CBP). B,  Representative 
traces of [Ca2+]i as a function of time recorded from a different neuron during 
acidosis following preincubation in 5 μM latrunculin A (Latrunculin A, 4 hrs at 37º 
C) in the absence (Control) and presence of 50 μM CBP (CBP). C, Mean 
changes in peak [Ca2+]i (± SEM) measured in response to acidosis with 
(Latrunculin A, n = 222) or without (DMSO, n = 276) latrunculin A preincubation 
in the absence (Control) and presence of 50 μM CBP (CBP). Asterisks denote 
significant differences from respective Control groups (p < 0.05), pound symbol 
indicates significant difference between DMSO and latrunculin A groups within 
CBP (p < 0.05), and dagger denotes significant difference between DMSO and 
latrunculin A groups within Control (p < 0.05). D, Percent inhibition of [Ca2+]i 
increases (± SEM) by CBP under control conditions (Control) and in the 
presence of latrunculin A (Latrunculin A). Asterisk denotes significant difference 
between the groups (p < 0.05). 
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Figure 3.6 - Latrunculin A preincubation disrupts the actin cytoskeleton. Cells 
were treated with either vehicle (A, DMSO) or latrunculin A (B, 5 μM) for 4 hours 
at 37°C. Cells were then stained with phalloidin to detect actin filaments 
cytochemically (A and B, right images). For comparison, bright field pictures are 
also shown (A and B, left images). All scale bars are 25 μm. 
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Figure 3.7 - Sigma receptor-mediated inhibition of ASIC1a currents are blocked 
by preincubation in pertussis toxin. A and B, Superimposed ASIC1a currents 
evoked by application of low pH solution (pH = 6) in the absence (Control) and 
presence of 100 μM DTG (DTG) from cortical neurons without (A) and with 
preincubation for 24 hrs (37 °C) in 200 ng/ml pertussis toxin (B, PTX). Cells were 
held at -70 mV. C, Bar graph of mean percent inhibitions (± SEM) of ASIC1a-
mediated currents elicited by 100 μM DTG under control conditions (Control) or 
following preincubation in pertussis toxin (PTX), n = 7. Asterisk denotes 
significant difference from Control group (p < 0.05). 
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Figure 3.8 - Sigma-1 receptors couple to ASIC1a channels via an 
AKAP150/calcineurin complex. ASIC1a currents were elicited in whole-cell 
perforated patched, voltage-clamped (-70 mV) neurons by a 10 second 
application of pH 6.0 PSS. A, Representative traces of ASIC1a currents as a 
function of time recorded from a neuron in the absence (Control) and presence of 
100 μM CBP (CBP). B, Representative traces of ASIC1a-mediated currents as a 
function of time recorded from a different cell in the absence (Control) and 
presence of 10 nM VIVIT (VIVIT) and during coapplication of VIVIT with 100 μM 
CBP (VIVIT/CBP). C, Mean peak proton-gated current densities (± SEM) 
measured from neurons without (Control) or with 100 μM CBP (CBP) in the bath 
solution (n = 6). Asterisks denote significant difference from respective Control 
group (p < 0.01). D, Mean peak proton-gated current densities (± SEM) recorded 
under control conditions, in the presence of VIVIT alone, and in the presence of 
VIVIT plus CBP (n = 5). There were no significant differences between Control, 
VIVIT and VIVIT/CBP groups, (p = 0.972).
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Discussion 
Results from this study suggest the signaling cascade linking σ-1 
receptors to ASIC1a channels in rat cortical neurons involves direct protein-
protein interactions involving PTX-sensitive G proteins, calcineurin and 
AKAP150. σ-1 receptors are shown to colocalize with both ASIC1a channels and 
the scaffolding protein AKAP150, not only in regions of the cell body but also 
along the dendritic processes of these cells. Like previous studies in our 
laboratory and others, which showed that σ receptors affect ion channel function 
via mechanisms consistent with protein-protein interactions, σ-1 receptors 
modulate ASIC1a channels via a pertussis toxin-sensitive G protein-coupled 
signal transduction cascade. Furthermore, σ-1 receptors are also shown here to 
couple to ASIC1a channels via the second messenger calcineurin anchored to 
AKAP150. This coupling results in decreases in both ASIC1a-mediated currents 
and concomitant elevations in cytosolic Ca2+ following σ-1 receptor activation.  
σ receptors are the only reported instance of receptor mediated 
downregulation of ASIC activity. Thus far, only the NMDA receptor, acting via a 
Ca2+-calmodulin kinase II cascade (CaMKII), has been shown to modulate 
ASIC1a channels (Gao et al., 2005). Activation of NMDA receptors enhances 
ASIC1a-mediated currents, which consequently exacerbates acidotoxicity during 
ischemia (Gao et al., 2005). ASIC channels are also regulated in a similar 
manner by C kinase-1 (PICK-1), which binds to the C-terminus of several ASIC 
isoforms (Duggan et al., 2002). PICK1 has been shown to promote the 
stimulation of homomeric ASIC2a and heteromultimeric ASIC3/ASIC2b channels 
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by protein kinase C (PKCα) (Baron et al., 2002; Deval et al., 2004), while several 
protein kinase C isoforms (PKCβI or PKCβII) have also been shown to inhibit 
ASIC1 (Berdiev et al., 2002). Protein kinase A phosphorylation of ASIC interferes 
with the binding of PICK-1 to these channels, and disrupts PICK1-ASIC1 
colocalization (Leonard et al., 2003). Furthermore, various signaling molecules 
have been linked to the regulation of ASIC. Three distinct kinases (CaMKII, 
protein kinase C and protein kinase A) have all been shown to modulate the 
function of ASIC, by direct phosphorylation of the channel (Baron et al., 2002; 
Leonard et al., 2003; Gao et al., 2005). Kinase anchoring proteins such as PICK-
1 and AKAP150 have also been shown to bind to ASIC subtypes, and appear to 
increase currents through these channels by facilitating protein kinase C and 
protein kinase A  phosphorylation of the channels, respectively (Baron et al., 
2002; Deval et al., 2004; Chai et al., 2007).  Conversely, inhibition of calcineurin 
has been shown to potentiate currents through ASIC1a and ASIC2a channels, 
and thus dephosphorylation of the channels by this phosphatase may be 
involved in downregulation of ASIC (Chai et al., 2007). Our results with the 
calcineurin inhibitors, cyclosporin A and FK-506, demonstrate that σ-1 receptor-
mediated block of ASIC1a is dependent on activation of this phosphatase. 
Interestingly, reports have shown that calcineurin may be activated by a 
pertussis toxin-sensitive G protein (Gromada et al., 2001). Consistent with this 
observation, our study shows that a pertussis toxin-sensitive G protein is involved 
in the signaling cascade coupling σ-1 receptors to ASIC1a. It has been proposed 
that σ receptors regulate ion channel function via protein-protein interactions 
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(Aydar et al., 2002). Moreover, inhibition of G proteins either by cell dialysis with 
GDP-β-S or preincubation in pertussis toxin failed to affect σ-1 and σ-2 receptor 
modulation of voltage-gated K+ and Ca2+ channels in intracardiac neurons 
(Zhang and Cuevas, 2002; Zhang and Cuevas, 2005). To date, nearly all reports 
of σ receptor modulation of ion channels suggest that the effects involve a 
membrane-delimited signaling pathway which likely involves a protein-protein 
interaction. However, σ receptor activation has been shown to stimulate GTPase 
activity in mouse prefrontal membranes (Tokuyama et al., 1997). A pertussis 
toxin-sensitive G protein has been implicated in the modulation of NMDA 
receptors by σ receptors in rat CA3 dorsal hippocampus neurons (Monnet et al., 
1994), whereas a cholera toxin-sensitive G protein has been suggested to couple 
σ-1 receptors to the channels mediating the A-current in frog pituitary 
melanotopes (Soriani et al., 1999). However, others have argued that σ receptors 
do not couple to G proteins (Hopf et al., 1996). Our findings demonstrate that σ-1 
receptors can modulate ion channel function via activation of a PTX-sensitive G 
protein, and these results are the first evidence of a receptor coupling to ASIC1a 
through this mechanism.   
AKAP150 has been shown to be involved in the regulation of receptor 
activity and localization, and in the regulation of synaptic structure during 
developmental synapse formation, in synaptic plasticity in learning and memory, 
and neuronal dysfunction and cell death during pathophysiological conditions 
(Dell'Acqua et al., 2006). Additionally, a calcineurin/AKAP150 complex has been 
shown to modulate both ASIC1a and ASIC2a function (Chai et al., 2007). Our 
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immunohistochemical studies suggest that σ-1 receptors colocalize with both 
ASIC1a channels and AKAP150 in the plasma membrane of the cell body and 
along the neuronal processes of the cells. Furthermore, the similarity of the 
distributions of σ receptors colocalized with ASIC1a channels and with AKAP150 
is consistent with previous studies showing colocalization of ASIC channels and 
AKAP (Chai et al., 2007). Disruption of the actin cytoskeleton by chemical agents 
or by NMDA activation has been shown to result in the redistribution of AKAP150 
away from the plasma membrane (Gomez et al., 2002). Our data shows that both 
of these manipulations significantly prevents σ-1 receptor modulation of ASIC1a-
induced [Ca2+]i elevations. The small but significant block by NMDA of σ-1 
receptor modulation of ASIC1a can probably be attributed to additional effects of 
Ca2+ overload following preincubation in NMDA which led to increases in basal 
calcium levels. 
Previous results in our laboratory have shown that most of the elevations 
in [Ca2+]i triggered by acidosis are the result of Ca2+ channels (NMDA and AMPA 
receptors, voltage-gated Ca2+ channels) opening downstream of ASIC1a 
activation, and that activation of σ-1 receptors effectively suppresses these 
secondary Ca2+ fluxes. AKAP150 has been shown to modulate glutamate 
receptors like the internalization of AMPA receptors and NMDA receptors during 
long term potentiation or depression (Rosenmund et al., 1994; Westphal et al., 
1999; Colledge et al., 2000; Gomez et al., 2002; Smith et al., 2006). In addition, 
AKAP also regulates voltage-gated Ca2+ channel function (Oliveria et al., 2007). 
Data presented here shows that σ-1 receptors functionally couple to ASIC1a 
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channels via AKAP150, which is consistent with all of these observations. 
Moreover, these results also raise the possibility that AKAP150 is a component in 
the modulation of other ion channels (voltage-gated Ca2+ channels) and 
receptors (NMDA and AMPA) by σ-1 receptors.  
The strongest evidence that σ-1 receptors couple to ASIC1a channels via 
a calcineurin/AKAP150 complex comes from experiments using the VIVIT 
peptide. Whole-cell patch clamp experiments with VIVIT suggest that when this 
peptide competes with calcineurin for binding to the PxIxIT-like motif in AKAP150 
and thus prevents calcineurin binding to AKAP150, σ receptor activation loses its 
ability to regulate ASIC1a function. The disruption of this interaction prevents σ-1 
receptors from functionally coupling to ASIC1a channels. Similarly, VIVIT has 
been implicated in the disruption of calcineurin/AKAP150 modulation of L-type 
Ca2+ channels in hippocampal neurons (Oliveria et al., 2007).  
In conclusion, our data show that the signaling cascade between σ-1 
receptors and ASIC1a channels involves a PTX-sensitive G protein and an 
AKAP150/calcineurin complex in cortical neurons. This coupling results in 
decreases in both ASIC1a-mediated membrane currents and concomitant 
elevations in cytosolic Ca2+ following σ-1 receptor activation. Moreover, 
calcineurin may be a potential component of the neuroprotective properties of σ 
receptors. Furthermore, our results also raise the possibility of σ-1 receptors 
coupling to downstream Ca2+ channels (voltage-gated Ca2+ channels) and 
receptors (NMDA and AMPA) via a similar signaling cascade. All of these 
channels and receptors have been implicated in pathophysiological conditions, 
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such as stroke (Tanaka et al., 1997; Tanaka et al., 1999; Tanaka et al., 2002). σ-
1 receptors are the first receptor shown to downregulate ASIC1a channel 
function and remain as the only receptor identified thus far to negatively 
modulate ASIC1a channels.  
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CHAPTER 4 
 
 
SIGMA-1 RECEPTOR INHIBITION OF INTRACELLULAR Ca2+ 
DYSREGULATION DUE TO SYNERGISTIC INTERACTION  
BETWEEN ACIDOSIS AND ISCHEMIA 
 
 
Introduction 
 
 
Glucose and oxygen deprivation associated with brain ischemia initiates a 
switch in metabolism from aerobic to anaerobic glycolysis to produce cellular 
energy. The accumulation of lactic acid, the end product of anaerobic glycolysis, 
leads to acidosis in the ischemic region, activating Acid-Sensing Ion Channels 
(ASIC) (Xiong et al., 2004; Gao et al., 2005; Pignataro et al., 2007). Synaptic 
vesicles contain not only the neurotransmitter glutamate but also protons that are 
released along with glutamate during neurotransmission. It remains to be 
elucidated if protons released during neurotransmission also activate ASIC.  
ASIC subtypes are distinguishable by the pH of half-maximal activation, 
Ca2+ permeability and tissue expression pattern. The predominant ASIC subtype 
in the central nervous system (CNS) contains the ASIC1a subunit, which can 
form homomultimeric or heteromultimeric channels with ASIC2a (Askwith et al., 
2004). ASIC1a channels are activated by pH ≤ 7 and have a pH of half-maximal 
activation of ~ 6.0 - 6.5 (Waldmann et al., 1997b; Xiong et al., 2004), which is 
similar to the pH seen during an ischemic insult (Nedergaard et al., 1991; Back et 
 114 
 
al., 2000). The homomeric ASIC1a channel is the only ASIC subtype that is 
highly permeable to both Na+ and Ca2+ ions (Xiong et al., 2004; Yermolaieva et 
al., 2004).  
ASIC1a has been implicated in various neuronal physiological processes 
such as synaptic plasticity, fear conditioning, and learning and memory (Wemmie 
et al., 2002; Wemmie et al., 2003; Wemmie et al., 2004). ASIC1a has also been 
shown to be activated following cerebral ischemia, and has been linked to 
neuronal cell death (Xiong et al., 2004; Gao et al., 2005; Pignataro et al., 2007). 
Compared to wild-type mice, transgenic mice deficient in ASIC1a have reduced 
infarct size in response to middle cerebral artery occlusion (MCAO) (Xiong et al., 
2004). Furthermore, pharmacological inhibition of ASIC1a with either the non-
selective Na+ channel blocker amiloride or the homomultimeric ASIC1a selective 
inhibitor psalmotoxin1 (Diochot et al., 2007), diminishes ischemic brain injury 
(Xiong et al., 2004). Thus, there is a direct correlation between infarct size, brain 
acidosis and ASIC activation, suggesting the acidotoxicity occurring during stroke 
is in part mediated by ASIC1a channels (Xiong et al., 2004).  
The demise of neurons during ischemia and acidosis is predicated by 
intracellular calcium overload (Xiong et al., 2004; Yermolaieva et al., 2004). Our 
laboratory has shown that σ-1 receptors inhibit Ca2+ dysregulation evoked by 
ischemia (Katnik et al., 2006) as well as acidosis, and that activation of σ 
receptors is neuroprotective at delayed time points in a rat model of ischemic 
stroke (Ajmo et al., 2006). Moreover, σ-1 receptors regulate ionotropic glutamate 
receptors, voltage-gated K+ channels and voltage-gated Ca2+ channels (Hayashi 
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et al., 1995; Aydar et al., 2002; Zhang and Cuevas, 2002; Zhang and Cuevas, 
2005). The inhibition of ionotropic glutamatergic receptors by σ receptors 
prevents elevations in [Ca2+]i associated with glutamate-induced excitotoxicity 
(Klette et al., 1995; Klette et al., 1997). All of these voltage-gated ion channels as 
well as NMDA receptors have been shown to contribute to the demise of neurons 
during ischemia (Tanaka et al., 2002). Consistent with this observation, our 
laboratory has also shown that most of the elevations in [Ca2+]i  triggered by 
acidosis are the result of Ca2+ channels (NMDA and AMPA receptors and 
voltage-gated Ca2+ channels) opening following ASIC1a activation, and 
stimulation of σ-1 receptors effectively suppressed these secondary Ca2+ fluxes 
by inhibiting both ASIC1a and these Ca2+ channels directly.  
Previous reports have indicated that the glucose-oxygen deprivation 
model of ischemia potentiates ASIC1a-mediated currents in neurons (Xiong et 
al., 2004). Moreover, it has also been shown that ischemia enhances ASIC1a 
currents through phosphorylation of the channel by CaMKII as a result of 
activation of NMDA receptor (Gao et al., 2005). But how ASIC1a activation 
affects the responses to ischemia and whether acidosis has any temporal effects 
during ischemia remains to be determined. Furthermore, it is unknown whether 
acidosis and ischemia interact in terms of the Ca2+ dysregulation produced. 
Interestingly, ASIC have been shown to remain active for greater than 4 hours 
following an ischemic insult (Pignataro et al., 2007). Pharmacological blockade of 
ASIC1a by amiloride or PcTx1 administered even 5 hours after MCAO has been 
shown to diminish stroke injury (Simon and Xiong, 2006; Pignataro et al., 2007). 
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These observations raise the possibility that σ receptors may provide 
neuroprotection when stimulated several hours after an ischemic insult by directly 
inhibiting ASIC1a channels as well as Ca2+ channels opening in response to 
membrane depolarizations produced by ASIC1a activation.  
Experiments were undertaken to determine whether ASIC1a activation 
and ischemia interact to produce potentiated elevations in [Ca2+]i and to 
determine if activation of σ-1 receptors is able to block this synergistic 
potentiation. Ratiometric Ca2+ fluorometry experiments demonstrated that 
acidification of the extracellular solution from pH 7.4 to 6.0 produced a 
potentiation of the ischemia-induced elevations in [Ca2+]i. Inhibition of ASIC1a 
channels with either amiloride or PcTx1, significantly decreased ischemia-
induced elevations in [Ca2+]i at pH values ranging from 7.4 to 6.0, suggesting that 
homomeric ASIC1a channels are activated during ischemia alone and that these 
channels contribute to the pH dependence of these [Ca2+]i increases. 
Furthermore, inhibition of synaptic transmission with tetrodotoxin prevented 
ischemia-evoked increases in [Ca2+]i but the effect of tetrodotoxin was overcome 
by acidification of the extracellular solution (pH 6.0). The selective σ-1 receptor 
agonist, carbetapentane, significantly decreased ischemia-mediated Ca2+ 
dysregulation at all pH values tested (7.4-6.0), suggesting that activation of σ-1 
receptors modulate ischemic- and ASIC1a-activated [Ca2+]i increases individually 
while also effecting the mechanism mediating the synergistic interaction between 
these two initiators of Ca2+ influx pathways in cortical neurons.    
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Materials and Methods 
Primary Rat Cortical Neuron Preparation 
 Primary cortical neurons from embryonic (E18) rats were cultured as 
previously described by our laboratory (Katnik et al., 2006). All procedures were 
done in accordance with the regulations of the University of South Florida 
Institutional Animal Care and Use Committee. Cells were used after 10-21 days 
in culture. 
Calcium Imaging Measurements 
The effects of acidosis and chemical ischemia on intracellular Ca2+ 
concentrations were examined in isolated cortical neurons using fluorescent 
imaging techniques. Cytosolic free-Ca2+ was measured using the Ca2+ sensitive 
dye, fura-2. The membrane permeable ester form of fura-2, fura-2 AM, 
acetoxymethyl ester (AM), was loaded and imaged as we have previously 
described (DeHaven and Cuevas, 2004). Cells plated on coverslips were 
incubated for 1 hour at room temperature in Neurobasal (Invitrogen) medium 
supplemented with B27 (Invitrogen) and 0.5 mM L-glutamine, or in physiological 
saline solution (PSS) consisting of (in mM): 140 NaCl, 5.4 KCl, 1.3 CaCl2, 1.0 
MgCl2, 20 glucose, and 25 HEPES (pH to 7.4 with NaOH). Both solutions 
contained 3 μM fura-2, acetoxymethylester (fura-2 AM) and 0.3 % dimethyl 
sulfoxide. The coverslips were washed in PSS (fura-2-AM free) prior to 
experiments being performed.   
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Electrophysiology Recordings 
 Na+-mediated membrane currents were recorded using a protocol 
previously described by our laboratory (Dr. Hongling Zhang, unpublished data). 
Briefly, neurons plated on glass coverslips were transferred to a recording 
chamber and membrane currents were amplified, filtered at 1 kHz, digitized at 5 
kHz, and acquired using Clampex 8 (Axon). Cells were patch-clamped using the 
conventional dialysis whole-cell configuration and voltage-clamped at -90 mV. 
Na+ currents were activated by stepping cells to -10 mV for 250 msec. The 
control pipette solution consisted of (in mM): 130 CsCl, 10 NaCl and 10 HEPES 
(titrated to pH 7.2 with CsOH). The extracellular solution consisted of (in mM): 72 
NaCl, 79 TEA-Cl, 5 KCl, 1.4 CaCl2, 1 MgCl2, 10 glucose, 5 BaCl2, 0.1 CdCl2, and 
10 HEPES (titrated to pH 7.4 or 6.0 with TEA-OH). Both the external and internal 
solutions were modified from other protocols (Dr. Hongling Zhang, unpublished 
data, and (Mike et al., 2003)). Patch electrodes were pulled from thin-walled 
borosilicate glass (World Precision Instruments Inc., Sarasota, FL) using a Sutter 
Instruments P-87 pipette puller (Novato, CA) and had resistances of 2.0 – 5.0 
MΩ. Access resistances (Rs) were monitored throughout experiments for stable 
values ≤ 20 MΩ and were always compensated at 40% (lag, 10 µs). All cells 
were voltage-clamped at -90 mV. 
Solutions and Reagents 
The control bath solution for all experiments was PSS.  All drugs were 
applied in this solution using a rapid application system identical to that 
previously described (Cuevas and Berg, 1998). ASIC activation was induced by 
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applying PSS buffered to pH values of 7.4, 7.0, 6.5 and 6.0 (+/- drug). Chemical 
ischemia was induced by applying glucose-free PSS containing 4mM azide (+/- 
drug) and titrated to pH 7.4, 7.0, 6.5, and 6.0. Individual cells were exposed to ≤ 
3 ischemic or acidic+ischemic insults to prevent rundown of responses (Katnik et 
al., 2006). All chemicals used in this investigation were of analytical grade. The 
following drugs were used: carbetapentane (Tocris Bioscience, Ellisville, MO); 
psalmotoxin1 venom (Spider Pharm, Yarnelle, AZ); psalmotoxin1 peptide 
(Peptide International, Louisville, KY); tetrodotoxin (Alomone Labs, Jerusalem, 
Israel); amiloride (Alexis Biochemicals, Lausen, Switzerland); sodium-azide 
(Sigma-Aldrich, St. Louis, MO); and fura-2 AM (Molecular Probes, Eugene, OR).  
Data Analysis 
  Analysis of measured intracellular Ca2+ responses and Na+-current 
activation was performed using Clampfit 9 (Axon instruments). Imaging data files 
collected with SlideBook 4.02 (Intelligent Imaging Innovations, Inc.) were converted 
to a text format and imported into Clampfit for subsequent analysis. Statistical 
analysis was conducted using SigmaPlot 9 and SigmaStat 3 software (Systat 
Software, Inc.). Statistical differences were determined using paired and unpaired 
t-tests for within group and between group experiments, respectively, and were 
considered significant if p < 0.05. For multiple group comparisons either a 1-way or 
a 2-way ANOVA, with or without repeat measures, were used, as appropriate. 
When significant differences were determined with an ANOVA, post-hoc analysis 
was conducted using a Tukey Test to determine differences between individual 
groups. 
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Results 
The low extracellular pH associated with ischemia can activate ASIC 
(Xiong et al., 2004; Gao et al., 2005; Pignataro et al., 2007), and ASIC-mediated 
currents are potentiated during ischemia (Xiong et al., 2004; Gao et al., 2005). 
During neurotransmission, protons are released along with glutamate but it 
remains to be elucidated whether these protons can activate ASIC at 
physiological pH values. Experiments were carried out to determine if ASIC are 
activated during ischemia at normal physiological pH (7.4) and to determine the 
effects of pathophysiological pH values (7.0 - 6.0) during ischemia on [Ca2+]i 
dysregulation. Figures 4.1A and 4.1B show representative traces of [Ca2+]i as a 
function of time evoked by ischemia at pH 7.4 (A) and pH 6.0 (B) in the absence 
(Control) and presence of the ASIC blocker amiloride (100 µM). Similar 
experiments demonstrate that amiloride significantly inhibits ischemia-induced 
peak elevations in [Ca2+]i by 48% in solutions buffered to pH 7.4 (Figure 4.1C). 
These results indicate that protons released along with glutamate during 
neurotransmission under physiological conditions activate ASIC. The application 
of ischemia + acidosis resulted in more robust peak increases in [Ca2+]i and 
these elevations were also inhibited by amiloride (Figure 4.1C). These data 
suggest that ASIC are activated during ischemia and potentiate ischemia-
induced Ca2+ dysregulation.  
The kinetics of the Ca2+ responses to the combination of ischemia + 
acidosis are noticeably different from those to ischemia or acidosis alone. To 
compare the kinetics of these responses, a single cell was exposed to acidosis 
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(pH 6.0), ischemia at pH 7.4, and ischemia at pH 6.0. Figure 4.2A shows 
representative traces of [Ca2+]i as a function of time from a single neuron during 2 
minute applications of acidosis (pH 6.0 PSS), ischemia at pH 7.4 (Ischemia), and 
ischemia at pH 6.0 (Acidosis + Ischemia) separated by 10 minute recovery 
periods. Acidosis alone produced an initial transient increase in [Ca2+]i with a 
rapid desensitization of the Ca2+ influx resulting in a return to basal levels within 
seconds of the acid application. In contrast, ischemia alone resulted in smaller 
initial transient increase in [Ca2+]i that decreased to a sustained elevated level 
which returned to basal levels only upon washout of the ischemia solution. The 
combination of acidosis + ischemia produced a significant potentiation in the 
initial transient peak [Ca2+]i elevations, which rapidly decreased to an elevated 
concentration which monotonically increased in the continual presence of the 
acidosis + ischemia solution. Upon washout of this solution, there was a transient 
rebound increase in [Ca2+]i which then slowly decayed to baseline levels. To 
quantitate the net elevations in the cytosolic Ca2+ concentration during these 
stimulations, increases in [Ca2+]i were integrated over the time period 
surrounding the acidosis + ischemia challenge yielding the area under the curve. 
Figure 4.2B shows that there is a synergistic increase in [Ca2+]i in response to the 
combination of ischemia + acidosis when compared to the responses observed 
to acidosis and ischemia alone. These results indicate that not only does 
ischemia enhances ASIC activation, as previously reported (Xiong et al., 2004; 
Gao et al., 2005), but that acidosis potentiates the response to ischemia. This is 
 122 
 
the first report showing the role of acidosis during ischemia and the effects of 
ASIC activation on ischemia-induced [Ca2+]i elevations. 
To better understand this synergistic interaction between acidosis and 
ischemia, experiments were performed to measure the [Ca2+]i responses to 
ischemic insults as a function of pH. Four parameters were used to compare 
these responses: (1) magnitude of the initial [Ca2+]i peak, (2) the steady state 
level of [Ca2+]i at the end of the ischemia application, (3) the peak magnitude of 
the rebound transient [Ca2+]i increase following washout of the ischemia solution, 
and (4) the net Ca2+ elevations measured in the cytosol as determined by 
integrating the area under the [Ca2+]i vs. time curve. Results from multiple 
experiments show a significant increase in initial [Ca2+]i peak (Figure 4.3A), 
rebound [Ca2+]i peak (Figure 4.3C) and area (Figure 4.3D) as the pH of the 
ischemia solution was reduced from 7.4 to 6.0. Interestingly, the steady state 
level of [Ca2+]i obtained at the end of azide application increased when the pH 
was reduced from 7.4 to 7.0, but then remained constant as the pH was further 
reduced to 6.0 (Figure 4.3B). These data suggest that ischemia-induced 
increases in [Ca2+]i are pH dependent. Furthermore, acidosis significantly affects 
ischemia-induced [Ca2+]i elevations such that greater synergy is observed as the 
pH decreased from 7.4 to 6.0.  
Psalmotoxin1 (PcTx1) from the venom of the tarantula Psalmopoeus 
cambridgei has been shown to be a selective inhibitor of homomultimeric ASIC1a 
channels (Diochot et al., 2007). To confirm that ASIC1a channels were mediating 
this synergistic potentiation of changes in [Ca2+]i during ischemia at low pH 
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values, cells were preincubated in the absence (PSS, Control) and presence of 
PcTx1 venom (PcTx1) in solutions buffered to the indicated pH values. The 
venom was present in the conditioning solution (PSS pH 7.4) as well as all the 
ischemia solutions (pH 7.4 - 6.0). PcTx1 venom inhibited the initial peak 
elevations in [Ca2+]i to a statistically significant degree at all pH values tested 
(Figure 4.4A). The venom also blocked the rebound increases in [Ca2+]i following 
washout of the ischemia solution at pH values lower than 7.0 (Figure 4.4C). 
Interestingly, at the lower pH values, the PcTx1 venom is unable to block 
elevated steady state levels of [Ca2+]i or the net [Ca2+]i elevation (area) in 
response to ischemia + acidosis (Figure 4.4B and 4.4D). This observation could 
be explained as a result of PcTx1 inducing a shift in the steady-state 
desensitization of the channel. In contrast, amiloride which directly blocks the 
channel, does inhibit steady state [Ca2+]i elevations. These results show that 
inhibition of ASIC1a channels prevents acidosis-associated synergistic 
potentiation of [Ca2+]i dysregulation during ischemia.  
As a negative control, PcTx1 venom was heat inactivated to denature all 
proteins. Figures 4.5A and 4.5B show representative traces of [Ca2+]i as a 
function of time recorded from a neuron during ischemia at pH 7.0 and from a 
second cell during ischemia + acidosis in the absence (Control) and presence of 
heat inactivated PcTx1 venom (h.PcTx1). After multiple experiments, changes in 
initial peak, steady state and rebound [Ca2+]i, and net [Ca2+]i (area) (± SEM) were 
measured in response to ischemia at pH 7.0 and ischemia at pH 6.0 (Figure 4.5C 
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and 4.5D). These results show that heat inactivated PcTx1 venom do not 
significantly affect ischemia-induced [Ca2+]i elevations at pH 7.0 or 6.0.  
Because PcTX venom is a cocktail of toxins (Psalmotoxin 1 (PcTx1), 
Psalmopeotoxin I (PcFK1), Psalmopeotoxin II (PcFK2), Vanillotoxin 1 (VaTx1), 
Vanillotoxin 2 (VaTx2), Vanillotoxin 3 (VaTx3)) experiments were performed with 
pure PcTx1 peptide during acidosis alone (pH 6.0), ischemia at pH 7.0 and 
ischemia at pH 6.0. Figures 4.6A and 4.6B show representative traces of [Ca2+]i 
as a function of time recorded from a neuron during ischemia at pH 7.0 and from 
a second neuron during ischemia + acidosis in the absence (Control) and 
presence of synthetic PcTx1 peptide (s.PcTx1). Similar to results from the venom 
experiments, PcTx1 peptide significantly inhibited changes in initial peak, steady 
state and rebound [Ca2+]i, and net [Ca2+]i (area) (± SEM) measured in response 
to ischemia pH 7.0 (Figure 4.6C). Furthermore, the peptide inhibited initial and 
rebound [Ca2+]i peaks in response to ischemia at pH 6.0 (Figure 4.6D). These 
data confirm the results shown in Figure 4.4 were due to the activity of PcTx1 
and not the other toxins in the venom. Therefore, ASIC1a channels are mediating 
the synergistic potentiation seen during the combination of ischemia and 
acidosis. 
The synergistic interaction between ischemia and acidosis raises the 
possibility that ASIC1a channels promote long-lived priming of presynaptic 
vesicles, and could thus, enhance release of neurotransmitter if stimulated prior 
to an ischemic event. To test this hypothesis, cells were exposed to acid alone 
prior to the ischemia application. Figure 4.7A shows representative traces of 
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[Ca2+]i as a function of time recorded from a neuron exposed to ischemia (black 
trace) and from a different cell exposed to a 10 second acid application prior to 
ischemia (gray trace). Analysis of the data comparing the two ischemia 
applications suggest that ASIC1a activation alone does not promote long-lived 
vesicle priming since the mean changes in peak [Ca2+]i were comparable (Figure 
4.7B). These data suggest that ASIC1a activation alone prior to ischemia does 
not result in greater glutamate release. Furthermore, these data are consistent 
with results presented in this study and confirm that the synergistic potentiation in 
Ca2+ observed is the result of the combination of ischemia + acidosis and that for 
the potentiation to occur, the events must take place simultaneously. Consistent 
with this observation, ischemia potentiates ASIC1a-mediated currents following 
OGD preincubation (Xiong et al., 2004).  
To further substantiate that the concurrent incidence of ischemia and 
acidosis is required to produce synergistic potentiation of Ca2+ dysregulation, the 
temporal effects of acidosis on the ischemia responses were studied. Figure 
4.7C shows representative traces of [Ca2+]i as a function of time recorded from a 
cell exposed to ischemia alone (black trace) and from a second neuron exposed 
to ischemia followed by the combination of ischemia + acidosis (gray trace). 
Addition of protons resulted in a statistically significant increases in mean 
changes in [Ca2+]i in peak, steady state, rebound peak, and net [Ca2+]i (area) 
(Figure 4.7D). These data confirm that the synergistic potentiation of Ca2+ 
dysregulation is due to the interaction between ischemia and acidosis. Moreover, 
 126 
 
these results indicate that ASIC1a channels can be activated again after the 
initial ischemic onset, exacerbating ischemia-induced Ca2+ dysregulation.  
Next we wanted to determine the mechanism responsible for the rebound 
increase in [Ca2+]i following washout of ischemia and acidosis. Figure 4.7E 
shows representative traces of [Ca2+]i as a function of time recorded from a 
neuron exposed to the combination of ischemia + acidosis (black trace) and from 
a second cell exposed to the combination of ischemia + acidosis then rapidly 
switched to ischemia (pH 7.4) alone (gray trace). In identical experiments, 
populations of cells exposed to these two treatments did not exhibit significant 
differences comparing mean changes in peak, steady state and net [Ca2+]i (area) 
(Figure 4.7F). In contrast, mean changes in rebound were significantly different 
(Figure 4.7F). Thus, these results suggest that the relief of proton block of 
downstream Ca2+ channels allows for the influx of Ca2+ contributing to the 
rebound [Ca2+]i elevations.  
σ receptor activation has been shown to modulate multiple ion channels 
which are opened following an ischemic insult. Figure 4.8 shows bar graph 
representation of data from multiple experiments in the absence (Control) and 
presence of the σ-1 receptor agonist carbetapentane (CBP) during ischemia at 
the indicated pH values. CBP significantly inhibited the initial transient ischemia-
induced [Ca2+]i elevations (Figure 4.8A), consistent with previous results showing 
σ-1 receptor inhibition of ASIC1a-activated Ca2+ increases. Similarly, CBP 
significantly reduced steady state (Figure 4.8B) and rebound (Figure 4.8C) levels 
of [Ca2+]i induced by ischemia at all pH values tested, consistent with σ-1 
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receptor inhibition of Ca2+ channels activated by ASIC1a-mediated 
depolarization. Likewise, CBP reduced the net [Ca2+]i elevations (area), 
suggesting σ-1 receptor activation not only inhibit  Ca2+ influx pathways but may 
also modulate release from intracellular stores and/or extrusion pathways 
(exchangers and ATPases) (Figure 4.8D). These results show that σ-1 receptor 
activation prevents the synergistic interaction between acidosis and ischemia. 
Moreover, the σ-1 selective ligand inhibits ischemia-induced Ca2+ dysregulation 
at all pH values (7.4 - 6.0).  
Tetrodotoxin (TTX) is an inhibitor of voltage-gated Na+ channels, and thus, 
subsequent synaptic transmission. The activation of postsynaptic Ca2+ channels 
and receptors following ASIC1a stimulation has been observed even when 
neuronal conduction is inhibited by TTX, suggesting a presynaptic localization of 
ASIC1a channels. Therefore, experiments were conducted to determine the 
effects of presynaptic ASIC1a channels during ischemia in the presence of TTX.  
Figures 4.9A and 4.9B show representative traces of [Ca2+]i as a function of time 
evoked by ischemia pH 7.4 (A) and ischemia pH 6.0 (B) in the absence (Control) 
and presence of tetrodotoxin (TTX, 500 nM). Similar to earlier reports, addition of 
TTX prevented ischemia-induced elevations in [Ca2+]i by 69 ± 2% when 
compared to control responses (Figure 4.9C and 4.9D) (Katnik et al., 2006). 
While in response to ischemia + acidosis, the effects of TTX on [Ca2+]i 
dysregulation were diminished, reducing only 9 ± 2% of the initial peak increase 
in [Ca2+]i (Figure 4.9C and 4.9D). These data suggest that presynaptic ASIC1a 
channels promote synaptic transmission during ischemia, and thus, overcome 
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block of synaptic transmission and enhance postsynaptic [Ca2+]i increases. This 
observation is consistent with the hypothesis that ASIC1a channels are located 
presynapticly and regulate neurotransmitter release probability (Cho and 
Askwith, 2008). 
To confirm that the lack of TTX block of ischemia-induced increases in 
[Ca2+]i by acidosis was not due to TTX being pH sensitive, whole-cell voltage-
clamp experiments were performed to measure voltage-gated Na+ currents in the 
absence and presence of TTX at pH 7.4 and 6.0. Cells were patch-clamped 
using the conventional dialysis whole-cell configuration and voltage-clamped at   
-90 mV. Na+ currents were activated by stepping cells to -10 mV for 250 msec. 
Figure 4.10A show representative current traces recorded from a single cell in 
the absence (Control) and presence of TTX (TTX, 500 nM) at pH 7.4 (i) and pH 
6.0 (ii). Analysis of the measured current densities shows that TTX significantly 
inhibits Na+ currents at pH 7.4 and pH 6.0 (Figure 4.10 B and 4.10C). Consistent 
with reports in the literature, our data also suggest that Na+ channels are pH 
sensitive (Figure 4.10B). Results from recordings of peak inward Na+ currents 
from 12 cells showed that TTX (500 nM) inhibited INa by 96.1 ± 0.9% at pH 7.4 
and 96.6 ± 1.0% at pH 6.0 (Figure 4.10C). No significant difference was noted 
between TTX-evoked inhibition at pH 7.4 and 6.0 (p = 0.68) (Figure 4.10C). In 
conclusion, our data indicate that TTX inhibition of voltage gated Na+ currents is 
not pH sensitive, and thus, confirm that presynaptic ASIC1a channels promote 
synaptic transmission during ischemia by overcoming block of neurotransmission 
by TTX and enhancing postsynaptic [Ca2+]i increases. 
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Figure 4.1 - ASIC activation contributes to ischemia-evoked [Ca2+]i increases in 
cultured rat cortical neurons. A, Representative traces of [Ca2+]i as a function of 
time recorded from a single cell during ischemia at pH 7.4 in the absence 
(Control) and presence of 100 μM amiloride (Amiloride).  B, Representative 
traces of [Ca2+]i as a function of time recorded from a single neuron during 
ischemia and acidosis (pH 6.0) in the absence (Control) and presence of 100 μM 
amiloride (Amiloride). C, Mean changes in peak [Ca2+]i (± SEM) measured in 
response to ischemia at pH 7.4 (n = 182) and pH 6.0 (n = 166) in the absence 
(Control) and presence of 100 μM Amiloride. Asterisks denote significant 
differences from respective Control groups (p < 0.001) and pound symbols 
indicates significant difference between pH 6.0 and pH 7.4 within Control and 
Amiloride groups (p < 0.001).  
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Figure 4.2 - ASIC activation and ischemia interact to produce a synergistic 
potentiation of elevations in [Ca2+]i. A, Representative traces of [Ca2+]i as a 
function of time recorded from a single cell during the indicated conditions. B, 
Quantification of net [Ca2+]i elevations from multiple experiments identical to that 
in (A) (n = 84). Net [Ca2+]i elevation is calculated by integrating Δ[Ca2+]i over time. 
Asterisks denote significant differences from the Acidosis group (p < 0.001), and 
pound symbols indicates significant difference from Ischemia group (p < 0.001).  
 
 132 
 
 
 
 
 
 
 
 
 
 
 
 133 
 
Figure 4.3 - Protons potentiate ischemia-induced increases in [Ca2+]i. Mean 
change in initial peak (A), steady state (B) and rebound peak (C) [Ca2+]i, and net 
increase in [Ca2+]i (area, D) (± SEM) measured in response to ischemia at pH 7.4 
(n = 80), pH 7.0 (n = 120), pH 6.5 (n = 120) and pH 6.0 (n = 121). Asterisks 
denote significant difference from pH 7.4 group (p < 0.05), pound symbols 
indicate significant differences from pH 7.0 group (p < 0.05), and daggers denote 
significant differences from pH 6.5 group (p < 0.05).
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Figure 4.4 - Inhibition of homomeric ASIC1a channels decreases ischemia + 
acidosis-induced elevations in [Ca2+]i at pH values ranging from 7.4 to 6.0. Mean 
change in initial peak (A), steady state (B) and rebound peak (C) [Ca2+]i, and net 
[Ca2+]i increase (area, D) (± SEM) measured in response to ischemia at pH 7.4 (n 
= 72), pH 7.0 (n = 87), pH 6.5 (n = 62) and pH 6.0 (n = 215) in the absence 
(Control) and presence of 500 ng/ml PcTx1 venom (PcTx1). Asterisks denote 
significant differences from pH 7.4 group (p < 0.05) and pound symbols indicates 
significant differences from respective Control groups (p < 0.05).  
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Figure 4.5 - Heat inactivated PcTx1 venom does not inhibit ischemia-induced 
increases in [Ca2+]i. Representative traces of [Ca2+]i as a function of time 
recorded from a neuron during ischemia at pH 7.0 (A) and from a second cell 
during ischemia + acidosis (B) in the absence (Control) and presence of heat 
inactivated PcTx1 venom (h.PcTx1). Mean changes in initial peak (peak), steady 
state (SS) and rebound (Rbd) [Ca2+]i, and net [Ca2+]i elevation (area) (± SEM) 
measured in response to ischemia pH 7.0 (C, n = 79) and ischemia pH 6.0 (D, n 
= 89). There is no significant difference between any of the groups.  
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Figure 4.6 - PcTx1 peptide inhibits ischemia-induced elevations in [Ca2+]i. 
Representative traces of [Ca2+]i as a function of time recorded from a neuron 
during ischemia at pH 7.0 (A) and from a second cell during ischemia + acidosis 
(B) in the absence (Control) and presence of synthetic PcTx1 peptide (s.PcTx1). 
Mean changes in initial peak (peak), steady state (SS) and rebound (Rbd) [Ca2+]i, 
and net [Ca2+]i elevation (area) (± SEM) measured in response to ischemia pH 
7.0 (C, n = 165) and ischemia pH 6.0 (D, n = 171). Asterisks denote significant 
difference between groups (p <0.001). 
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Figure 4.7 - Temporal effects of acidosis on ischemia-induced Ca2+ 
dysregulation. A, Representative traces of [Ca2+]i as a function of time recorded 
from a cell during ischemia pH 7.4 (black trace, protocol A) and from a second 
neuron during a 10 second acid application followed by ischemia pH 7.4 (gray 
trace, protocol B). B, Mean changes in initial peak (peak), steady state (SS) and 
rebound (Rbd) peak [Ca2+]i, (nM), and net [Ca2+]i elevation (area, nM * min)        
(± SEM) measured in response to ischemia pH 7.4 (protocol A, n = 81) and acid 
followed by ischemia pH 7.4 (protocol B, n = 108). Area was calculated using the 
two minute application of control protocol (A). Asterisks denote significant 
differences between the groups in peak [Ca2+]i (p < 0.05), rebound [Ca2+]i peak (p 
< 0.001) and area (p < 0.001). C, Representative traces of [Ca2+]i as a function of 
time recorded from a cell during ischemia pH 7.4 (black trace, protocol A) and 
from another neuron during ischemia pH 7.4 followed by ischemia + acidosis 
(gray trace, protocol C). D, Mean changes in initial ischemia pH 7.4 and ischemia 
+ acidosis peaks (Peak), steady state (SS) and rebound (Rbd) [Ca2+]i (nM), and 
net elevation in [Ca2+]i (area, nM * min) (± SEM) measured in response to 
ischemia pH 7.4 (protocol A, n = 49) and ischemia pH 7.4 followed by ischemia + 
pH 6.0 (protocol C, n = 149). Area was calculated using the two minute 
application of control protocol (A). Asterisks denote significant differences 
between the groups (p < 0.001). E, Representative traces of [Ca2+]i as a function 
of time recorded from a neuron during ischemia + acidosis (black trace, protocol 
D) and from a second cell during ischemia + acidosis followed by ischemia pH 
7.4 (gray trace, protocol E). F, Mean changes in initial peak (Peak), steady state 
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(SS) and rebound (Rbd) [Ca2+]i (nM), and net [Ca2+]i elevation (area, nM * min) (± 
SEM) measured in response to ischemia + acidosis (protocol D, n = 79) and 
ischemia + pH 6.0 followed by ischemia at pH 7.4 (protocol E, n = 294). Area was 
calculated using the two minute application of control protocol (D). Asterisks 
denote significant differences between the groups (p < 0.001).  
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Figure 4.8 - Sigma-1 receptor activation inhibits ischemia-mediated Ca2+ 
dysregulation at pH values ranging from 7.4 to 6.0. Mean changes in initial peak 
(A), steady state (B) and rebound peak (C) [Ca2+]i, and net [Ca2+]i elevation 
(area) (D) (± SEM) measured in response to ischemia at pH 7.4 (n = 141), pH 7.0 
(n = 110), pH 6.5 (n = 196) and pH 6.0 (n = 181) in the absence (Control) and 
presence of 50 µM carbetapentane (CBP). Asterisks denote significant 
differences from pH 7.4 group (p < 0.05) and pound symbols indicate significant 
differences from respective Control groups (p < 0.05).  
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Figure 4.9 - Effects of synaptic transmission inhibition are overcome by 
presynaptic ASIC1a channels. A, Representative traces of [Ca2+]i as a function of 
time recorded from a neuron during ischemia (pH 7.4) in the absence (Control) 
and presence of 500 nM tetrodotoxin (TTX). B, Representative traces of [Ca2+]i 
as a function of time recorded from a different cell during the combination of 
ischemia and acidosis (pH 6.0) in the absence (Control) and presence of 500 nM 
tetrodotoxin (TTX). C, Mean changes in peak [Ca2+]i (± SEM) measured in the 
absence (Control) and presence of TTX (TTX, 500 nM) in response to ischemia 
(pH 7.4, n = 126) and ischemia + acidosis (pH 6.0, n = 240). D, Percent inhibition 
of changes in peak [Ca2+]i by TTX measured during ischemia at pH 7.4 and pH 
6.0. Asterisks denote significant differences from respective Control groups (p < 
0.001). 
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Figure 4.10 - TTX inhibits Na+ currents at pH 7.4 and 6.0. A, Representative Na+ 
current traces as a function of time recorded from a single cell in the absence 
(Control) and presence of TTX (TTX, 500 nM) at pH 7.4 (i) and pH 6.0 (ii). Cells 
were patch-clamped using the conventional dialysis whole-cell configuration and 
voltage-clamped at -90 mV. Na+ currents were activated by stepping cells to -10 
mV for 250 msec. B, Mean peak voltage-gated Na+ current densities (± SEM) 
measured from neurons under the indicated conditions (n = 12). Asterisks denote 
significant difference from respective Control group (p < 0.01) and pound 
symbols indicate significant difference between pH 7.4 and pH 6.0 within Control 
(p < 0.01). C, Percent inhibition of Na+ currents (± SEM) by TTX at pH 7.4 and 
pH 6.0. There was no significant difference between pH 7.4 and pH 6.0 groups, 
(p = 0.683).  
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Discussion 
The results from this study demonstrate that in rat cortical neurons, 
acidosis and ischemia synergistically interact to produce potentiated elevations in 
[Ca2+]i that are inhibited by σ-1 receptor activation. Acidification of the ischemia-
inducing extracellular solution to pathophysiological pH values (pH ≤ 7.0) 
produced elevations in [Ca2+]i that were greater than the sum of the changes 
evoked by acidosis and ischemia alone. Moreover, the kinetics of these 
responses were significantly different. Inhibition of ASIC1a channels with either 
amiloride or PcTx1, significantly decreased ischemia-induced increases in [Ca2+]i 
at pH values ranging from 7.4 to 6.0, suggesting that homomeric ASIC1a 
channels are activated during ischemia and that these channels contribute to the 
pH dependency of these [Ca2+]i increases. While our data indicate that activation 
of ASIC1a channels does not induce long-lived priming of synaptic vesicles for 
release, channel activation does have a temporal effect on ischemia-mediated 
[Ca2+]i increases after ischemia onset. Moreover, relief of proton block of Ca2+ 
influx pathways mediates the rebound of [Ca2+]i following washout of the acidic 
ischemia solution. The selective σ-1 receptor agonist, carbetapentane, 
decreased ischemia-mediated Ca2+ dysregulation at all pH values tested (7.4-
6.0). TTX was shown to block  ~70% of the initial ischemia-induced [Ca2+]i 
increases when the external solution was buffered to 7.4, but only produced 
~10% block when the solution was acidified to pH 6.0, suggesting that 
presynaptic ASIC1a channels promote synaptic transmission which leads to 
postsynaptic [Ca2+ ]i increases. 
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Previous studies have shown that ischemia and the acidosis that 
accompanies ischemia, produces marked increases in [Ca2+]i (Katnik et al., 
2006), which is one of the main mechanisms leading to cell death (Tombaugh 
and Sapolsky, 1993; Murai et al., 1997; Mattson, 2000; Xiong et al., 2004; 
Yermolaieva et al., 2004). ASIC1a-mediated currents in neurons have also been 
shown to be potentiated by oxygen-glucose deprivation (Xiong et al., 2004; Gao 
et al., 2005). Though the effects of ASIC1a currents during ischemia have been 
established, this study is the first report showing how ASIC1a activation affects 
the responses to ischemia and how acidosis and ischemia interact with each 
other to produce a synergistic dysregulation in [Ca2+]i. Our in vitro model of 
ischemia using the combination of azide in glucose-free PSS and acidosis (pH 
6.0), resembles in vivo models of stroke since similar pH values have been 
observed during ischemia in whole animal studies (Nedergaard et al., 1991). 
Together, ischemia and acidosis produced elevations in [Ca2+]i that were greater 
than the sum of the changes evoked by acidosis and ischemia alone. There was 
also a noticeable difference in the kinetics of the observed [Ca2+]i transients 
resulting from acidosis, ischemia, and ischemia + acidosis. These differences 
cannot be explained by ischemia potentiating ASIC currents because ASIC1a 
channels desensitize within seconds. Thus, we conclude the effects seen 
minutes after the initial insult (steady state, rebound and net Ca2+ elevations) 
following ischemia + acidosis are the result of ASIC1a activation potentiating 
ischemia-mediated [Ca2+]i increases. Therefore, ischemia and ASIC1a activation 
interact to produce potentiated elevations in [Ca2+]i dysregulation.  
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The fact that ASIC1a inhibitors amiloride and PcTx1 reduce the ischemia-
induced increases in [Ca2+]i when the external solution was buffered to pH 7.4 
suggests that the acidosis produced by metabolic inhibition is not responsible for 
ASIC1a activation. Instead, it is reasoned that protons released from glutamate 
containing synaptic vesicles during neurotransmission (DeVries, 2001; Traynelis 
and Chesler, 2001) are the source of ASIC1a channel activation. Therefore, 
there are two sources of protons associated with ischemia. First, an internal 
source as glucose and oxygen deprivation initiates a metabolic switch to 
anaerobic glycolysis to produce cellular energy leading to the accumulation of 
lactic acid, the end product of anaerobic glycolysis. Second, protons released 
along with glutamate during synaptic transmission. In our model, ischemia 
produces increased action potential firing and thus acidification of the synaptic 
cleft and the accumulation of lactic acid is mimicked by buffering external 
solutions to pH 6.0. Increased neurotransmission would activate more ASIC1a 
channels, inducing a feed-forward mechanism which promotes further synaptic 
transmission and greater Ca2+ accumulation. These increases in [Ca2+]i, if of 
sufficient duration, would produce Ca2+ overload and eventually lead to cell 
death. Consistent with these conclusions, the interaction between ischemia and 
acidosis leads to the synergistic potentiation of Ca2+ dysregulaton, which is what 
is expected to be seen in vivo following an ischemic stroke (Tombaugh and 
Sapolsky, 1993; Murai et al., 1997; Mattson, 2000; Xiong et al., 2004; 
Yermolaieva et al., 2004).  
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The [Ca2+]i responses to ischemia + acidosis were characterized by four 
parameters, the initial transient peak amplitude, the steady state level just prior to 
washout of the ischemia + acid solution, the transient rebound amplitude 
following washout and the net [Ca2+]i elevations, calculated by integrating Δ[Ca2+]i 
for the duration of the response. The strongest evidence that the initial peak in 
ischemia-induced [Ca2+]i elevations reported here is due to activation of 
homomeric ASIC1a channels is the inhibition produced by both amiloride and the 
selective ASIC1a channel blocker PcTx1 (Diochot et al., 2007). The steady state 
[Ca2+]i is a function of the activated Ca2+ influx and efflux pathways. Interestingly, 
the steady state level of [Ca2+]i obtained at the end of ischemia applications 
increased as the pH was reduced from 7.4 to 7.0, but then remained constant as 
the pH was reduced to 6.0. Previous studies suggest most of the elevations in 
[Ca2+]i triggered by acidosis are the result of Ca2+ channels (NMDA and AMPA 
receptors and voltage-gated Ca2+ channels) opening in response to ASIC1a 
mediated membrane depolarization. These results suggest that acidosis results 
in increased ASIC1a channel opening but the effects of pH are countered by 
increased H+ block of other ion channels. The antioxidant MnTMPyP (25 nM) did 
not significantly affect the transient rebound increase in [Ca2+]i, suggesting that 
reactive oxygen species production do not account for the rebound mechanism. 
In contrast, the transient rebound increase in [Ca2+]i observed during washout of 
acidosis + ischemia solution is due to the removal of a block of Ca2+ influx 
pathways by protons as the proton concentration is reduced to pH 7.4. Since this 
feature of the [Ca2+]i response is not observed following applications of ischemia 
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at pH 7.4, it is unlikely that when observed at lower pH values it is due to the 
washout of the ischemia solution. The transient rebound is expected to be more 
robust at the lower pH values due to a greater proton block of these Ca2+ 
channels being relieved.  
Conditions which produce large net [Ca2+]i elevations, or Ca2+ overload, 
are likely to lead to apoptosis. Acidosis alone, while producing a large [Ca2+]i 
increase, has a very small net Ca2+ elevation because the transient increase is 
short lived. Likewise, while ischemia produces a maintained elevated [Ca2+]i level 
in the presence of the ischemia solution, it is only a moderately high level which 
returns quickly to baseline upon washout, and thus results in a small net 
elevation. The synergistic interaction of acidosis and ischemia, on the other 
hand, produces potentiated increases at all times during the agonist-evoked 
application as well as an extenuated rebound increase and a slower decay back 
to baseline. All these contribute to produce net elevations in [Ca2+]i which are 
~400% times greater than that for acidosis or ischemia alone. This pronounced 
Ca2+ overload would be more likely to trigger apoptosis.  
PcTx1 from the venom of the tarantula Psalmopoeus cambridgei has been 
shown to be a selective blocker of homomultimeric ASIC1a channels with no 
effect on other ASIC subtypes (1b, 2a or 3) or voltage-gated channels (Na+, K+, 
Ca2+) (Diochot et al., 2007). PcTx1 induces a shift in the steady-state 
desensitization of the channel. At normal pH (7.4) this shift puts ASIC1a 
channels in the inactive state (Chen et al., 2005). When studying ASIC1a 
activation, it is sufficient to include the toxin only in the conditioning media 
 155 
 
because the on and off rates are slow compared to the rate of channel 
desensitization (Chen et al., 2005; Chen et al., 2006). This also avoids the 
problem of the peptide being degraded in the low pH solutions. For this study, 
however, the venom was included in the conditioning media as well as the test 
solutions because the cellular response to ischemia lasted for the duration of the 
ischemia application. PcTx1 venom blocks the initial ischemia + acidosis-
mediated [Ca2+]i increases as well as rebound and the elevated steady state 
levels at pH values > 6.5. Thus, blocking ASIC1a channels significantly 
prevented activation of the downstream Ca2+ channels responsible for the initial 
[Ca2+]i peak as well as disrupting the synergistic interaction between acidosis and 
ischemia. Moreover, experiments performed with a synthetic PcTx1 peptide 
provided similar results to those obtained with the venom. Therefore, ASIC1a 
channels are mediating the synergistic potentiation seen during the combination 
of ischemia and acidosis.  
 Similar to earlier reports, blockade of voltage-gated Na+ channels with 
TTX and subsequent synaptic transmission inhibition, prevents ischemia-induced 
elevations in [Ca2+]i at physiological pH (Katnik et al., 2006). Interestingly, with 
the more acidic conditions present during the combination of ischemia and 
acidosis at pH 6.0, the inhibition of [Ca2+]i increases by TTX were overcome, 
most likely by the additional activation of ASIC1a channels. This observation 
suggests a presynaptic localization of ASIC1a, whereby activation of the channel 
by protons results in synaptic transmission and subsequent activation of 
postsynaptic receptors. Consistent with this theory, the activation of postsynaptic 
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Ca2+ channels and receptors following ASIC1a stimulation during acidosis alone 
(pH 6.0) are observed even when neuronal conduction is inhibited by TTX. It has 
been proposed that ASIC1a activation may facilitate neurotransmission by 
compensating for the decrease in excitatory neurotransmission caused by direct 
inhibition of postsynaptic Na+ and Ca2+ channels by protons which are released 
during exocytosis (Krishtal et al., 1987; Zha et al., 2006). Thus, action potential 
inhibition alone is not sufficient to prevent Ca2+ overload, as ASIC1a channel 
activation is able to overcome this block of glutamate release by depolarizing the 
presynaptic membrane to potentials capable of activating voltage-gated Ca2+ 
channels and thus, evoking synaptic transmission. In addition, these results also 
raise the possibility of ASIC1a activation resulting in enough Ca2+ influx to 
promote synaptic transmission and glutamate release. Similarly, heteromeric 
complexes of alpha 5 and/or alpha 7 subunits of nicotinic receptors have been 
shown to conduct Ca2+ and thus, resulting in nicotine-induced presynaptic 
facilitation (Girod et al., 1999). 
σ receptors have been identified in both pre and postsynaptic membranes 
(Gonzalez-Alvear and Werling, 1995; Alonso et al., 2000), modulating ion 
channels in both regions. σ receptor activation has been shown to modulate the 
function of multiple ion channels, several of which have been linked to neuronal 
death following an ischemic insult. Studies have shown that the affinity of 
carbetapentane for σ-1 receptors is >50-fold greater than for  σ-2 receptors 
(Rothman et al., 1991; Vilner and Bowen, 2000). The concentrations of CBP 
used in this study are consistent with CBP acting as a σ-1  receptor agonist 
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(Thurgur and Church, 1998). Moreover, similar concentrations of CBP have 
previously been shown to inhibit ischemia-evoked increases in [Ca2+]i (Katnik et 
al., 2006) as well as ASIC1a-induced [Ca2+]i increases and membrane currents. 
Unlike the results seen with inhibition of ASIC1a by PcTx1 venom, CBP 
activation of σ-1 receptors is pH insensitive and significantly inhibited the 
synergistic increases in [Ca2+]i produced by ischemia and acidosis as measured 
by initial peak amplitude, steady state, rebound and net elevations of [Ca2+]i.  
In conclusion, σ-1 receptors inhibit [Ca2+]i increases following ASIC1a 
channel activation, ischemia-induced increases in [Ca2+]i as well as the 
synergistic potentiation during ischemia + acidosis. Because acidic conditions 
exist during ischemic episodes, σ-1 receptors should be targeted for 
development of treatments for stroke and other pathophysiological conditions 
where ASIC1a channel activation are involved. σ-1 receptor mediated inhibition 
of Ca2+ channels activated by membrane depolarizations produced by ASIC1a 
channel activation or metabolic inhibition and the ASIC1a channels themselves, 
may contribute to the enhanced neuronal survival observed following 
administration of σ receptor agonists 24 hr post-stroke in rats (Ajmo et al., 2006). 
For these reasons, σ-1 receptors should be targeted for therapeutic intervention 
during ischemia, expanding the therapeutic window of stroke treatment. 
The finding that ASIC1a activation at any point during an ischemic insult 
results in synergistic [Ca2+]i increases has significant physiological and 
pathophysiological implications. Our data indicate that though ASIC1a channels 
rapidly desensitize, they are able to be re-activated minutes into the ischemic 
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insult. This suggests that during pathophysiological conditions it is possible to get 
repeated activation of ASIC1a channels if the extracellular media is buffered 
back to normal pH for even a short time. Even more dramatic though, is that 
under ischemic conditions these repetitive activations of ASIC1a channels 
synergistically interact with ischemia to produce potentiated elevations in peak, 
steady state, and rebound [Ca2+]i elevations and net [Ca2+]i elevation (area), 
suggesting that to prevent the consequences of Ca2+ overload during ischemia it 
is critical to control ASIC1a activation. Consistent with these results, it has been 
suggested that the acidosis that occurs in vivo during ischemia exacerbates 
ischemic injury at later time points after the initial ischemic insult. The finding that 
ASIC1a activation interacts with ischemia to produce synergistic potentiation of 
Ca2+ dysregulation is a novel finding and suggests that this channel should be 
targeted even at delayed time points after stroke onset to prevent Ca2+ overload 
and neuronal apoptosis.  
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DISCUSSION 
 
 
Conclusions 
 
 
Stroke remains the 3rd leading cause of death and the leading cause of 
long term disability in the United States. Ischemic stroke, as a result of an 
embolus and restriction of blood flow to the brain, is the most common type of 
stroke accounting for over 80% of these cases. Thus far, only one drug (tissue 
plasminogen activator, tPA) has been approved by the FDA for the treatment of 
ischemia. This study has determined how σ-1 receptors modulate ASIC1a 
channels during physiological and pathophysiological conditions, and also 
suggest that this regulation could be one of the mechanisms of neuroprotection 
by σ receptor activation. Thus, σ receptors could be a potential therapeutic target 
for the treatment of stroke at delayed time points.  
ASIC are regulated by various factors such as pH, membrane distention 
and arachidonic acid, and therefore, function as signal integrators in the CNS 
(Allen and Attwell, 2002; Lopez, 2002), but these factors elicit or potentiate ASIC-
mediated responses. NMDA receptors modulate ASIC1a function via the 
activation of a CaMKII signaling cascade, but activation of this pathway results in 
an increase in currents through ASIC1a (Gao et al., 2005). Similarly, ASIC are 
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also regulated by C kinase-1 (PICK-1), which binds to the C-terminus of several 
ASIC isoforms (Duggan et al., 2002). PICK1 has been shown to promote the 
stimulation of homomeric ASIC2a and heteromultimeric ASIC3/ASIC2b channels 
by protein kinase C (Baron et al., 2002; Deval et al., 2004), while several protein 
kinase C isoforms have also been shown to inhibit ASIC1 (Berdiev et al., 2002). 
Protein kinase A phosphorylation of ASIC interferes with the binding of PICK-1 to 
these channels, and disrupts PICK1-ASIC1 colocalization (Leonard et al., 2003). 
Three distinct kinases (CaMKII, protein kinase C and protein kinase A) have all 
been shown to modulate the function of ASIC, by direct phosphorylation of the 
channel (Baron et al., 2002; Leonard et al., 2003; Gao et al., 2005). Kinase 
anchoring proteins such as PICK-1 and AKAP150 have also been shown to bind 
to ASIC subtypes, and appear to increase currents through these channels by 
facilitating protein kinase C and protein kinase A  phosphorylation of the 
channels, respectively (Baron et al., 2002; Deval et al., 2004; Chai et al., 2007). 
Conversely, activation of σ receptors depresses ASIC1a-mediated responses 
and remains the only reported instance of receptor mediated downregulation of 
ASIC activity. 
The responses observed throughout these studies are specifically 
mediated by ASIC1a channels and this conclusion is supported by the inhibition 
produced by amiloride and the selective ASIC1a channel blocker, PcTx1 venom 
as well as the PcTx1 peptide (Diochot et al., 2007). Furthermore, cultured cortical 
neurons from embryonic mice deficient in the ASIC1a subunit fail to show 
increases in [Ca2+]i or membrane currents at the same proton concentrations 
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used here (Xiong et al., 2004). ASIC2a and ASIC2b subunits are also expressed 
in the CNS, but homomeric ASIC2a channels are activated below pH 5.5, and 
ASIC2b does not generate currents in response to low pH (Lingueglia et al., 
1997). In addition, neither homomeric ASIC2a nor heteromultimeric 
ASIC1a/ASIC2a channels conduct Ca2+, and thus could not account for the 
changes in [Ca2+]i observed (Yermolaieva et al., 2004). However, PcTx1 itself 
may not be an ideal pharmacological agent for stroke patients because of its 
size, stability and inability to cross the blood brain barrier (Xiong et al., 2008). 
Therefore, the development of better compounds is undergoing for the treatment 
of stroke.  
   The σ-1 receptor subtype modulates neuronal responses to ASIC1a 
activation. Studies have shown that the affinity of carbetapentane for σ-1 
receptors is >50-fold greater than for σ-2 receptors (Rothman et al., 1991; Vilner 
and Bowen, 2000). The calculated IC50 for carbetapentane inhibition of ischemia-
evoked increases in [Ca2+]i via σ-1 receptor activation is 18.7 µM (Katnik et al., 
2006), which is comparable to the 13.8 μM IC50 for CBP inhibition of ASIC1a-
induced [Ca2+]i increases. Carbetapentane also inhibits epileptiform activity in rat 
hippocampal slices via σ-1 receptors with an IC50 value of 38 µM (Thurgur and 
Church, 1998). Similarly, other σ-1 agonists, dextromethorphan (IC50 = 22 μM) 
and PRE-084 (IC50 = 13.7 μM), both of which have >100-fold greater affinities for 
σ-1 than σ-2 receptors, blocked ASIC1a-mediated responses at concentrations 
consistent with those reported in the literature. Dextromethorphan inhibits 
spreading depression in rat neocortical brain slices with an IC50 ~ 30 μM 
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(Anderson and Andrew, 2002), whereas PRE-084 protects human retinal cells 
against oxidative stress with an IC50 ~ 10 μM (Bucolo et al., 2006). The IC50 
values determined here for carbetapentane, dextromethorphan and PRE-084 are 
in the low μM range and suggests that it is unlikely these agonists are affecting 
ASIC1a activity via σ-2 receptors, since high μM to mM concentrations of these 
compounds are required to stimulate σ-2 receptors. Moreover, σ-2-selective 
agonists (ibogaine and PB28) failed to inhibit ASIC1a-mediated responses at 
concentrations consistent with σ-2 specific effects and in a metaphit-insensitive 
manner.  
 Pharmacological studies with the σ antagonists, metaphit and BD1063, 
confirm that σ-1 receptor activation modulates ASIC1a channels. Metaphit has 
been shown to bind irreversibly to σ-1 receptors with an IC50 value of 50 μM (Wu, 
2003). Preincubation in metaphit blocks σ-1 receptor modulation of voltage-gated 
K+ channels in intracardiac neurons and depression of ischemia-induced 
elevations in [Ca2+]i in cortical neurons (Zhang and Cuevas, 2005; Katnik et al., 
2006).  Preincubation of cortical neurons in 50 μM metaphit antagonized CBP 
inhibition of ASIC1a by ~ 40%. BD1063 has a higher affinity for σ-1 than σ-2 
receptors and attenuates the dystonia produced by DTG in rats in a dose-
dependent manner, suggesting this ligand acts as an antagonist at σ sites 
(Matsumoto et al., 1995). CBP is unable to block acid-induced increases in 
[Ca2+]i when co-applied with BD1063, suggesting the effects are mediated by σ-1 
receptors. In addition, metaphit fails to inhibit the effects of the σ-2 agonist, 
PB28, on ASIC1a-mediated responses. Taken together, these data show that 
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increases in [Ca2+]i in response to ASIC1a activation are modulated only by σ-1 
receptors. 
Inhibition of the second messenger calcineurin has been shown to 
potentiate currents through ASIC1a and ASIC2a channels, and thus 
dephosphorylation of the channels by this phosphatase may be involved in 
downregulation of ASIC (Chai et al., 2007). The calcineurin inhibitors, cyclosporin 
A and FK-506, demonstrate that σ-1 receptor-mediated block of ASIC1a is 
dependent on activation of this phosphatase (Figure 5.1). Interestingly, reports 
have shown that calcineurin may be activated by a pertussis toxin-sensitive G 
protein (Gromada et al., 2001). Consistent with this observation, the effects of σ 
receptor activation on ASIC1a-mediated [Ca2+]i increases are significantly 
lessened in cortical neurons following preincubation in pertussis toxin, suggesting 
a pertussis toxin-sensitive G protein is involved in the signaling cascade coupling 
σ-1 receptors to ASIC1a-mediated responses.  
This study demonstrates that σ-1 receptors modulate ASIC1a channel 
function via activation of a PTX-sensitive G protein, and these results are the first 
evidence of a receptor coupling to ASIC1a through this mechanism (Figure 5.1). 
σ receptors regulate ion channel function via protein-protein interactions (Aydar 
et al., 2002). Moreover, inhibition of G proteins either by cell dialysis with GDP-β-
S or preincubation in pertussis toxin failed to affect σ-1 and σ-2 receptor 
modulation of voltage-gated K+ and Ca2+ channels in intracardiac neurons 
(Zhang and Cuevas, 2002; Zhang and Cuevas, 2005). To date, nearly all reports 
of σ receptor modulation of ion channels suggest that the effects involve a 
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membrane-delimited signaling pathway which could involve a protein-protein 
interaction. However, σ receptor activation has been shown to stimulate GTPase 
activity in mouse prefrontal membranes (Tokuyama et al., 1997). A pertussis 
toxin-sensitive G protein has been implicated in the modulation of NMDA 
receptors by σ receptors in rat CA3 dorsal hippocampus neurons (Monnet et al., 
1994), whereas a cholera toxin-sensitive G protein has been suggested to couple 
σ-1 receptors to the channels mediating the A-current in frog pituitary 
melanotopes (Soriani et al., 1999). However, others have argued that σ receptors 
do not couple to G proteins (Hopf et al., 1996).  
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Figure 5.1 - Signaling cascade linking ASIC1a channels and sigma-1 receptors. 
Activation of σ-1 receptors inhibits ASIC1a-induced Ca2+ dysregulation via a 
PTX-sensitive G protein and a calcineurin/AKAP complex, resulting in a decrease 
in [Ca2+]i elevations. Sigma-1 receptors directly couple to ASIC1a channels via a 
PTX-sensitive G protein and a calcineurin/AKAP complex. 
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  AKAP150 is involved in the regulation of receptor activity and localization, 
and in the regulation of synaptic structure during developmental synapse 
formation, in synaptic plasticity in learning and memory, and neuronal 
dysfunction and cell death during pathophysiological conditions (Dell'Acqua et al., 
2006). σ-1 receptors colocalize with both ASIC1a channels and AKAP150 in the 
plasma membrane of the cell body and along the neuronal processes of the cells. 
Consistent with this finding, a calcineurin/AKAP150 complex has been shown to 
modulate both ASIC1a and ASIC2a function (Chai et al., 2007). Furthermore, the 
similarity of the distributions of σ receptors colocalized with ASIC1a channels and 
with AKAP150 is consistent with previous studies showing colocalization of ASIC 
channels and AKAP (Chai et al., 2007). Disruption of the actin cytoskeleton by 
chemical agents or NMDA receptor activation, results in the redistribution of 
AKAP150 away from the plasma membrane (Gomez et al., 2002), and thus, 
preventing σ-1 receptor modulation of ASIC1a-induced [Ca2+]i dysregulation 
(Figure 5.1).  
Depletion of Ca2+ from intracellular stores indicates that most, if not all, of 
the acid-induced increases in [Ca2+]i is due to plasma membrane influx. Multiple 
ion channels downstream of ASIC1a activation were shown to contribute to 
acidosis-induced elevations in [Ca2+]i, including NMDA and AMPA/kainate 
receptors and VGCC. σ receptors have been identified in both presynaptic and 
postsynaptic sites (Gonzalez-Alvear and Werling, 1995; Alonso et al., 2000), and 
thus may modulate channels in both regions. In the presence of specific 
inhibitors of ionotropic glutamate receptors, activation of σ-1 receptors with CBP 
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further decreased proton-evoked increases in [Ca2+]i, but the effects of CBP and 
the glutamate channel inhibitors were less than additive. Thus, σ-1 receptors also 
inhibit Ca2+ entry via NMDA and AMPA/kainate receptors directly by inhibiting 
these channels and indirectly by depressing ASIC1a activation. Application of the 
L-type VGCC inhibitor, nifedipine, and the broad-spectrum Ca2+ channel inhibitor, 
cadmium, blocked ASIC1a-induced increases in [Ca2+]i by >70% and >90%, 
respectively. This observation indicates that most of the increases in [Ca2+]i 
produced upon ASIC1a activation is dependent on Ca2+ influx through VGCC. 
Co-application of CBP with nifedipine, but not with Cd2+, resulted in further 
reduction in the proton-evoked increases in [Ca2+]i. 
The activation of NMDA and AMPA/kainate receptors following ASIC1a 
stimulation was observed even when neuronal conduction was inhibited with 
tetrodotoxin. This observation suggests a presynaptic localization of ASIC1a, 
whereby activation of the channel by protons results in synaptic transmission and 
subsequent activation of postsynaptic glutamatergic receptors. Consistent with 
this hypothesis, ASIC1a has been found to regulate neurotransmitter release 
probability in mouse hippocampal neurons (Cho and Askwith, 2008). 
AKAP150 has been shown to modulate the internalization of AMPA 
receptors, NMDA receptors during long term potentiation and depression 
(Rosenmund et al., 1994; Westphal et al., 1999; Colledge et al., 2000; Gomez et 
al., 2002; Smith et al., 2006) and voltage-gated Ca2+ channels function (Oliveria 
et al., 2007). Since most of the elevations in [Ca2+]i  triggered by acidosis are the 
result of Ca2+ channels opening downstream of ASIC1a activation, and 
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stimulation of σ-1 receptors effectively suppresses these secondary Ca2+ fluxes, 
these results also raise the possibility that AKAP150 is a constituent in the 
modulation of these downstream ion channels (e.g. voltage-gated Ca2+ channels) 
and receptors (e.g. NMDA and AMPA) by σ-1 receptors (Figure 5.1).  
Simultaneous Ca2+ fluorometry and whole-cell patch clamp recordings 
confirmed that Ca2+ influx through ASIC1a channels itself contributed only a 
small fraction to the total observed [Ca2+]i increases. Cells voltage-clamped at     
-70 mV, which prevents NMDA receptor and VGCC activation, demonstrated 
minimal acid-evoked elevations in [Ca2+]i. Thus, the increases in [Ca2+]i evoked 
by ASIC1a activation are the result of synaptic transmission and subsequent 
opening of multiple Ca2+ channels, and that stimulation of σ-1 receptors 
downregulates all of these events. However, the fact that activation of σ-1 
receptors depresses ASIC1a-mediated currents in cells voltage-clamped at         
-70 mV indicates that σ-1 receptors are functionally coupled to ASIC1a, and that 
the depression in acid-evoked increases in [Ca2+]i is not exclusively the result of 
σ-1 receptors blocking channels downstream of ASIC1a.  
The effects of σ receptor activation on ASIC1a-mediated membrane 
currents are significantly lessened in cortical neurons following preincubation in 
pertussis toxin. These results suggest a pertussis toxin-sensitive G protein is 
involved in the signaling cascade coupling σ receptors to ASIC1a channels 
(Figure 5.1). Moreover, σ-1 receptors couple to ASIC1a channels via a 
calcineurin/AKAP150 complex resulting in a decrease in acid-induced membrane 
currents (Figure 5.1). Whole-cell patch clamp experiments with VIVIT suggest 
 170 
 
that when this peptide competes with calcineurin for binding to the PxIxIT-like 
motif in AKAP150, and thus prevents calcineurin binding to AKAP150, σ receptor 
activation loses its ability to regulate ASIC1a function. Thus, the disruption of this 
interaction prevents σ-1 receptors from functionally coupling to ASIC1a channels. 
Similarly, VIVIT has been implicated in the disruption of calcineurin/AKAP150 
modulation of L-type Ca2+ channels in hippocampal neurons (Oliveria et al., 
2007).  
Pertinent to ischemia, ASIC1a is being studied as a putative target for 
neuroprotection due to the observation that ASIC1a is involved in neuronal death 
following ischemic brain injury (Xiong et al., 2004; Yermolaieva et al., 2004). 
These studies also implicated calcium influx through these channels as a key 
mechanism leading to neurodegeneration (Waldmann et al., 1997b; Chu et al., 
2002; Xiong et al., 2004; Yermolaieva et al., 2004). Transgenic mice deficient in 
ASIC1a have reduced infarct size in response to middle cerebral artery 
occlusion, relative to wild-type mice (Xiong et al., 2004; Xiong et al., 2006). The 
increases in [Ca2+]i that are evoked by acidosis are also absent in these 
transgenic animals, giving insight into how these channels may contribute to 
neuronal injury (Xiong et al., 2004; Xiong et al., 2006). Furthermore, it has been 
shown that either blocking ASIC1a by amiloride or gene knockout of ASIC1a 
provides additional neuroprotection during oxygen glucose deprivation even in 
the presence of the NMDA receptor antagonist, memantine (Xiong et al., 2004; 
Xiong et al., 2006). It has also been established that PcTx1 inhibits ASIC1a via 
chronic desensitization of the channel (Chen et al., 2005) and also diminishes the 
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effects of NMDA-induced cell death (Xiong et al., 2004; Gao et al., 2005). 
Ischemia has also been shown to enhance ASIC1a currents through 
phosphorylation at Ser478 or Ser479 by calcium/calmodulin protein kinase II 
(CaMKII), and specific blockade of CaMKII prevented potentiation of the 
ischemia-induced ASIC1a currents, cytoplasmic calcium dysregulation, and 
neuronal death (Gao et al., 2005). 
Neurons within the penumbra region remain viable for hours after the 
ischemic insult but are subject to apoptosis if perfusion is not re-established. 
Previous studies have shown that ischemia and the acidosis that accompanies 
ischemia, produces marked increases in [Ca2+]i, which is one of the main 
mechanisms leading to cell death (Tombaugh and Sapolsky, 1993; Murai et al., 
1997; Mattson, 2000; Xiong et al., 2004; Yermolaieva et al., 2004). ASIC1a-
mediated currents in neurons have also been shown to be potentiated by 
oxygen-glucose deprivation (Xiong et al., 2004; Gao et al., 2005). Though the 
effects of ASIC1a currents during ischemia have been established, this study is 
the first report showing how ASIC1a activation affects the responses to ischemia 
and how acidosis and ischemia interact with each other to produce a synergistic 
dysregulation in [Ca2+]i. Our in vitro model of ischemia using the combination of 
azide in glucose-free PSS and acidosis (pH 6.0), resembles in vivo models of 
stroke since similar pH values have been observed during ischemia in whole 
animal studies (Nedergaard et al., 1991). Together, ischemia and acidosis 
produced elevations in [Ca2+]i that were greater than the sum of the changes 
evoked by acidosis and ischemia alone. There was also a noticeable difference 
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in the kinetics of the observed [Ca2+]i transients resulting from acidosis, ischemia, 
and ischemia + acidosis. These differences cannot be explained by ischemia 
potentiating ASIC currents because ASIC1a channels desensitize within 
seconds. Thus, we conclude the effects seen minutes after the initial insult 
(steady state, rebound  and net Ca2+ elevations) following ischemia + acidosis 
are the result of ASIC1a activation potentiating ischemia-mediated [Ca2+]i 
increases. Therefore, ischemia and ASIC1a activation interact to produce 
potentiated elevations in [Ca2+]i dysregulation.  
The fact that ASIC1a inhibitors amiloride and PcTx1 reduce the ischemia-
induced increases in [Ca2+]i when the external solution was buffered to pH 7.4 
suggests that the acidosis produced by metabolic inhibition is not responsible for 
ASIC1a activation. Instead, it is reasoned that protons released from glutamate 
containing synaptic vesicles during neurotransmission (DeVries, 2001; Traynelis 
and Chesler, 2001) are the source of ASIC1a channel activation. Therefore, 
there are two sources of protons associated with ischemia. First, an internal 
source as glucose and oxygen deprivation initiates a metabolic switch to 
anaerobic glycolysis to produce cellular energy leading to the accumulation of 
lactic acid, the end product of anaerobic glycolysis. Second, protons released 
along with glutamate during synaptic transmission. In our model, azide produces 
increased action potential firing and thus acidification of the synaptic cleft and the 
accumulation of lactic acid is mimicked by buffering external solutions to pH 6.0. 
Increased neurotransmission would activate more ASIC1a channels, inducing a 
feed-forward mechanism which promotes further synaptic transmission and 
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greater Ca2+ accumulation. These increases in [Ca2+]i, if of sufficient duration, 
would produce Ca2+ overload and eventually lead to cell death. Consistent with 
these conclusions, the interaction between ischemia and acidosis leads to the 
synergistic potentiation of Ca2+ dysregulaton, which is what is expected to be 
seen in vivo following an ischemic stroke (Tombaugh and Sapolsky, 1993; Murai 
et al., 1997; Mattson, 2000; Xiong et al., 2004; Yermolaieva et al., 2004).  
Several mechanisms are responsible for the different phases of Ca2+ 
responses to the combination of ischemia and acidosis observed in these 
neurons. The strongest evidence that the initial peaks associated with ischemia-
induced [Ca2+]i elevations reported here are due to activation of homomeric 
ASIC1a channels is the inhibition produced by both amiloride and the selective 
ASIC1a channel blocker PcTx1 (Diochot et al., 2007). The steady state [Ca2+]i is 
a function of the activated Ca2+ influx and efflux pathways. Interestingly, the 
steady state level of [Ca2+]i obtained at the end of ischemia applications 
increased as the pH was reduced from 7.4 to 7.0, but then remained constant as 
the pH was reduced to 6.0. Previous studies suggest most of the elevations in 
[Ca2+]i triggered by acidosis are the result of Ca2+ channels (NMDA and AMPA 
receptors and voltage-gated Ca2+ channels) opening in response to ASIC1a 
mediated membrane depolarization. These results suggest that acidosis results 
in increased ASIC1a channel opening but the effects of pH are countered by 
increased H+ block of other ion channels. 
The transient rebound increase in [Ca2+]i observed during washout of the 
acidosis + ischemia solution is most likely due to the removal of a block of Ca2+ 
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influx pathways by protons as the proton concentration is reduced to pH 7.4. 
Since this feature of the [Ca2+]i response is not observed following applications of 
azide in pH 7.4 PSS, it is unlikely that when observed at lower pH’s it is due to 
the washout of azide. Consistent with observations in this study, the transient 
rebound is expected to be more robust at the lower pH values due to the relief of 
a greater proton block of these Ca2+ channels.  
Conditions which produce large net [Ca2+]i elevations, or Ca2+ overload, 
are likely to lead to apoptosis. Acidosis alone, while producing a large [Ca2+]i 
increase, has a very small net Ca2+ elevation because the transient increase is 
short lived. Likewise, while ischemia produces a maintained elevated [Ca2+]i level 
in the presence of ischemia, it is only a moderately high level which returns 
quickly to baseline upon washout, and thus results in a small net elevation. The 
synergistic interaction of acidosis and ischemia, on the other hand, produces 
potentiated increases at all times during the agonist-evoked application as well 
as an extenuated rebound increase and a slower decay back to baseline. All 
these contribute to produce net elevations in [Ca2+]i which are ~400% times 
greater than that of acidosis or ischemia alone. This pronounced Ca2+ overload 
would be more likely to trigger apoptosis, probably too due to endoplasmic 
recticulum stress.  
Blockade of voltage-gated Na+ channels by TTX and subsequent synaptic 
transmission inhibition, prevents ischemia-induced elevations in [Ca2+]i at 
physiological pH values (Katnik et al., 2006). Interestingly, during the 
combination of ischemia and acidosis at pH 6.0, the inhibition of [Ca2+]i increases 
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by TTX were overcome, most likely by the additional activation of ASIC1a 
channels. This observation suggests a presynaptic localization of ASIC1a, 
whereby activation of the channel by protons results in synaptic transmission and 
subsequent activation of postsynaptic receptors. Consistent with this theory, the 
activation of postsynaptic Ca2+ channels and receptors following ASIC1a 
stimulation during acidosis alone (pH 6.0) are observed even when neuronal 
conduction is inhibited by TTX. It has been proposed that ASIC1a activation may 
facilitate neurotransmission by compensating for the decrease in excitatory 
neurotransmission caused by direct inhibition of postsynaptic Na+ and Ca2+ 
channels by protons which are released during exocytosis (Krishtal et al., 1987; 
Zha et al., 2006). Thus, action potential inhibition alone is not sufficient to prevent 
Ca2+ overload, as ASIC1a channel activation is able to overcome this block of 
glutamate release by depolarizing the presynaptic membrane to potentials 
capable of activating voltage-gated Ca2+ channels and thus, evoking synaptic 
transmission. Thus, even in the absence of glutamate release, ASIC1a would 
depolarize the cell and subsequently, activate voltage-gated Ca2+ channels to 
promote neurotransmission. In addition, these results also raise the possibility of 
ASIC1a activation resulting in enough Ca2+ influx to promote synaptic 
transmission and glutamate release. Similarly, heteromeric complexes of alpha 5 
and/or alpha 7 subunits of nicotinic receptors have been shown to conduct Ca2+ 
and thus, resulting in acetylcholine-induced presynaptic facilitation (Girod et al., 
1999).  
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The σ-1 selective ligand, CBP, has previously been shown to inhibit 
ischemia-evoked increases in [Ca2+]i (Katnik et al., 2006) as well as ASIC1a-
induced [Ca2+]i increases and membrane currents. Unlike the results seen with 
inhibition of ASIC1a with PcTx1 venom, CBP activation of σ-1 receptors is pH 
insensitive and significantly inhibited the synergistic increases in [Ca2+]i produced 
by ischemia and acidosis as measured by initial peak amplitude, steady state, 
rebound and net elevations of [Ca2+]i.  
 
Overall Significance 
The finding that σ-1 receptors can inhibit ASIC1a channels has significant 
physiological implications (Figure 5.2). It has been proposed that ASIC1a 
activation may facilitate neurotransmission by compensating for the decrease in 
excitatory neurotransmission caused by direct inhibition of post-synaptic Na+ and 
Ca2+ channels by protons which are released during exocytosis (Krishtal et al., 
1987; Zha et al., 2006) (Figure 5.2). Furthermore, the expression levels of 
ASIC1a have direct effects on the density of dendritic spines in hippocampal 
neurons (Zha et al., 2006). Thus, σ-1 receptors may influence cell-to-cell 
signaling in the CNS by affecting ASIC1a activity. One of the consequences of 
ASIC1a overexpression in mice is enhanced fear conditioning (Wemmie et al., 
2004), whereas stimulation of σ-1 receptors is known to ameliorate conditioned 
fear stress (Kamei et al., 1997). These observations, coupled with our current 
report, suggest that σ-1 receptor activation may produce anxiolytic effects via the 
inhibition of ASIC1a channels.   
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Figure 5.2 - Presynaptic ASIC1a channels under physiological conditions. 
Neurotransmitter release leads to acidification of the synaptic cleft, which will 
lead to decrease neuroexcitability due to the inhibitory effects of protons in the 
postsynaptic channels. ASIC1a provide a positive feedback by increasing 
intracellular calcium following activation leading to increased neuroexcitability, 
and thus, preserving synaptic transmission. 
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  The finding that σ-1 receptors can inhibit ASIC1a channels also has 
significant pathophysiological implications σ-1 receptors functionally couple to 
ASIC1a channels via a PTX-sensitive G protein and an AKAP150/calcineurin 
complex in cortical neurons (Figure 5.1). This coupling results in decreases in 
both ASIC1a-mediated membrane currents and concomitant elevations in 
cytosolic Ca2+ following σ-1 receptor activation. Furthermore, these results also 
raise the possibility of σ-1 receptors coupling to downstream Ca2+ channels 
(voltage-gated Ca2+ channels) and receptors (NMDA and AMPA) via a similar 
signaling cascade. All of these channels and receptors have been implicated in 
pathophysiological conditions. Moreover, calcineurin may be a potential 
component of the neuroprotective properties of σ receptors. σ-1 receptors are the 
first receptor shown to downregulate ASIC1a channel function and remain as the 
only receptor identified thus far to negatively modulate ASIC1a channels.  
Further evidence of the significance of σ-1 receptor modulation of ASIC1a 
channels during pathophysiological conditions was the finding that ASIC1a 
activation at any point during an ischemic insult results in synergistic [Ca2+]i 
increases which are σ receptor sensitive (Figure 5.3). First, ASIC1a channels are 
activated by ischemia alone (pH 7.4), which rapidly desensitize, but are able to 
be re-activated within less then 1 minute by application of an acidic external 
solution. This suggests that during pathophysiological conditions it is possible to 
get repeated activation of ASIC1a channels if the extracellular media is buffered 
back to normal pH for even a short refractory period. Consistent with this 
conclusion is the fact that lactate remains elevated and has been shown to 
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Figure 5.3 - Role of presynaptic ASIC1a channels during pathological conditions. 
The combination of ischemia and acidosis interact to produce greater glutamate 
release leading to a synergistic potentiation of postsynaptic [Ca2+]i elevations, 
resulting in Ca2+ overload, excitotoxicity and eventually cell death. Activation of 
σ-1 receptors prevents the synergistic interaction between ischemia and 
acidosis, and thus, Ca2+ overload. 
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rebound days after the initial ischemic event (Weinstein et al., 2004; Munoz 
Maniega et al., 2008). Even more dramatic though, was the observation that 
under ischemic conditions these repetitive activations of ASIC1a channels 
synergistically interact with ischemia to produce potentiated elevations in peak, 
steady state, rebound and net Ca2+ elevations in [Ca2+]i. These results suggest 
that in order to prevent the consequences of Ca2+ overload during ischemia it is 
critical to control ASIC1a activation. Equally important is the finding that all 
phases of these cellular responses are modulated by σ receptor activation. 
Consistent with these results, it has been suggested that the acidosis that occurs 
in vivo during ischemia exacerbates ischemic injury at later time points after the 
initial ischemic insult (Figure 5.3). The finding that ASIC1a activation interacts 
with ischemia to produce synergistic potentiation in Ca2+ dysregulation is a novel 
finding and suggests that this channel and σ receptors should be targeted even 
at delayed time points after stroke onset to prevent Ca2+ overload and the 
resulting neuronal apoptosis.  
The inhibition of ASIC1a by σ-1 receptors is a potentially important 
component of the neuroprotective properties of σ receptors, since activation of 
ASIC1a has been shown to contribute to stroke injury (Xiong et al., 2004). 
Moreover, σ-1 receptors inhibit [Ca2+]i increases following ASIC1a channel 
activation, ischemia-induced increases in [Ca2+]i as well as the synergistic 
potentiation of these increases observed during ischemia + acidosis insults 
(Figure 5.3). Importantly, inhibition of ASIC1a has been shown to be 
neuroprotective at delayed time points following ischemic stroke (Simon, 2006; 
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Pignataro et al., 2007). Because acidic conditions exist during ischemic 
episodes, σ-1 receptors should be targeted for development of treatments for 
stroke and other pathophysiological conditions where ASIC1a channel activation 
are involved. σ-1 receptor mediated inhibition of ASIC1a channels and Ca2+ 
channels (NMDA and AMPA/kainate receptors and VGCC) activated by 
membrane depolarizations produced by ASIC1a channel activation or metabolic 
inhibition and the ASIC1a channels themselves, may contribute to the enhanced 
neuronal survival observed following administration of σ receptor agonists 24 hr 
post-stroke in rats (Ajmo et al., 2006). All of these ion channels have been linked 
to ischemia-induced brain injury. Consistent with this pleiotropic effect of σ 
receptor activation on neurons, is our observation that σ-1 receptor activation 
suppresses extracellular high K+-induced increases in [Ca2+]i, which would also 
activate these downstream effectors. For these reasons, σ-1 receptors can be 
targeted for therapeutic intervention in pathophysiological conditions involving 
ASIC1a activation (like ischemia) and expand the therapeutic window of stroke 
treatment. 
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Appendix A – Pharmacological Compounds 
 
Drug Name Definition and 
Effective/ 
Inhibitory 
Concentrations
Mechanism of 
Action 
Reference 
Amiloride Nonspecific 
ASIC blocker 
(16 μM) 
Binds to residues 
within the 
channel’s pore 
region 
(Kleyman et 
al., 1999; 
Alvarez de la 
Rosa et al., 
2000; Xiong et 
al., 2004) 
Psalmotoxin1 
venom or synthetic 
peptide (PcTx1) 
Homomeric 
ASIC1a channel 
selective 
blocker (500 
ng/ml, 50 nM) 
Increases the 
affinity of the 
channel by H+ 
resulting in 
chromic 
desensitization of 
the channel 
(Escoubas et 
al., 2000; 
Chen et al., 
2005; Diochot 
et al., 2007) 
1,3-di-o-tolyl-
guanidine (DTG) 
Pan-selective 
sigma receptor 
agonist (100 
μM, 65 μM) 
Binds both sigma 
receptor subtypes 
(Klette et al., 
1995; Soriani 
et al., 1998; 
Kume et al., 
2002; Zhang 
and Cuevas, 
2002; Zhang 
and Cuevas, 
2005; Katnik 
et al., 2006) 
Carbetapentane 
citrate (CBP) 
Sigma-1 
selective 
agonist (14  μM, 
38 μM) 
Binds sigma-1 
receptors with 
>50-fold greater 
affinity than for 
sigma-2 receptors
(Rothman et 
al., 1991; 
Thurgur and 
Church, 1998; 
Vilner and 
Bowen, 2000; 
Katnik et al., 
2006) 
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Appendix A: (Continued) 
 
Opipramol Pan-selective 
sigma receptor 
agonist (10 μM) 
Binds both sigma 
receptor subtypes 
(Muller and 
Siebert, 1998; 
Volz et al., 
2000; Moller 
et al., 2001; 
Holoubek and 
Muller, 2003; 
Muller et al., 
2004; Volz 
and Stoll, 
2004) 
Dextromethorphan 
hydrobromide 
(DEX) 
Sigma-1 
selective ligand 
(30  μM) 
Binds sigma-1 
receptors with 
>100-fold greater 
affinity than for 
sigma-2 receptors
(Anderson and 
Andrew, 2002)
 
2-(4-
Morpholinethyl) 1-
phenylcyclohexane
carboxylate 
hydrochloride (Pre-
084) 
 
Sigma-1 
selective ligand 
(10 μM) 
 
Binds sigma-1 
receptors with 
>100-fold greater 
affinity than for 
sigma-2 receptors
 
(Bucolo et al., 
2006) 
Ibogaine  Sigma-2 
selective 
agonist (31 μM) 
Binds sigma-2 
receptors with 
>40-fold greater 
affinity than for 
sigma-1 receptors
(Vilner and 
Bowen, 2000; 
Zhang and 
Cuevas, 2002)
1-Cyclohexyl-4-(3-
(5-methoxy-
1,2,3,4-
tetrahydronaphthal
en-1-yl)-n-
propyl)piperazine 
dihydrochloride 
(PB28) 
Sigma-2 
selective 
agonist (2 μM) 
Potent sigma-2 
receptors agonist  
(Berardi et al., 
2004; 
Cassano et 
al., 2006) 
Metaphit (MET) Irreversible pan-
selective sigma 
antagonist (50 
μM) 
Inhibits both 
sigma receptor 
subtypes 
(Zhang and 
Cuevas, 2002; 
Wu, 2003; 
Zhang and 
Cuevas, 2005; 
Katnik et al., 
2006) 
 207 
 
Appendix A: (Continued) 
 
1-[2-(3,4-
dichlorophenyl)eth
yl]-4-
methylpiperazine 
dihydrochloride 
(BD1063) 
Sigma-1 
selective 
receptor 
antagonist (10 
nM, 1 μM) 
Binds sigma-1 
receptors with 
greater affinity 
than for sigma-2 
receptors 
(Matsumoto et 
al., 1995; 
Hamabe et al., 
2000; Nguyen 
et al., 2005) 
Thapsigargin 
(THAP) 
Depletes the 
ryanodine and 
IP3 sensitive 
stores (10 μM, 
20 μM) 
Blocks the 
sarcoplasmic/ 
endoplasmic 
reticulum Ca2+-
ATPase 
(DeHaven and 
Cuevas, 2004; 
Katnik et al., 
2006) 
Tetrodotoxin (TTX) Inhibits voltage-
gated Na+ 
channels (200 
nM, 400 nM) 
Blocks action 
potentials by 
binding to the 
pores of the 
voltage-gated Na+ 
channels 
(DeHaven and 
Cuevas, 2004; 
Katnik et al., 
2006) 
D-2-Amino-5-
phosphonovaleric 
acid (AP5) 
Selective NMDA 
receptors 
antagonist (100 
μM) 
Competitively 
inhibits NMDA 
receptors active 
site 
(Morris, 1989; 
Steele and 
Morris, 1999; 
MacGregor et 
al., 2003; 
Katnik et al., 
2006) 
1,4-Dihydro-2,6-
dimethyl-4-(2-
nitrophenyl)-3,5-
pyridinedicarboxyli
c acid dimethyl 
ester (Nifedipine) 
Dihydropyridine 
calcium channel 
blocker (5 μM, 
10 μM) 
L-type voltage-
gated Ca2+ 
channel blocker 
(Kim et al., 
2008; Tu et 
al., 2009) 
Cadmium Broad spectrum  
Ca2+ channel 
blocker (100 
μM, 1 mM) 
Inhibits Ca2+ 
channels 
(Ryan et al., 
2007; 
Staruschenko 
et al., 2007) 
6-Cyano-7-
nitroquinoxaline-
2,3-dione (CNQX) 
AMPA/kainate 
receptor 
antagonist (10 
μM) 
Competitively 
blocks AMPA and 
kainate receptors 
(MacGregor et 
al., 2003; 
Marino et al., 
2007) 
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Appendix A: (Continued) 
 
FK-506 Calcineurin 
inhibitor (1 μM, 
10 μM) 
Forms 
immunophilin 
complex with 
FKBP to bind 
calcineurin and 
competitively 
inhibit its activity 
by blocking the 
catalytic groove 
(Dumont, 
2000; 
Martinez-
Martinez and 
Redondo, 
2004; Chai et 
al., 2007) 
CyclosporinA Calcineurin 
inhibitor (1 μM , 
30 μM) 
Forms 
immunophilin 
complex with 
cyclophilinA to 
bind calcineurin 
and competitively 
inhibit its activity 
by blocking the 
catalytic groove 
(Martinez-
Martinez and 
Redondo, 
2004; Chai et 
al., 2007) 
Pertussis toxin 
(PTX) 
Inhibits G 
protein 
activation (100 
ng/ml, 200 
ng/ml) 
Catalyzes the 
ADP-ribosylation 
of the α subunits 
of Gi/Go, 
preventing the G 
protein 
heterotrimers 
from interacting 
with receptors 
 
(Locht and 
Antoine, 1995; 
Jajoo et al., 
2008) 
N-methyl-D-
aspartate (NMDA) 
NMDA receptor 
agonist (10 μM) 
Selectively 
activates NMDA 
receptors and not 
other glutamate 
receptors 
(Gomez et al., 
2002; Watkins 
and Jane, 
2006) 
Latrunculin A Disrupts the 
actin 
cytoskeleton (5 
μM) 
Disrupts the actin 
cytoskeleton, 
resulting in 
AKAP150 
dissociation from 
plasma 
membrane  
 
(Allison et al., 
1998; Sattler 
et al., 2000; 
Zhou et al., 
2001; Popp 
and Dertien, 
2008) 
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Appendix A: (Continued) 
 
VIVIT Inhibits 
calcineurin 
AKAP150 
interaction (1 
μM, 10 μM) 
Inhibits 
calcineurin/AKAP
150 interaction by 
disrupting 
calcineurin 
binding to a 
PxIxIT-docking 
motif in AKAP150 
 
(Oliveria et al., 
2007; 
Pereverzev et 
al., 2008) 
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